Structural analysis of single amino acid polymorphisms by Baresic, A.
UNIVERSITY COLLEGE LONDON
UCL Research Department of Structural and Molecular Biology
Structural analysis of
single amino acid polymorphisms
Anja Baresˇic´
A dissertation submitted to University College London
for the degree of Doctor of Philosophy
Declaration
I, Anja Baresˇic´, confirm that the work presented in this thesis is my own. Where in-
formation has been derived from other sources, I confirm that this has been indicated
in the thesis.
Anja Baresˇic´
September, 2011
2
Abstract
Understanding genetic variation is the basis for prevention and diagnosis of inherited
disease. In the ‘next generation sequencing’ era with rapidly accumulating variation
data, the focus has shifted from population-level analyses to individuals. This the-
sis is centred on the problem of gathering, storing and analysing mutation data to
understand and predict the effects single amino acid mutations will have on protein
structure and function. I present analysis of a subset of mutations and a new pre-
dictive method implemented to expand the coverage of the structural effects by our
pipeline.
I characterised a subset of pathogenic mutations: ‘compensated pathogenic devia-
tions’. These are mutations which cause disease in humans, but the mutant residues
are found as native residues in other species. During evolution, they are presumed
to spread through populations by coevolving with another, neutralising mutation.
When compared with uncompensated mutations, they often cause milder structural
disruptions, prefer less conserved structural environments and are often found on the
protein surface.
I describe the development of a new analysis to test the effects of mutations by
predicting residues involved in protein-protein interfaces where the structure of the
complex is unknown. Two machine learning methods (multilayer perceptrons and, in
particular, random forests) show an improvement over previously published protein-
protein interface predictors. This new method further increases the ability of the
3
4SAAPdb analysis pipeline to show the effects of mutations on protein structure and
function. Furthermore, it is a template for building prediction-based structural anal-
ysis methods for the pipeline, where available structural data are insufficient.
In summary this thesis examines mutations from both an evolutionary and a disease
perspective. In addition, a novel method for predicting protein interaction regions is
developed thus expanding the existing pipeline and furthering our ability to under-
stand mutations and use them in a predictive context.
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1.1 Mutations
Mutation (lat. mutare = change) in biology denotes any change in the genetic ma-
terial of an individual, ranging from single nucleotide changes to the gain or loss of
entire chromosomes. Mutations are what makes each of us unique in terms of our
genetic information. However, what we observe in everyday life, rather than the ge-
netic code itself, is the effect each mutation has on the phenotype of an individual:
deleterious mutations cause disease or, in extreme cases, may be lethal; neutral mu-
tations will not display any obvious changes at the level of the phenotype; beneficial
ones improve the fitness of an individual1.
Traditionally, mutations in humans are described using their phenotypic effect and,
where available, linking it to the location in the genome. However, in order prop-
erly to understand how a genetic modification causes the observed novel phenotype,
we need to understand which changes occurred at both the DNA level (change in
nucleotide sequence, mRNA stability, gene expression regulation, etc.) and the pro-
tein level, i.e. how that mutation affects protein sequence, structure and function.
The effect of mutations on the protein structure has been addressed by the SAAPdb
project (Hurst et al., 2008): an attempt to gather publicly available mutation data
on a regular basis, and automatically assign likely effects of these mutations to the
protein structures (SAAPdb is introduced in Section 2.1.7). Before going into more
specific details on my contribution to the SAAPdb project, this section introduces
the basic biological background on various types of mutations, concluding with a
short survey of available mutation effect prediction tools.
1this improvement is always measured with respect to present environmental conditions
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1.1.1 Deoxyribonucleic acid as the carrier of the genetic informa-
tion
For the majority of living organisms, the molecule carrying the genetic code is de-
oxyribonucleic acid, DNA, often termed the ‘blueprint of life’ (Berg et al., 2006,
p. 3). The building block of DNA is a nucleotide, consisting of a monosaccharide (2-
deoxyribose), a phosphate and a nucleobase: adenosine (A), cytosine (C), guanine(G)
or thymine (T); the structure is presented in Figure 1.1. DNA is structured as a dou-
ble helix stabilised by the ladder-like stacked hydrogen bonds between adenosine
and thymine (creating two hydrogen bonds) or guanine and cytosine (creating three
hydrogen bonds). These pairs are referred to as complimentary base pairs.
Figure 1.1: Structure of the double-stranded DNA and base pairing schema.
Figure obtained from http://en.wikipedia.org/wiki/DNA under Creative
Commons license.
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1.1.2 Variability in the human genome
The human genome has approximately 3.16 billion base pairs, coding for 20000 −
25000 proteins (International Human Genome Sequencing Consortium, 2004). Vari-
ations among individuals can occur on various scales: from single base pair differences
(also termed point mutations), insertions/deletions of several-nucleotide-long frag-
ments of DNA, loss of entire genes, to large-scale modifications, such as the loss or
rearrangement of entire chromosomes. On average, two humans differ in ∼ 3.5 million
base pairs and ∼ 61000 small insertions/deletions, as well as ∼ 6000 copy number
variations2 (Pelak et al., 2010; Moore et al., 2011).
Considering where mutations can appear in terms of cell types, somatic and germline
mutations are differentiated. Germline mutations occur in the germ cells, a cell
lineage ultimately producing mature gametes (i.e. sperm and egg cells) in animals. A
mutation anywhere in that lineage will result in the transfer of the mutated genotype
to the offspring. At the same time, this genetic change will not affect the parent’s
phenotype. However, in the next generation it will become incorporated in all cells of
the offspring. In contrast, somatic mutations occur in any cells that do not belong
to the germ cell lineage. These mutations are not passed down to the offspring,
however the mutation can spread through the organism in which it has appeared
(displaying selection on the level of cells within a single individual), provided the
mutation-containing cell is undergoing duplication. Thus the somatic cell and all cells
originating from it, will display the altered phenotype, provided there is one.
There is a whole range of effects these genetic aberrations can have on the
phenotype of an individual. Ideally, fitness effects should be measured on a
continuous scale. However in practice mutations are usually classified into
three groups, based on the fitness change: (i) beneficial mutations increase
the fitness of an individual, (ii) neutral ones lack a visible effect on the fitness,
2the latter was claimed by the authors to be an overestimate, but no similar studies are currently
available with a more reliable estimate
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and (iii) deleterious mutations (also termed pathogenic) lower the overall
fitness.
Not all changes are inherited in a Mendelian manner. So-called ‘high-penetrance’
mutations will cause a visible phenotypic change (irrespective of the magnitude of this
change), and these variations can be discussed in terms of Mendelian inheritance. On
the other hand, sometimes the same change in the genomic sequence will cause altered
phenotype in some individuals, and no visible change in others – these are termed
‘low-penetrance’ mutations, and they form a continuum between phenotypically silent
and high penetrance disease-associated mutations. Often low-penetrance phenotypes
are expressed as a result of interactions between two or more mutations, or as a result
of interactions with environmental factors.
Biomedical research (and incentives originating from the pharmaceutical industry)
predominantly revolves around human disease and how to improve quality of life.
Reflecting this, most of the studies available on human genetic variations present
data on pathogenic and neutral mutations (rarely presenting beneficial mutations);
the most relevant ones will be introduced in Section 1.1.4. This thesis builds on
publicly available mutation data sources, and as such will mostly discuss changes in
humans resulting in disease-associated phenotypes, or not affecting the phenotype at
all.
1.1.2.1 A single nucleotide polymorphism: the simplest mutation
Strictly a single nucleotide polymorphism (SNP) is defined as an allelic variant where
the least frequent allele occurs in at least 1% of a ‘normal’ population (The Inter-
national Hapmap Consortium, 2005). In other words it is a beneficial, neutral, or
low-penetrance mutation. However, the term is widely used simply to mean any
single-base nucleotide substitution. Indeed, the main repository of point mutations
in human and other genomes (dbSNP) refers to SNPs in this context.
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Figure 1.2: Hierarchy of SNP mutations and their effects.
SNP can be non-coding (ncSNP) or coding (cSNP). cSNPs can be synonymous
(sSNPs), nonsense (nSNPs), or non-synonymous (nsSNPs). nsSNPs result in a
single amino acid polymorphism (SAAP) at the protein level. These can be phe-
notypically silent (sSAAP), low penetrance (lpSAAP), or high penetrance dele-
terious mutations (DMs) also known as disease-associated mutations (DAMs).
A DAM can be compensated in another species (a compensated pathogenic
deviation, CPD) or un-compensated (a pathogenic deviation, PD). Figure and
(adjusted) caption text obtained from Baresˇic´ and Martin (2011).
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Various outcomes of this simplest mutation event are presented in Figure 1.2. When
a SNP occurs in non-coding regions of the DNA (ncSNP), although it will not
directly affect the sequence of protein during translation, it can still affect regula-
tory regions (i.e. transcription factor binding sites) thus affecting expression, or may
change mRNA splice sites. A SNP within the coding exons (cSNP), can have three
outcomes regarding the protein sequence: (i) a synonymous SNP (sSNP) is a mu-
tation where the modified codon in which the mutated nucleotide occurs encodes for
the same amino acid as the native codon, e.g. TTG→CTG will not change the pro-
tein sequence as both codons code for leucine (see Figure 1.3). While an sSNP will
not change the encoded protein sequence, it may still affect expression or splicing.
(ii) A nonsense SNP (nSNP) is a change from an amino-acid-producing codon to
a stop codon. This results in premature termination of translation yielding a trun-
cated, often non-functional protein product. (iii) A non-synonymous SNP (nsSNP)
is a change where the mutated codon is translated to a different amino acid type
compared with the native codon. This results in a single amino acid change (also
termed a ‘single amino acid polymorphism’, SAAP) in the protein. For example,
TTG→TTC will change a native leucine to a mutant phenylalanine (Figure 1.3),
potentially affecting protein folding, stability, or function.
The term ‘SNP’ is also often used to refer to a SAAP with no phenotypic effect (or
with low penetrance), in contrast to a Mendelianly inherited deleterious ‘Disease As-
sociated Mutation’ (DAM). Types of SAAPs are introduced in Section 1.1.3. Unless
otherwise stated, the term SNP will hereafter correspond to a missense mutation (at
the DNA or protein level) lacking a documented pathogenic effect, thus presumed to
be phenotypically neutral, or having very low penetrance.
1.1.3 Point mutations at the protein level
This thesis analyses only nsSNPs; to be more precise, the focus is on SAAPs as
the project revolves around protein structures and the effects of mutations at the
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Figure 1.3: DNA codon table (read from the center outwards).
∗ stands for the start codon, and † denote three stop codons. Figure (originally with
RNA codons) created by Florian Hollandt and obtained from http://www.texample.
net/tikz/examples/rna-codons-table/.
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structural level, presented in the lower rectangle of Figure 1.2. As mentioned above
a SAAP is the protein manifestation of an nsSNP, also termed a missense muta-
tion. Hereafter, a SAAP will be defined as any single amino acid change using a
unique combination of four values as shown in Figure 1.4. For example, consider the
OMIM:107300.0031 entry3: a mutation of wild-type serine, the 323rd residue in the
sequence of the human antithrombin-III protein (UniProtKB/Swiss-Prot accession
number P01008), to proline caused by a single base change of TCN→CCN (where N
stands for any nucleotide type). This is defined as (P01008:S:323:P).
Figure 1.4: An example of a single amino acid polymorphism annotation.
Each mutation is a unique combination of: (i) UniProtKB/Swiss-Prot pri-
mary accession number of a protein in which the mutation occurs (for def-
inition, see Section 2.1.3), (ii) the amino acid type found native in disease-
unaffected individuals, (iii) residue position in protein sequences, as reported
by the UniProtKB/Swiss-Prot, and (iv) the amino acid type found in the mu-
tated genotype.
In practice, publicly available data consist of (i) neutral mutations (sSAAPs from
Figure 1.2, henceforth termed SNPs), deposited for example in dbSNP (Sherry et
al., 2001); mildly pathogenic and beneficial ones (lpSAAPs found also in dbSNP,
often first listed as neutral and then corrected), and disease-associated SAAPs (high-
penetrance deleterious mutations, termed DAMs, or DMs), stored in OMIM (Am-
berger et al., 2009) and locus-specific mutation databases (LSMDBs). For a list of
LSMDBs used in SAAPdb, see Table 2.1.
In simplified terms, for a protein to keep its fitness constant, it needs to maintain
functional and structural integrity. A function-affecting SAAP may cause (i) a loss-of-
function, or (ii) a gain-of-function. Loss-of-function mutations are often inherited in
recessive way: if the individual is heterozygous, he/she will display reduced function,
3http://omim.org/entry/107300
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while the homozygous individuals carrying two copies of the mutation fully lack the
functionality performed by that protein. Three examples of loss-of-function SAAPs
will be introduced in more detail in Section 3.1.2. In contrast, a gain-of-function
mutation is inherited in a dominant manner: the mutated individual displays a novel
(often detrimental) phenotype. In case of the Lys183→Arg mutation found in human
thyrotropin receptor results in its hypersensitivity to human chorionic gonadotropin,
resulting in hereditary gestational hyperthyroidism (Rodien et al., 1998).
Proteins consist of 20 standard amino acids. When compared with the choice of only
4 nucleotides, it is obvious that the protein world offers a significantly greater variety
of possible structural combinations. In that respect, identifying the exact structural
change caused by a SAAP, and linking it to the observed phenotype is a challenge,
addressed by many groups (for more details on available pathogenicity-predicting
tools, see Section 1.2.3). Structural features of a protein can be summarised in its
ability to fold properly into an active form, to stay in that form (its stability) and
its ability to perform some function. Several folding- and stability-impairing SAAP
types will be introduced in Section 2.1.7.
In short, SAAPs preventing correct folding, result in an unstructured protein suscep-
tible to protein degradation. Furthermore, most proteins have a surprisingly narrow
range of thermodynamic stability between −3 and −10 kcal/mol (DePristo et al.,
2005). Should a SAAP cause a drop in stability below these values, the protein will
unfold; while an increase in stability usually reduces the responsiveness of the pro-
tein to cell signalling and the loss of activity (DePristo et al., 2005). Additionally,
often the change of stability results in increased propensity for protein aggregation.
Considering that each SAAP leads to a ∆∆G of 0.5− 5 kcal/mol, it is not surprising
that the majority of SAAPs destabilise the protein and are thus pathogenic.
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1.1.4 Cataloguing human mutation data
With the rapid expansion of known genomic sequence space as a result of improved
sequencing technologies, the last decade has seen as emergence of numerous databases
containing information on human variations, accumulating various types of (mostly)
single nucleotide or amino acid variations, and providing additional structural, evo-
lutionary or functional context.
The first major attempt to gather human SNP data (defined as genetic variation
occurring in at least 1% of human population) and identify patterns of commonly
co-inherited mutations (termed haplotypes) was started in 2002 by research groups
in six countries forming the International HapMap Consortium. The International
HapMap Project4 (HapMap stands for ‘haplotype mapping’) focused on identi-
fying novel SNPs, their frequencies and correlations, grouping correlated mutations
into haplotypes, and identifying which SNPs could be used for haplotype identifi-
cation (The International Hapmap Consortium, 2003). Ultimately these haplotypes
would be tested for correlation with the common diseases, with the aim of iden-
tifying combinations of low-penetrance SNPs (in combination with environmental
factors), causative of and/or indicative of complex diseases in humans. Phase three
of this project, finished in 2010, has surveyed 1.6 million common SNPs (deposited in
dbSNP, a resource to be introduced in Section 2.1.6.2) in genomes obtained from 1184
individuals from 11 different populations (The International Hapmap 3 Consortium,
2010).
The central project developing methodology, establishing strategies and standards for
the comparison of full genomic sequences from various humans and finally, providing
an exhaustive list of human variations to the public, is the 1000 Genomes Project5.
Taking advantage of a drop in prices (and time requirement) for sequencing after the
introduction of next-generation sequencers in 2005 (Metzker, 2010), this project aims
4http://hapmap.ncbi.nlm.nih.gov/
5http://www.1000genomes.org/
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to provide 95% of SNPs occurring in humans (defined as single nucleotide variations
with a minimum of 1% frequency in normal population).
In the pilot phase of the project (The 1000 Genomes Project Consortium, 2010),
three sub-projects were performed: (i) low-coverage6 whole-genome sequencing of
179 individuals from four populations (assessing how to compare genomes of dif-
ferent individuals) identified 14.4 million SNPs, 1.3 million short indels and 20000
structural variants, (ii) deep-sequencing of two mother-father-daughter trios using
different research facilities and sequencing platforms (tests comparability of different
genomic sequence sources) yielded 5.9 million reported SNPs, 650000 short indels and
14000 structural variants, and (iii) exon-sequencing of 697 individuals from seven lo-
cations, covering exons of 907 randomly chosen genes. Finally the goal of this project
is to provide an extensive dataset of human SNPs by sequencing 2500 human genomes
from 25 populations in total at 4x coverage, aiming to have finished by the end of
2011. For more details on databases of mutations, see Sections 1.2.3 and 2.1.6.
1.2 Protein structure
1.2.1 The four levels of protein structure
Protein structure is defined on four levels (Berg et al., 2006), presented in Fig-
ure 1.5.
Primary protein structure will hereafter be termed protein sequence, and will be
treated as a string with each letter coming from an alphabet of 20 standard amino
acids. The secondary structure will be considered as either one of its two ma-
jor structured components (the α-helix and the β-strand), or as a third option a
non-α, non-β alternative termed ‘coil’. The key features of tertiary structure – its
6coverage refers to the average number of times each sequence position gets sequenced, e.g. 20x
coverage means each residue is present in approximately 20 sequenced segments
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Figure 1.5: The protein structure hierarchy.
Figure obtained from http://en.wikipedia.org/wiki/File:Main_protein_
structure_levels_en.svg under Creative Commons license.
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stabilising elements (hydrogen bonds, pairing of charged residues, electrostatic inter-
actions and disulphide bonds and its core-and-surface topology) will be introduced in
Section 2.1.7. Most attention will be allocated to the quaternary structure: in par-
ticular the difference between the minimal repeating unit in the crystallised protein
termed the ‘asymmetric unit’, and the molecular assembly observed in vivo, called
the ‘biological unit’.
Quaternary structure refers to the number and orientation of chains in the biological
unit. If there is only one chain in the biological unit, the protein is a monomer,
otherwise we refer to it as a protein complex. If a complex contains all identical
chains, it is termed a homomeric complex, whereas if it consists of different protein
chains it is referred to as a heteromeric complex. Further, based on the number of
chains in the biological unit, a complex can be a dimer, a trimer, a tetramer, etc.,
up to multimeric structures with several dozens of chains (usually viral capsids).
Figure 1.6 presents examples of several types of quaternary structures.
1.2.2 Obtaining three-dimensional structures of proteins
1.2.2.1 X-ray crystallography
X-ray crystallography is the predominant method for obtaining high quality three-
dimensional structures of proteins. The idea of purifying proteins into crystals in
order to observe diffraction patterns of X-rays after passing through these crystals
originated at the beginning of the last century (Bragg, 1913). The principle behind
this molecular imaging technique, shown in Figure 1.7, is simple: electromagnetic
waves, once emitted onto the sample, get diffracted in a specific manner depen-
dent on the positioning of electrons in a molecule7. The results of diffraction are
then recorded and after applying Fourier transformations to these data, the electron
7only proteins are considered here as targets for structure elucidation, although this method
is successfully used for smaller compounds, and other macromolecules (fragments of DNA, whole
viruses, etc.)
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Figure 1.6: Examples of biological assemblies of proteins, one colour used for each chain.
(A) A homodimer: triosephosphate isomerase from S. cerevisiae (PDB ID:
2YPI). (B) A homotrimer: human tumour necrosis factor-alpha (PDB ID:
1TNF). (C) A heterodimer: Bni1p Formin Homology 2 Domain from S. cere-
visiae in a complex with ATP-actin from O. cuniculus (PDB ID: 1Y64). (D) A
heterotrimer: human von Willebrand factor in a complex with botrocetin from
B. jararaca (PDB ID: 1IJK). (E) A tetramer: human deoxyhaemoglobin (2
α and 2 β chains) (PDB ID: 2HHB). (F) A hexamer: human transthyretin
and retinol-binding protein from G. gallus (PDB ID: 1RLB). All images were
obtained from http://proteopedia.org/wiki/index.php/Main_Page.
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Figure 1.7: X-ray crystallography methodology schema.
Figure obtained from http://en.wikipedia.org/wiki/File:X_ray_
diffraction.png under Creative Commons licence.
CHAPTER 1. INTRODUCTION 36
density maps of the crystallised molecule are obtained. However, phase information
is lost in the collection of the diffraction pattern as only intensities are recorded,
creating the so-called ‘phase problem’, which is addressed below. Modelling using
chemical restrictions (the experimenter has some prior knowledge about the investi-
gated molecule, e.g. the primary structure of the protein) will then result in obtaining
the three-dimensional layout of the atoms from the electron density map.
The procedure for obtaining the protein structure using X-ray crystallography can
be divided into three steps:
Obtaining the crystal is necessary because the diffraction signal of a single
molecule is very weak: periodically repeating structures will yield signal ampli-
fication by wave interactions sufficient for detection above the noise level. This
step is still considered to be the main limiting factor in the success of crystal-
lography. The general rule is that the required sample crystal has to have a
minimum size of 0.1 mm in all three dimensions, with a minimal amount of
chemical impurities8 and structural anomalies. For more details on theoretical
minimal crystal size, and discussion in the context of other technical parameters
see Holton and Frankel (2010) and references therein.
Recording diffraction outputs while varying the angle between the X-ray and
the sample (typically over the range of slightly more than 180◦) results in a two-
dimensional image of dots representing diffraction maxima for each measured
angle. Each diffraction maximum is a result of interacting waves in the same
phase, so the intensity of the dot is a function of the wave’s amplitude. Waves
of opposite phase cancel each other out, and this signal is lost.
Processing diffraction patterns includes Fourier transformation and solving the
phase problem, followed by fitting. Fourier transformations are used to obtain
electron density maps from diffraction patterns, provided the amplitude and the
8desired sample purity is 90%, ideally over 98%
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phase of the wave are known. While the amplitude is obtained from the dot
intensity, calculating the phase is not a trivial procedure. The ‘phase problem’
is solved by methods such as multiple isomorphous replacement, molecular
replacement, or multi-wavelength anomalous dispersion to recover the phases
(Hendrickson and Ogata, 1997, and references therein). The vast majority of
proteins will not be fully rigid in the crystal: there will be flexible regions
resulting in small differences between repeating units within the crystal. These
inconsistencies ultimately result in noise in the diffraction patterns, and the
experimenter usually fits a model by adding information on the protein sequence
or other structural restraints in order to obtain the missing structural data.
One limitation of diffraction is resolution: the minimal separation observable from
the diffraction pattern is dependent on (and approximately equal to) the wavelength
of the electromagnetic source used for the diffraction. X-rays are used because their
wavelengths are in the range of 0.5 − 4A˚, similar to the distances observed when
studying covalent bonds and atomic radii. Another indication of the quality of the
structure is the R-factor. It measures how different the theoretical diffraction pattern
of the modelled structure is from the pattern obtained experimentally. The R-factor
can range from 0.00 (perfect match) to 0.63 (set of random atoms). The general
threshold for a reliable structure is R < 0.20 (Morris et al., 1992). Evaluating
modelled structures by the R-factor may result in overfitting, so a crystal structure
has another value associated with it, Rfree (Bru¨nger, 1992); in each refinement step,
90% of the atomic model is used for the improvement, and the remaining 10% are
used to evaluate the improvement in this step. The advantages of Rfree over R have
been discussed in detail by Kleywegt and Jones (1997).
Once a novel protein structure (or an improvement over a previously submitted struc-
ture in terms of resolution or R-factor) is obtained, it is submitted to a central repos-
itory: the Protein Data Bank (Berman et al., 2000), which will be introduced in
Section 2.1.1. Typically, an entry refers to a single crystallographic experiment and
it contains details of the experimental conditions, modelling procedures, information
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about the protein sequence, chains and their length, ligands and finally, the coordi-
nates of the atoms.
It is worth noting that crystal packing is not a spontaneous event for most proteins
(under physiological conditions), and the assemblies reported in the PDB do not al-
ways present chain number, orientation and interchain contacts that reflect in vivo
structures. Therefore, the so called asymmetric unit, observed in the crystal pre-
pared for the structure-solving experiment does not necessarily reflect the biological
unit (the biologically-active form of the protein also termed the quaternary struc-
ture, see Section 1.2.1). This distinction should be considered whenever PDB data
are used as models for the biologically-active conformations, as further discussed in
the context of protein-protein interfaces in Section 4.2.1.1.
1.2.2.2 Nuclear magnetic resonance spectroscopy
The main alternative method to X-ray crystallography used to determine the struc-
tural details of proteins is nuclear magnetic resonance spectroscopy, NMR. In
short, NMR relies on the different response of atoms in a sample (based on the spin
properties of atomic nuclei) to exposure to a magnetic field (Rabi et al., 1938). The
sample in a solution is exposed to radio-frequency pulses: magnetic nuclei absorb
some of the energy from the pulse and start resonating at a specific frequency. The
radio waves which they give off as they relax reveal information about the chemical
environment surrounding that nucleus.
These two methods of elucidating protein structures have significantly different ap-
proaches, methodological advantages and pitfalls, and thus are often used in combi-
nation for the full picture of the three-dimensional structure. NMR gives a better
picture of the molecular dynamics, as the crystallographic sample is immobilized in
the crystal lattice, occasionally not in the native state of the examined protein. On
the other hand, NMR can only process relatively small, water-soluble compounds,
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whereas X-ray crystallography can solve any structure, provided a crystal of the
appropriate size and purity can be obtained. Discussion of the advantages of one
method over the other (mostly in terms of validity as templates for computational
protein design) is further covered by Schneider et al. (2009), and references therein.
On average, available crystal structures provide structural information in higher res-
olution, a single structure per file, and because of the inferred information in NMR
structure files, this experimental method is unsuitable for determination of hydrogen
bonds and other detailed information. Therefore, only structures obtained by X-ray
crystallography are considered hereafter in this thesis.
1.2.3 Effects of mutations on protein structure
After mutation data became abundant in public databases, several groups turned
to developing tools that would automatically calculate properties of these muta-
tions, in particular, trying to predict the effect the mutation has on the phenotype.
Databases of pathogenic and neutral mutations will be described in Section 2.1.6.1
and Section 2.1.6.2, respectively. If information on the phenotypic effect is unknown
(owing to the lack of experimental or clinical data) or not specified, several tools set
out to predict whether a mutation is detrimental or not; these predictors are briefly
introduced in Section 1.2.3.1. However, in order for the prediction to be successful,
information had to be accumulated on the features distinguishing deleterious from
neutral mutations; several tools and algorithms that provide large-scale analyses of
SNPs (nsSNPs or SAAPs, in particular) are introduced in Table 1.1.
TopoSNP (Stitziel et al., 2004) and ModSNP (Yip et al., 2004) focused primarily on
positioning mutations onto the, usually native, protein structure, where one was avail-
able (in case of TopoSNP), or on a modelled structure (ModSNP). It is worth men-
tioning here that any properties obtained from modelled protein structures are not
experimentally-verified, and should be avoided when structural properties of SAAPs
are used for pathogenicity prediction.
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StSNP (Uzun et al., 2007) and SNPeffect (Reumers et al., 2006) use structural
information to calculate various properties of mutation’s position in the structure
(e.g. transmembrane regions, phosphorylation/glycosylation site, putative aggrega-
tion sites, etc.), or to characterise the nature of the substitution (e.g. secondary
structure-disrupting, introducing changes in solvent-accessibility, etc.).
Finally, a web-based tool currently providing the widest range of structural informa-
tion for a nsSNP (both pathogenic and neutral) is SAAPdb (Hurst et al., 2008),
described in detail in Section 2.1.7. In short, it maps a mutation to PDB struc-
ture(s) where available, and describes sequence conservation and a range of folding-,
function-, stability- and interface-impairing effects that the mutation may have on the
protein structure. On a dataset of 4319 DAMs and 2022 SNPs successfully mapped
to a position in at least one protein structure, Figure 1.8 displays the distribution of
pathogenic versus neutral SAAPs in terms of their effects on the protein structure.
In this study, Hurst et al. (2008) showed that disease-associated SAAPs display more
radical changes (in terms of volume change, native and mutated amino acid similar-
ity), more often affect conserved residues, and are preferentially found in the protein
core when compared with the neutral SAAPs.
1.2.3.1 Mutation pathogenicity prediction: currently available
tools
Clearly, the distinction between neutral and disease-related variations is interesting
as a diagnostic and preventive tool, and costly wet-lab studies can slowly be replaced
by in silico predictive tools.
In general, the predictive modelling process starts with gathering a list of mutations
with known pathogenicity level, i.e. a training dataset, and a list of features, pre-
sumably correlated with the level of pathogenicity. Some machine learning method
is then applied to build a classifier identifying the combination of feature values
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Figure 1.8: Structural effects of neutral and pathogenic SAAPs.
The results for DAMs and SNPs are shown in yellow and grey, respectively. ∗
denotes p < 0.05 and ∗∗ denotes p < 0.01, when χ2 test with Yates correction
is used to test different frequencies per category, in two mutation datasets. For
the category definitions, check Table 2.2, or the original publication. Figure
obtained from Hurst et al. (2008), with permission from the authors.
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which indicate ‘neutral’ or ‘disease-associated’ outcome for a mutation. Choosing
the appropriate training dataset is tricky: nsSNPs are abundant, but defined (in the
case of the dbSNP) only as a less frequent variant of the wild-type allele. In other
words, there is no guarantee that every nsSNP is phenotypically neutral: some can
be mildly detrimental (or beneficial) or of low penetrance, but this effect has not yet
been documented. In fact, some SNPs are initially reported as neutral variations,
only to appear later in OMIM; for an example see Hurst et al. (2008). In addition to
OMIM, DAMs are stored in various small LSMDBs in different formats, and while
these mutations are clearly pathogenic, getting sufficiently large (and representative)
datasets requires a lot of data mining and processing.
A list of the most successful publicly-available pathogenicity predictors is presented
in Table 1.2. A wide range of machine learning methods have been utilised: SVMs
(LS-SNP, SNPs3D, HybridMeth), neural networks (PMUT, SNAP), profile-based
scoring function (SIFT), random forest (nsSNP Analyzer), naive Bayesian classifier
(PolyPhen); it seems all these methods are equally appropriate for the task of SNP
pathogenicity prediction.
In terms of predictors, it is tempting to use only sequence-based information since
protein sequences are more abundant than structures and functional annotations. In-
deed several quite successful predictors have been built exclusively based on sequence
data: e.g. PolyPhen (Ramensky et al., 2002), SIFT (Ng and Henikoff, 2003), one im-
plementation of PMUT (Ferrer-Costa et al., 2005) and SNPs3D (Yue et al., 2006),
followed by HybridMeth (Capriotti et al., 2006) and SNAP (Bromberg and Rost,
2007). However, improved performance is obtained by adding structural information
such as solvent-accessibility and secondary structure elements (nsSNP Analyzer (Bao
et al., 2005)), thermodynamic stability (SNPs3D (Yue et al., 2006)), and functional
information, e.g. the pathways in which a protein is involved (LS-SNP (Karchin et
al., 2005)). Both Hybrid and SNAP showed improved accuracy and robustness once
structural information was added. Thusberg et al. (2010) have shown that although
the above mentioned methods all show reasonable accuracy, the outputs of different
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methods are not highly correlated, indicating that the attribute space has not been
sufficiently exploited, and there is still room for significant improvement in the field
of automated SNP pathogenicity prediction.
Furthermore, the aforementioned methods have focused so far on the prediction of
DAMs; the more interesting (and less trivial) problem to solve would be developing a
successful predictor of low penetrance mutations as many of the diseases unexplained
at present are caused by complex interactions between several low penetrance muta-
tions. Finally, these advances (in both DAM and lpSAAP prediction) would result in
classifiers precise enough to be used in clinical practice. At the moment, this practice
is not recommended (Kumar et al., 2009), rather, these tools should be considered
an experimental aid, i.e. to narrow down a list of potential disease-associated mu-
tation candidates. Nonetheless, with PolyPhen, SIFT is regularly used in clinical
diagnostics laboratories (Nick Lench, personal communication).
1.3 A list of aims
This thesis sets out to broaden the knowledge on single amino acid polymorphisms
and their structural features. In general, the work performed by Hurst et al. (2008) is
expanded in two directions: an analysis of a specific subset of SAAPs, followed by the
introduction of predicted interface structural effect, a novel category to be added
to the SAAPdb pipeline. More precisely, the work on compensated pathogenic
deviations in Chapter 3 analyses an evolutionary interesting subset of DAMs, com-
paring them to ‘background’ uncompensated DAMs. Next, analysis of features in
Chapter 4 and consequently prediction of the protein-protein interface residues
in Chapter 5 is a methodological refinement for SAAPdb: it will expand the space of
likely structural effects one can detect for a SAAP to include protein-protein inter-
faces in multichain complexes, when the structure of the complex is not solved.
Chapter 2
An Introduction to Tools and
Resources
This chapter presents resources, tools and algorithms used in the fol-
lowing chapters. Finally it provides an overview of statistical tests used
throughout this thesis.
46
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2.1 Data resources
This section covers basic databases and web-resources used in this thesis. It starts
with resources of protein structural data: the PDB and PQS (and an alternative for-
mat for these data – XMAS), followed by the main database of sequences: UniProt,
and the mapping between sequence and structure: PDBSWS. Next is a database
providing a carefully created dataset of functionally-equivalent homologous proteins
(FOSTA) and databases containing various mutation data: dbSNP, OMIM and
LSMDBs. Finally, SAAPdb is introduced, the centre point of all projects presented
in this thesis.
2.1.1 PDB
The Protein Data Bank1, PDB, is the central repository for structural data on
proteins and, contrary to its name, other macromolecules (Berman et al., 2000).
The PDB is a data bank, i.e. a set of individual files, each containing plain-text
information about a single experiment. Each entry can be divided into a header and
the atomic coordinates section: the header provides experimental details (authors,
methodology, experimental conditions, number of chains in the asymmetric unit,
ligand types and numbers, modelling procedure, etc.), and the body of the file has
coordinates for each observed atom (ATOM and HETATM entries for the macromolecule
and non-protein/nucleic acid atoms, respectively).
As of July 2011, the PDB contains 74428 structures, 93% of which are structures
of proteins, the remainder comprising nucleic acids and other molecules of interest.
In terms of experimental techniques used to obtain the structures, the majority of
PDB data (87%) was obtained by X-ray crystallography, 12% by NMR spectroscopy
(for introduction of these methods, see Section 1.2.2), and the remaining ∼ 1% of
structures by electron microscopy and other methods.
1http://www.rcsb.org/
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The PDB supplies pointers to the protein sequence data, providing cross-links to
UniProtKB/Swiss-Prot sequences in headers of some files. In order to expand this
sequence-structure mapping to all proteins for which sequence and structure are avail-
able, Andrew Martin has developed a tool called PDBSWS with improved coverage
over PDB’s sequence mapping (Martin, 2005). PDBSWS will be introduced in more
detail in Section 2.1.4.
2.1.1.1 PDB remediation
Processing PDB data is never a trivial task, owing to the data format either being
poorly defined in some aspects, or misused by authors submitting the structures.
Considering this is one of the most frequently accessed biochemical data resources2,
the issue of the PDB being inconsistent and on occasions erroneous, deserves to be
addressed here as the vast majority of the results presented in this thesis rely on
structural data originating from the PDB.
Since its creation, this resource has grown 10000 times, and recently it was in definite
need of a systematic update, both in terms of data format and deposited data clean-
up. Most of the issues were addressed in the 2007 PDB remediation project; to
list a few: (i) adjusting terminology to adhere to IUPAC nomenclature, (ii) giving
names to non-standard amino acid types, rather than having standard amino acid,
and HETATM entries with the same residue numbering, (iii) giving each ATOM a chain
identifier (all single chain entries now have chain ‘A’ rather than an empty string); for
the full list of changes, check Henrick et al. (2008). These recent major improvements
(another two smaller remediations were published in 2008 and 2011), along with
constant effort by the PDB’s curators, improved overall accuracy of structural data,
consequently reducing the fraction of data lost while analysing them using automated
pipelines.
2in 2009 on average, more than 7 files were downloaded from it every second, and in 2011 over
2000 other web sites linked to PDB pages (Bluhm et al., 2011)
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However, a number of inconsistencies and exceptions still exist among PDB data:
multiple atoms or and chains with the same coordinates (1C0I, 1GTV, respectively),
overlapping atoms causing steric clashes (8CHO), atoms listed to interact with them-
selves (1EH9), non-existing atom names (‘H2’ for hydrogen in 966C), residues num-
bered in the C′ to N′ direction (3SGA), to name but a few.
2.1.1.2 PDB data in XML-like format
While PDB files contain an abundance of structural data, consistency of which is
being constantly improved, there are several weaknesses to its flat file format. The
most important issue is the inability to add extra information at the level of protein
atoms. Some software utilise the columns used to store B-values or occupancies for
this purpose, but such programs cannot be run sequentially to add the results of
different analyses. There is a lot of higher-level information that can be calculated
from the raw experimental data stored in the PDB format, e.g. solvent-accessibility,
hydrogen bonds, secondary structure, interacting residues, etc. In large-scale analyses
like the SAAPdb pipeline and building a training set of protein-protein interfaces3, it
is computationally infeasible to re-calculate this information from scratch every time
it is required.
Transforming PDB data into an XML-like format would enable creating additional
data layers, where the additional information would be stored and easily accessed.
Exactly to that end a hybrid XML/ASN.1 format, XMAS, was developed by An-
drew Martin (Martin, personal communication). All PDB files are automatically
processed and data are added on hydrogen bonds (calculated according to the Baker
and Hubbard (1984) method), secondary structure elements (Kabsch and Sander
(1983)) and solvent-accessibility (according to Lee and Richards (1971)).
3to name just a few using thousands of PDB files in one run
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In 1999 when XMAS was created, the PDB team had already started introducing
their own XML-format for PDB files: PDBML (Westbrook et al., 2005). However,
even at present XMAS is considered superior since it structures the data in chains and
residues, whereas PDBML recognises only ATOM level entries (providing residues and
chain information for every atom), thus complicating data parsing. Finally, XMAS
was designed for leaf-heavy data (special attention was payed to minimisation of
markup for the leaves), enabling it to hugely reduce storage space.
2.1.2 PQS
While the PDB provides the tertiary structures of proteins, it is often misleading in
terms of quaternary structure information. As previously mentioned, the asymmetric
unit is the minimal unique unit in the protein crystal, however, it is not indicative of
the biological unit - the quaternary structure the protein as found in in vivo. Although
PDB files sometimes specify biological units provided by the experimentalists (in
headers), that information is scarce and often experimentally unverified.
Henrick and Thornton (1998) developed the Protein Quaternary Structure4 (PQS)
database, an automated system that builds biological units (BUs) from asymmetric
units (ASUs) provided in PDB files. In brief, every structure in the PDB obtained
by X-ray crystallography is separated into individual chains, thus removing crystal
contacts, and then the quaternary structure of the macromolecule is rebuilt. The
output PQS file is conveniently in PDB format, enabling easy parsing of PQS files
utilising various tools and scripts prepared for PDB data handling. When compared
to biological units provided in PDB files (for PDB files containing that information),
PQS corrects biological units for 18% of structures (Xu et al., 2006).
In spite of being the most widely used automated tool for quaternary structure pre-
diction, PQS is outperformed by PISA, Protein Interfaces, Surfaces and Assemblies5,
4http://www.ebi.ac.uk/pdbe/pqs/
5http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html
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developed by Krissinel and Henrick (2007). Based on thermodynamic stability cal-
culations, PISA predicts different biological units from PQS for 23% of structures,
often resulting in a smaller assembly than PQS. Although PISA shows more promis-
ing performance on the data on which it was trained, (90% of correctly predicted
quaternary structures compared with 77% for PQS), PQS was used throughout this
thesis for two reasons. First, PISA currently does not provide a bulk download of
predicted BUs for the whole PDB. Second, PISA is not appropriate for protein-ligand
interface studies, because it fixes positions of ligands as surface modifiers. While this
simplification does not affect the work presented here, it might become an issue if the
protein-protein interface prediction is expanded to protein-ligand interfaces.
The most reliable approach to quaternary structure prediction is to consider only
modelled biological units which were further verified through manual quaternary
structure curation, as is done by PiQSi6 (Levy, 2007). This community-based tool
confirms or dismisses PQS-determined quaternary structures, after consulting liter-
ature for evidence on the number of subunits, SwissProt annotation and/or PISA
annotation of close homologues. As of 2010, this initiative has tested ∼ 15000 PDB
structures, correcting 15% of sampled biological units. Furthermore, on a benchmark
set of 187 PQS entries, Levy (2007) showed that PiQSi detects and corrects biologi-
cal units in 34% of cases. Although these results display an obvious need to improve
and/or manually verify current automated methods, the gain in accuracy does not
justify the low coverage of only ∼ 25% of currently available PDB structures when
extensive coverage of protein quaternary structure space is required.
Consequently, the work in Chapters 4 and 5 resorts to PQS as the main source of
biological units. This method seemed to be a good compromise between reliability of
a model, and the coverage of structures in different protein families. However, future
updates of the work will have to switch to PISA, as PQS has been discontinued in
2010, and a switch to PISA is suggested.
6http://supfam.mrc-lmb.cam.ac.uk/elevy/piqsi/piqsi_home.cgi
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2.1.3 UniProtKB/Swiss-Prot
The Universal Protein Resource7 (UniProt, (The UniProt Consortium, 2009)) is
the most comprehensive, publicly accessible repository of protein sequence data. It
is currently divided into four databases: UniParc (archives of protein sequences),
UniRef (clustered sequences for faster searches), UniMES (database of metagenomic
data) and UniProtKB (core database of annotated protein sequences). The UniProt
Knowledgebase, UniProtKB, consists of automatically retrieved, unprocessed se-
quences in UniProtKB/TrEMBL and a smaller database of manually-curated,
non-redundant sequences termed UniProtKB/Swiss-Prot. The current version
of UniProtKB/Swiss-Prot (Release 2011-07) contains 530264 sequence entries: 188
million amino acids, averaging 354 amino acids per entry, from 199650 references.
UniProtKB/TrEMBL currently contains 16 million sequences: 5 billion amino acids,
and an average of 323 amino acids per sequence (Release 2011-07).
Every protein sequence has a unique identifier – the primary accession number (in
the past termed primary accession code, hence the AC abbreviation), an entry name
and optional secondary accession numbers. The primary accession number (primary
AC) is unique for a sequence and is stable over time. In case several sequences are
merged owing to redundancy, all but one will become secondary accession numbers
and will be kept for future reference. Similarly, if a sequence is revised or split into
several entries, each entry will get a new primary AC, and the old one will become a
secondary AC. Accession numbers are a combination of six symbols, currently in two
acceptable formats: [A-N,R-Z][0-9][A-Z][A-Z, 0-9][A-Z, 0-9][0-9] or [O,P,Q][0-9][A-Z,
0-9][A-Z, 0-9][A-Z, 0-9][0-9]. For example, the full name of the human p53 protein
entry presented in Figure 2.18 is ‘cellular tumor antigen p53’. It has a primary AC
P04637 (green) and several secondary ACs (for example Q15086 and Q9UQ61) (or-
ange). Henceforth unless otherwise stated, when an accession number is mentioned,
it refers to the primary accession number of the protein in question.
7http://www.uniprot.org/
8http://www.uniprot.org/uniprot/P04637
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Figure 2.1: A section of the UniProtKB/Swiss-Prot human p53 entry.
The entry name is shown in blue, the primary accession number in green, and
secondary accession numbers in orange.
The entry name9 is a more intuitive label implying the biological role of the se-
quence, but UniProt states that it should not be used to refer to Swiss-Prot sequences
in the literature. The entry name contains up to five alphanumeric symbols constitut-
ing a protein identifier, followed by an underscore symbol and up to five alphanumeric
symbols corresponding to the species in which the protein was found. For the P04637
example listed above, the entry name is P53_HUMAN, shown in blue in Figure 2.1.
2.1.4 PDBSWS
PDBSWS10 provides mapping from a PDB residue to a UniProtKB residue, either
Swiss-Prot or TrEMBL, in the form of a relational database, accessible through a
RESTful web service (Martin, 2005). It uses cross-references to UniProtKB entries
available in PDB files, then adds cross-references to PDB entries found in UniProtKB
files (created by SSMap (David and Yip, 2008)), and finally, it attempts to map the
remaining PDB chains to UniProtKB entries by ‘brute-force scanning’ (sequence-
level mapping). Finally, the UniProtKB sequence is aligned to the ATOM sequence
from the PDB file and an alignment-based (residue-level) mapping is stored in the
database.
9formerly protein identifier, ID
10http://www.bioinf.org.uk/pdbsws/
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It is worth noting here that, while this database was originally built uniquely to map
from the PDB to UniProtKB, it can be used to provide PDB residue(s) for a given
UniProtKB entry. However in this direction, since several PDB entries could have
mapped to the same UniProtKB entry, the mapping is not unique and does not give
any indication of the ‘best’ PDB file for a given UniProtKB entry. It may also be
incomplete as UniProtKB entries having just one or two mutations compared with a
PDB file will not be mapped if there is also an exact (or better) match.
PDBSWS is at the moment, the most appropriate method for sequence to structure
mapping available. Being an in-house tool, it is easily accessible and regularly up-
dated. It outperforms other methods in coverage and/or level of automation (SIFTS
and MSD (Velankar et al., 2005)), and is preferred over methods lacking residue-
level mapping (Seq2Struct (Via et al., 2005), not updated since 2006). Therefore, it
has been the method of choice in the SAAPdb project, and throughout this thesis,
whenever sequence-structure pairs were required at residue- or protein-levels.
2.1.5 FOSTA
Functional Orthologues from Swiss-prot Text Analysis11, FOSTA, is a relational
database of families of automatically annotated functionally-equivalent proteins
(McMillan and Martin, 2008). The schema of the algorithm extracting families of
functionally-equivalent proteins is shown in Figure 2.2.
For a given human protein, FOSTA identifies a list of homologues using a BLAST
search (introduced in Section 2.2.3) against the UniProtKB/Swiss-Prot database. It
then uses a series of text analyses of the UniProtKB/Swiss-Prot annotations, initially
looking for a match in the protein identifier part of the UniProtKB/Swiss-Prot entry
name (see Section 2.1.3), followed by the EC number, and finally by matching syn-
onyms at multiple levels of specificity from the UniProtKB/Swiss-Prot description
11http://www.bioinf.org.uk/fosta/
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Figure 2.2: A schema of the FOSTA method.
The FOSTA filtering process: homologues are identified by BLAST-ing against
the UniProtKB/Swiss-Prot database (i); these are then filtered to retain only
those with similar function (ii); finally one protein per species (the FEP, or func-
tionally equivalent protein) is chosen using a hierarchy of functional matches
to eliminate functionally diverged homologues (FDHs) (iii). Figure and caption
obtained from McMillan and Martin (2008), with permission from the authors.
(DE) field. Provided a non-human homologue passes any of the three filters, it is
marked as a functionally-equivalent protein, FEP, and added to the same FEP
family with the human protein.
Although McMillan and Martin (2008) demonstrated the high quality of Swiss-Prot
functional annotation, they identified examples where FOSTA correctly assigns FEPs
with otherwise questionable functional annotation, and several families sharing the
same entry name protein identifier. For examples of these inconsistencies, see the HOX
proteins and the PROC_HUMAN example in McMillan and Martin (2008). Thus, FOSTA
is preferred over standard lists of orthologues when highly reliable data are required,
because when gathering very distant orthologues using traditional methods, they may
diverge in function (for example, owing to mutations in functional residues).
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2.1.6 Databases of single amino acid polymorphisms
As discussed in Section 1.1, there are many ways of dividing mutations into types
and subtypes. This thesis focuses on protein-level variations and considers only
SAAPs: substitutions of one amino acid in the protein sequence at a time. SAAPs
can, based on their effect on the phenotype, be divided into neutral and pathogenic.
The main data sources of deleterious mutations will be presented in Section 2.1.6.1,
and a resource providing data on neutral or low-penetrance SAAPs is presented in
Section 2.1.6.2.
2.1.6.1 Databases of disease-associated mutations: OMIM and
LSMDBs
There is an ever growing number of annotated deleterious single amino acid polymor-
phisms (SAAPs), mainly because these mutations are simple to link to a disease state,
and are consequently interesting for diagnostic and disease-prevention purposes. The
most wide-ranging resource of disease-associated SAAPs is the Online Mendelian In-
heritance in Man, OMIM (McKusick, 2000), at present date containing 20706 muta-
tions obtained from peer-reviewed literature12. Although this is the largest source of
missense mutations, it is not meant to be an exhaustive list of all Mendelian disorders;
instead it provides a list of relevant examples (Amberger et al., 2009). If not other-
wise stated, when OMIM mutations are mentioned in this thesis, this refers to the
missense mutations found in OMIM, with silent SNPs, frameshifts, larger insertions
and deletions and nonsense mutations removed from consideration.
More elaborate lists of mutations for a given gene or disorder can be found in nu-
merous locus-specific mutation databases (LSMDBs), created and maintained by
research groups interested in a particular condition or a group of diseases. At the
moment, some ∼ 1500 publicly-available LSMDBs listed by the Human Genome
12http://www.ncbi.nlm.nih.gov/omim/
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Variation Society (HGVS) can be found at http://www.hgvs.org/dblist/glsdb.
html, with various other sources scattered all over the Internet and published litera-
ture. Many of these LSMDBs are stored in LOVD format: the Leiden Open-source
Variation Database is a ‘LSMDB-in-a-Box’ tool, an attempt to impose and pro-
vide a clear and unified format for human variation data (Fokkema et al., 2011).
Unfortunately however, LOVD does not support bulk download of the data at the
moment.
The main challenges with this wealth of data are (i) parsing them into the same
format, and (ii) extracting unique mutations, by mapping to the SwissProt sequence
and providing the protein identifier, position, and native and mutant amino acid
types. The first issue is addressed in the Martin group by developing parsers, one
per LSMDB format, which generate a common XML format. This is obviously a slow
and tedious process and any unification in data formats is welcomed. The second
issue has been addressed in the Martin group by an OMIM-to-UniProtKB/Swiss-Prot
sequence position mapper, see Section 2.2.2.
2.1.6.2 dbSNP
dbSNP13 is the central database of single nucleotide polymorphism data, also in-
cluding short insertions and deletions (Sherry et al., 2001). There are two kinds of
SNPs in this database, with different level of validation: submitted have ‘ss’ pre-
ceding the SNPid number, and validated start with ‘rs’: validated SNPs have been
confirmed by non-computational methods, i.e. frequency studies. The current ver-
sion of dbSNP (build 132) contains 4.4 million validated human SNPs and muta-
tion data for another 83 organisms. The current SAAPdb release is populated by
non-synonymous SNPs from build 129 and also uses mappings to protein sequences,
provided in dbSNP.
13http://www.ncbi.nlm.nih.gov/projects/SNP/
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2.1.7 SAAPdb
The Single Amino Acid Polymorphisms database, SAAPdb14, is a PostgreSQL
relational database of single amino acid polymorphisms, with both neutral and
pathogenic phenotypes (Hurst et al., 2008). It provides a range of likely structural
effects of SAAPs on structures of human proteins based on mappings of the
mutations to the structural data. This project originated as a limited analysis
of seven structural effects of mutations in p53 (Martin et al., 2002) and G6PD
(Kwok et al., 2002) in the Martin group. Eventually several sources of mutation
data were integrated and other structural analyses were added to the pipeline.
To keep terminology used here in accordance with mutation types introduced in
Section 1.1.3, deleterious mutations termed PDs in the SAAPdb paper (Hurst et
al., 2008) are here termed DAMs, while PDs represent a subset of DAMs which
have not been observed compensated in a functionally-equivalent protein.
SAAPdb can be divided into two parts: (i) tables with formatted mutation data
mapped to protein sequence and protein structure (where available), presented in
Section 2.1.7.1, and (ii) the results of automated analyses (a pipeline) assigning likely
structural effects to all mutations successfully mapped to structure described in Sec-
tion 2.1.7.2. The schema of SAAPdb is shown in Figure 2.3.
14http://www.bioinf.org.uk/saap/db/
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(a) HANDLING THE SNPs
(b) HANDLING THE PDs
(c) STRUCTURAL ANALYSIS
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Figure 2.3: SAAPdb schema.
Mutation data and mappings to protein sequence and structures are coloured
blue, and results of structural analyses in red. Foreign keys are connected with
black lines. Adapted from Lisa McMillan’s PhD thesis. (McMillan, 2009)
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2.1.7.1 Mutation data in SAAPdb
Mutations are divided into separate tables based on pathogenicity: DAMs have re-
ported pathogenic effects and SNPs cover silent and low-penetrance SNPs (for defini-
tions see Section 1.1.2.1). Some SNPs may have low-penetrance pathogenicity, with-
out their effect being observed or correlated to the mutation in a Mendelian sense.
In work by Hurst et al. (2008), six mutations which were found in both datasets were
removed from the SNP dataset: three were found in dbSNP and OMIM and another
three in dbSNP and IARC p53 simultaneously. Each SAAP is stored with mappings
to sequence data and to structural data, where structures are available.
Databases used to populate the latest version of SAAPdb (released on August 28th,
2008) are shown in Table 2.1: one SNP source, OMIM and ten LSMDBs. The Mar-
tin group has been working on expanding this list in terms of coverage of deleterious
mutations: for example, since a parser for the LOVD format introduced in Sec-
tion 2.1.6.1 has been developed for the ZAP70Base and this format is becoming the
de facto standard for submission of DAM data, several more LOVD-based LSMDBs
listed on the HGVS web site could be included in the next SAAPdb build.
The SNPs extracted from dbSNP are all validated non-synonymous SNPs in cod-
ing regions of the human genome. Mapping to sequence data for SNPs is provided
by dbSNP. DAM mappings are retrieved where available, and then added, verified
and/or corrected by a OMIM-to-UniProtKB/Swiss-Prot mapping algorithm ((Mar-
tin, in preparation), for details of the algorithm, see Section 2.2.2). Mapping to
structural data for both SNPs and DAMs is achieved using PDBSWS as described
in Section 2.1.4.
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2.1.7.2 Likely structural effects in the SAAPdb pipeline
The SAAPdb pipeline currently contains 15 structural analyses and one sequence-
based analysis15, shown in Table 2.2, all aiming to ‘explain’ how SAAPs affect protein
structure: in particular interfaces with other proteins, functional sites, folding and
stability of the mutated protein. Each analysis is implemented as a separate Perl
script or C program and will output a positive (‘explained’) or negative (‘not ex-
plained’) result for every SAAP in every category. Therefore the SAAPdb result for
a mutation can be viewed as a vector of binary values (1 for
√
and 0 for ×), as shown
in Figure 2.4.
Figure 2.4: Structural effects assigned by SAAPdb to a DAM in human UDP-galactose
4-epimerase.
SAAPdb (http://bioinf.org.uk/saap/db/) was queried for UniProtKB/Swiss-
Prot accession number Q14376 and Asn43→Ser was chosen as a representative
pathogenic mutation (OMIM: 230350). The mutation is mapped to several
residues in different protein structures (only the top three are shown here).
The analysis summarised in a vector shows that this mutation is located in a
PQS, binding and interface site residue, and it carries a UniProtKB/Swiss-Prot
functional identifier.
15introduced elsewhere, check Martinet al. (2002), Cuff (2004) and McMillan (2009)
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Table 2.2: SAAPdb categories.
The horizontal line separates structural categories from the sequence-based one.
Category Effect of mutation
Interfacea Affecting residues in contact with a different protein chain or ligand
based on biological units reported in the PDB.
PQSa Affecting residues in the interface with a different protein chain or
ligand identified from a PQS file (and therefore more likely to reflect
biologically relevant interactions) by a change in solvent-accessibility.
bindingb Affecting residues involved in specific binding interactions (a hydrogen
bond, salt bridge, or packing interaction) with a different protein chain
or ligand.
MMDBb Affecting residues in contact with a ligand, according to the MMDB
database.
sprotFTb Residues annotated in SwissProt Feature records as having a func-
tional significance.
prolinec Mutations to proline where the backbone angles are restrictive.
glycinec Mutations from glycine where the backbone angles are restrictive.
clashc Causing a clash between atomic radii of the neighbouring residues.
cisprolinec Mutations from a cis-proline.
hbondingd Causing the disruption of hydrogen bonds between residues.
voidd Causing an internal void ≥275A˚3 to open in the protein owing to the
substitution with a smaller residue.
corephilicd Introducing a hydrophillic residue in the protein core.
surfacephobicd Introducing a hydrophobic residue on the protein surface.
buriedcharged Introducing an unsatisfied charge in the protein core owing to the
substitution with, or of, a charged residue.
SSgeometryd Causing the disruption of a disulphide bridge.
struc explained Explained by any of the categories listed above.
highconse Affecting residue with highly conserved sequence, according to Im-
PACT (McMillan, 2009)
explained Explained by any of the categories listed above.
The structural explanation categories are described in detail by Hurst et al. (2008).
aInterface-damaging; bFunctionally-impairing; cFolding (fold-preventing); dInstability (desta-
bilizing); eSequence conservation.
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2.2 Algorithms and tools
This section introduces methodology used in the work chapters. It starts with two
algorithms used for data pre-processing tasks: solvent-accessibility calculation en-
ables us to divide residues in the protein structure into buried and surface ones,
and OMIM sequence mapping verification sorts out inconsistencies in OMIM residue
numbering. Next, two key algorithms are introduced: BLAST identifies the likely
homologues, and CLUSTALW and MUSCLE align them. Finally, PISCES provides
a list of non-redundant structures.
2.2.1 Solvent-accessible surface calculation
The molecular surface area of a residue or atom (sometimes also termed ‘Connoly
surface area’ (Connoly, 1983)), is defined as the as the area of that residue or atom,
in contact with the solvent molecule. More often used term is the Accessible Surface
Area (ASA), where instead of measuring the area of the atom’s or residue’s sur-
face a solvent molecule can reach, the area the centre of solvent molecule covers is
measured.
The algorithm to obtain ASA measures the area of the surface obtained by rolling a
sphere along the surface of the molecule (in this case a protein), obtained by merging
van der Waals radii of atoms in the protein. The sphere’s radius is usually set to
1.4A˚, the van der Waals radius of a water molecule. The area the centre of the
solvent probe covers while rolling along the protein surface is the ASA, defined by
Lee and Richards (1971). Further in the same work, Lee and Richards presented
average solvent-accessibilities for the 20 standard amino acid types ASAav(X) in
Ala-X-Ala tripeptides thus introducing the relative solvent-accessibility of a residue,
rASA:
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rASA(X) = ASA(X)/ASAav(X) (2.1)
where ASA(X) is the observed accessible surface area for a residue of type X, here-
after termed absolute solvent-accessibility value, and referred to as ASA. rASA val-
ues > 1 indicate above average absolute ASA, common for the first or last residues
in a chain, or residues with unusual (and often erroneously measured or modelled)
bond angles or lengths.
In this thesis an in-house implementation solv (Martin, 1999) was used to calculate
relative and absolute solvent-accessibility, based on Lee and Richards (1971) solvent-
accessibility calculation method, and using the default sphere radius of 1.4A˚. solv
calculates a total of four solvent-accessibility values: relative and absolute solvent-
accessibility of a residue in the structure as provided by the PDB file termed rASAc
and ASAc respectively (‘c’ indicating this value was measured in the whole PDB
complex). The second pair of values are relative and absolute solvent-accessibility in
the monomeric chain, obtained by simply separating the PDB entry into individual
chains and then applying the Lee-Richards algorithm, termed rASAm and ASAm,
respectively (‘m’ stands for ‘monomeric’). Obviously, for residues in PDB entries
consisting of a single chain, solvent-accessibilities in the monomer and in the complex
will be identical. solv is also used on PQS files to identify interacting residues
by looking at the difference in relative solvent-accessibility between complex and
monomeric chains (for more details, see Section 4.2.1.3).
2.2.2 OMIM-to-UniProtKB/Swiss-Prot mapping
Both OMIM and LSMDBs provide information of various age and from many
sources. While these SAAPs are predominantly reported in the [AC, position,
native, mutated] format presented in Section 1.1.3, the residue position needs
to be verified, and often corrected. To address this issue, Andrew Martin has
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developed an OMIM-to-UniProtKB/Swiss-Prot mapping algorithm (manuscript in
preparation)16, the algorithm for which is shown in Figure 2.5.
In short, a partial sequence is constructed from all the native residues found in OMIM
for a single protein. This sequence fragment is matched to the complete (Swiss-Prot)
sequence, in order to identify an offset which will yield the most successful mapping
(in terms of correctly aligned ‘native’ residues) between the two.
2.2.3 BLAST
Basic Local Alignment Search Tool, BLAST, finds similar sequences to the provided
(query) sequence, in a database of sequences (Altschul et al., 1990). While there are
many BLAST implementations aimed at different tasks and sequence types, only the
basic protein-sequence-targeted version will be presented here: blastp. The user
provides a query protein sequence, and the database against which to search against
for ‘similar’ sequences. The level of similarity, and various aspects of the search can
be finely tuned through a variety of user-adjustable parameters.
The speed of the search is achieved by partitioning the queried sequence, and all
sequences in the target database into all possible substrings of a given length. The
default length of these substrings (also termed words) for blastp is three. The next
step is finding the words in the database with similarity above the threshold with the
words in the query sequence – these will be the seeds for building local alignments.
The similarity between two words is typically measured using one of the substitution
matrices, see for example Dayhoff et al. (1978), Henikoff and Henikoff (1992), Altschul
(1993) and Altschul et al. (2005).
Once a word in a database entry is identified with sufficient similarity to the word in
the query sequence, creating a high-scoring segment pair, HSP, these two words are
aligned. Then the algorithm expands the alignment in both directions as long as the
16mappings available from http://www.bioinf.org.uk/omim/
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    |    |    |    |    |    |
ADNASHPNTAASASVNYMYAPIRIEFLHKMAP
matches = 4/5
offset = −3
 −−−−− −−−−− −−− −−−−−−− S     A     A   P       K
 −−−−− −−−−− −−− −−−−−−− S     A        P       KA
S     A     A   P       K −−−−− −−−−− −−− −−−−−−− 
S     A         P       K −−−−− −−−−− −−− −−−−−−− A
      A                   S  A P K−−−−− −−−−− −−− −−−−−−−
(b) ADNASHPNTAASASVNYMYAPIRIEFLHKMAP
matches = 1/5
matches = 0/5
matches = 0/5
matches = 1/5
matches = 1/5
(a)
    S−−−−−A−−−−−A−−−P−−−−−−−K
S 8 −> T
A14 −> R
P24 −> L
K32 −> S
A20 −> L
S 5 −> T
A11 −> R
P21 −> L
K29 −> S
A20 −> L
(d)
Figure 2.5: (a): a partial sequence is reconstructed from the native residues described in
the OMIM record; (b): this partial sequence is slid along the UniProtKB/Swiss-
Prot sequence to which it is mapped in OMIM and the number of matches for
each position is recorded (matches are shown in green, mismatches are shown
in red); (c): the best matching position is used to calculate the offset (note
that the A20 record (shown in blue) could be correct with an offset of 0 (i.e.,
the OMIM annotation is correct) as an alanine does exist at position 20); (d):
the offset is applied to the matched original mutations (i.e., the residues found
to match in (c)) to generate a corrected numbering and all probably correct
mutations (those matched using an offset of 0) are also included in the dataset
(again, the probably correct A20 example is highlighted in blue). Image and
caption obtained from Lisa McMillan’s PhD thesis (McMillan, 2009).
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similarity is above certain threshold, outputting the aligned pair (the query sequence
and a ‘hit’ from the database) along with several performance measures. The two
main measures of similarity are P-value and E-value.
The P-value is the probability of observing a certain similarity by chance: i.e. the
similarity is the result of random chance, and thus not indicating an evolutionary
connection of the queried sequence and the hit. The expectation measure, E-value,
denotes the number of times one expects to observe a given similarity score (or better)
by chance in a database of a given size – essentially it is P multiplied by the size of
the database searched to find potential hits. Like the P-value, the good hits are the
ones with the low E-values: usually E < 0.01 is used as a threshold for a significant
hit (indicating a potential homologue of the queried sequence).
2.2.4 Aligning protein sequences
Almost every bioinformatics project requires aligning protein or nucleotide sequences
at some stage. The predominant tool for this purpose is CLUSTALW (Thompson
et al., 1994), although novel, and more efficient algorithms have emerged in the last
decade (listed in Section 2.2.4.2). CLUSTALW- and MUSCLE-created alignments
are used in Chapters 3 and 4, respectively.
2.2.4.1 CLUSTALW
CLUSTALW (Thompson et al., 1994) is a dynamic programming multiple alignment
method, based on pairwise alignments of all sequences. Briefly, CLUSTALW first
creates a distance matrix for each pair of sequences, and builds a tree from all the
provided sequences based on the neighbour joining method (Saitou and Nei, 1987).
The multiple sequence alignment is built by aligning two sequences at a time, starting
from the terminal nodes on the tree, using sequence weighting to reduce the impor-
tance of very similar (thus containing lots of duplicate information) sequences. In
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addition to sequence weighting, improved alignment sensitivity is obtained by vari-
able, residue-specific gap penalties, aiming to restrict gaps in secondary structure
elements more than gaps in unstructured sequence segments, and preferring creation
of larger gaps over opening many short ones.
2.2.4.2 Choice of MUSCLE over other tools
While it is still the most popular and widely used tool, CLUSTALW is outper-
formed by several recently developed methods (Edgar and Batzoglou, 2006): T-
coffee (Notredame et al., 2000), PROBCONS (Do et al., 2005), MUSCLE (Edgar,
2004b) and MAFFT (Katoh et al., 2005). Despite being highly accurate, T-coffee
and PROBCONS become very time-consuming when large sequence datasets (> 100
sequences) are aligned (Edgar, 2004b; Edgar and Batzoglou, 2006). MUSCLE and
MAFFT have lower time complexity, however MUSCLE achieves marginally better
accuracy than MAFFT (Edgar, 2004c). For this reason, MUSCLE was chosen as
the preferred MSA tool, appropriate for production of comparable and reproducible
alignments with an optimal accuracy-to-speed trade-off.
2.2.4.3 The MUSCLE algorithm
MUSCLE17 (Multiple Sequence Comparison by Log-Expectation) will be briefly
presented here, for more details see Edgar (2004b). MUSCLE produces an optimal
multiple sequence alignment in three steps: draft alignment, progressive alignment
and refinement steps. Depending on the settings, the refinement step can be omit-
ted18, increasing the speed of the method, at the expense of reduced accuracy.
17download from http://www.drive5.com/muscle/download3.6.html
18implemented as MUSCLE-prog option
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A progressive alignment is created at the end of each step, in a similar way:
• a similarity measure is applied to every pair of sequences yielding a distance
matrix
• a binary tree is calculated from the matrix
• moving from the leaves towards the root, pairs of sequences (in the case of two
leaves) or pairs of profiles (in the case of non-leaf nodes) are aligned until the
root is reached, producing a progressive multiple alignment of all sequences
In the first step, a draft alignment, M1, is created from unaligned sequences, focusing
on speed rather than on the alignment quality. The kmer distance of every sequence
pair is calculated; more related sequences will share more common subsequences
(words) of length k and their similarity score will be higher. All pairwise similarity
scores are stored in the similarity matrix D1. After UPGMA clustering (Sneath and
Sokal, 1973) of the distance matrix, a binary tree, T1, is obtained. The prelimi-
nary (draft) alignment is built, aligning nodes, starting with leaf nodes towards the
root.
In the second step, the draft alignment is further optimised. The errors produced by
kmer distance calculations are corrected by using the Kimura distance19 (Kimura,
1980), resulting in a new distance matrix, D2. Again, after clustering D2 with UP-
GMA, a tree, T2, is produced and an improved progressive alignment, M2, is cre-
ated.
The final step is based on ‘tree-dependent restricted partitioning’ (Hirosawa et al.,
1995). T2 is bipartitioned (divided into two sub-trees) by deleting an edge20. The
profile alignment is calculated for every sub-tree and these two profiles are aligned,
19Kimura distance, -loge(1 − D − D2/5), unlike kmer distance proportional to D (where D is
fractional identity of two compared sequences, for more details, see Edgar (2004a)), corrects for
multiple mutation events at the same position
20starting from the leaves, edges progressively closer to the root are deleted, one at a time
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creating a multiple alignment, M3. If the refinement step was successful and M3 has
improved over M2, M2 is discarded for the refined alignment which becomes a base
for the next refinement iteration. Both second and third steps are iterated for the
user-specified number of cycles, or until the alignments converge.
2.2.5 Creating non-redundant protein datasets with PISCES
PISCES21 (Wang and Dunbrack, 2005) is a server providing clusters of protein en-
tries in the PDB format, grouped by sequence identities, i.e. once a sequence identity
threshold is set to X, all entries within a cluster will have maximum sequence identity
of X. Several user-adjustable filters have been implemented in order to set the accept-
able resolution range, R factor threshold and range of chain lengths from the PDB
files, and to remove NMR entries and entries lacking all-atom coordinates (Cα-only
entries). Entries within a cluster are ordered by method (X-ray crystallography then
NMR); then by ascending resolution within same-method entries; then by ascending
R-factor if the resolution is the same (Wang and Dunbrack, 2003).
If a set of PDB entries is culled using PISCES, choosing the first protein from every
cluster22 ensures an even coverage of all the PDB: it provides a dataset of proteins
in which no two have more than X pairwise sequence similarity. In Chapter 4, this
method was used to obtain a list of non-redundant protein chains, in order to provide
an unbiased set of protein-protein interfaces.
21http://dunbrack.fccc.edu/Guoli/PISCES_OptionPage.php
22by definition, this is the highest-quality structure in that cluster
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2.3 Statistical methods
This section presents the basic statistical concepts and tests used throughout this
thesis. The χ2 test and Fisher’s exact test are used when categorical data are tested
for difference in frequency distributions (usually two datasets for the presence or
absence of a single feature). Student’s t-test is used for two populations surveyed for
a feature measured on a continuous scale: it tests the significance of the difference
in the means of the two samples. Finally linear regression models approximate the
behaviour of two-dimensional data with a single line and as such, provide the line of
best fit through the observed data.
2.3.1 χ2 test
The Chi-squared test (χ2 test) (Mood et al., 1974) is a nonparametric test used
on nominal, categorical data to compare a frequency distribution of a sample to
a theoretical frequency distribution (i.e. a goodness of fit test). Alternatively, two
samples are compared, the null-hypothesis being that they are drawn from the same
frequency distribution (test of independence). Data are divided into n datasets, and
k categories of outcomes. Outcome categories have to be mutually exclusive and
frequency probabilities for a given dataset, over all categories have to sum to 1.
When defined in this way, the test has (n− 1)(k− 1) degrees of freedom and the test
statistic is calculated as follows:
χ2 =
n∑
i=1
(Oi − Ei)2
Ei
(2.2)
where Oi is the observed count and Ei is the expected count.
The χ2 test assumes sampled data conform to the χ2 distribution, which is a special
case of the gamma distribution. When expected counts of 5 or less appear in the
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2×2 contingency table, this assumption leads to significant errors: it increases the χ2
value and thus erroneously decreases the p-value. This issue is somewhat corrected
by introduction of the Yates correction for continuity (Yates, 1934): subtracting an
additional 0.5 from the difference between the observed and expected value increases
the p-value, but this procedure is known to over-correct. The only way to completely
avoid using this assumption about the distribution of the tested data, is to use an
exact test introduced in Section 2.3.2.
In this thesis the χ2 test, implemented as a Perl script, was used when comparing
frequencies of disulphide bonds, hydrogen bonds and secondary structure elements in
interface and non-interface surface patches in Section 4.3.2. Two datasets were tested
for one property at a time, thus having a 2 × 2 contingency table and performing
a test of independence with one degree of freedom. All data points were labelled 1
(property exists) or 0 (property not observed), and raw counts were tested without
normalisation.
2.3.2 Fisher’s exact test
The Fisher’s exact test (Fisher, 1935) is used instead of a χ2 test when counts ≤ 10
or empty fields occur in 2 × 2 contingency table. It provides an exact p-value, thus
removing discrepancies between the sampling and theoretical χ2 distribution for small
datasets. fisher.test implemented in R was used, using default parameters.
Table 2.3: Fisher’s exact test.
A B
Set X xA xB xA + xB
Set Y yA yB yA + yB
xA + yA xB + yB N
CHAPTER 2. AN INTRODUCTION TO TOOLS AND RESOURCES 74
For the example shown in Table 2.3, the p-value is:
p =
(xA + xB)!(yA + yB)!(xA + yA)!(xB + yB)!
N !xA!xB!yA!yB!
(2.3)
where X and Y are datasets, A and B are categories, and N is the total count
xA + xB + yA + yB.
The only limitation of the Fisher’s exact test is its calculation complexity: if the
dataset is very large it soon becomes unfeasible to calculate the p-value. Indeed, this
is the reason why the χ2 test was used instead in Chapter 4, as mentioned in the
section above.
2.3.3 Bonferonni correction for multiple testing
Multiple testing using the same test on the same dataset, increases the chance of
observing a relevant score by chance, i.e. a false positive. In order to eliminate this
multiple testing bias, the Bonferonni correction needs to be employed: for every
performed test, the α value should be reduced N times for a result to be assessed as
significant, where N is the number of times a tests was repeated on the same data.
Only p-values smaller than α/N are then considered statistically significant.
2.3.4 T-test
The t-test is a non-parametric statistical test measuring the significance of the differ-
ence in means of two normally-distributed populations. Student’s t-test is often used
as a synonym, although strictly speaking, Student’s t-test assumes that the variances
of the two populations are equal. Further, Markowski and Markowski (1990) have
shown that, in the case where two samples have roughly the same size, Student’s
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t-test can still be successfully used, irrespective of variance differences between sam-
ples. Finally, if the two populations differ in both variance and dataset sizes, Welch’s
t-test is used (Welch, 1947), calculating the t-statistic (for the null hypothesis that
the means of the two samples are of equal values) as follows:
t =
X¯1 − X¯2√
s21
N1
+ s
2
2
N2
(2.4)
where X¯ is the mean of the sample, s2 is the sample variance and N is the number of
data points in that sample. In this case, the degrees of freedom cannot be calculated,
rather, they are approximated using the Welch-Satterthwaite equation (Equation 28
in Welch (1947)). The approximation of the total degrees of freedom is based on the
linear combination of degrees of freedom from each of the sample’s variances, a value
not directly linkable to the sample size. t.test implemented in the R language was
used, defaulting to the two-sided Welch’s t-test.
2.3.5 Linear regression models
A linear regression model outputs a line, defined by the slope and the y-axis intercept
with the best fit for data consisting of two variables (Wilkinson and Rogers, 1973).
There are several uses for this line equation: sometimes it represents a biologically
interesting parameter, sometimes it is used to infer an X value for an unknown Y
value or vice-versa. Using lm in R, linear regression was inferred by the least squares
method where the line
y = αx+ β (2.5)
is found in order to minimise the sum of squared residuals (SSE)
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SSE =
n∑
i=1
e2i (2.6)
where ei = yi − yˆi is the residual, yi is the observed value, yˆi is the expected value
(value on the line for xi) and n is the number of data points. Given the average of
x values x¯ and the average of y values y¯, the best fit line slope and intercept are,
respectively:
α =
∑n
i=1(xi − x¯)(yi − y¯)∑n
i=1(xi − x¯)2
, β = y¯ − αx¯ (2.7)
If the experimentalist has some prior knowledge about the data, and consequently the
line parameters, one can ‘force’ the line to pass through a certain data point. Such
a model is termed a ‘restrained linear regression model’, and should be used with
caution (only for very obvious restraints) as it adds bias to the model, and in turn,
reduces the effect data have on the line formula. An example of sensible restraints
imposed on the linear model is presented in the CPD sphere conservation analysis,
in Section 3.2.3.1.
It should be noted that this method does not return an indication of how sensible
it is to approximate a data relationship with a straight line, it simply provides the
most appropriate line equation given the data. Calculating a correlation coefficient
will show whether, and to what extent, the two variables are dependent.
Chapter 3
Compensated Pathogenic
Deviations
The work presented in this chapter was a continuation of preliminary
work in an undergraduate project by Hubert Rogers. While I reused
some of his methodologies (the dataset preparation and mapping to the
sequence and structure), I had to re-implement most of the code used in
Sections 3.2.1 and 3.2.5, with the help of Lisa McMillan. Additionally I
implemented analyses presented in Sections 3.2.3, 3.2.4 and 3.2.5.1. Some
of the work presented in this chapter has been published in Baresˇic´ et al.
(2010) and Baresˇic´ and Martin (2011).
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3.1 Introduction
3.1.1 Protein evolution: an overview
Molecular evolution is mostly investigated at the protein level, since proteins are
traditionally viewed as effector molecules, thus enabling a more straightforward link
from their function/structure to the observed changes in phenotype. This section
defines several basic evolutionary mechanisms and terms using examples from the
protein world, to be used throughout the following chapters.
At the molecular level, the evolutionary path of a protein is affected by other
molecules, i.e. interaction partners and environmental factors. When two molecules
display a similar evolutionary path, they are considered to be coevolving, usually
resulting from a shared cellular pathway, localisation, expression pattern or
co-adaptation (Pazos and Valencia, 2008). In co-adaptation, two molecules affect
each other’s evolution. A similar scenario is termed epistasis: the total change in
fitness cannot be obtained by adding the fitness contributions of individual alleles,
owing to the inter-dependence of these alleles. In classical population genetics
terminology, epistasis refers to interdependency between different gene products or
proteins; for a review see Cordell (2002). It is intuitive to expand this principle to
two SAAPs within the same protein having a combined effect on fitness, which
could not be predicted from each SAAP occurring alone in that protein: for
example, when these two SAAPs form a new hydrogen bond, thus affecting that
protein’s stability and aggregation rate.
Let’s consider a special case: sign epistasis, when a detrimental effect of a
pathogenic SAAP (P ) is turned into a mildly positive (or at least a neutral)
one through epistatic interactions with another SAAP (C). In other words, C
is neutralising whatever the negative effect of P is (thus the symbol ‘C’ as a
compensatory mutation), while on its own, C would not display a beneficial
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effect on the fitness. This phenomenon is also known as ‘fitness reversal’ and
it is an important mechanism for organisms to sample protein space through
various SAAPs, traversing along ridges of the fitness landscape (Cowperthwaite
et al., 2006). Employing the same annotation as above: if P is found as a
disease-associated SAAP in one organism and at the same time, it is found
neutralised through compensation with C (or several variations) in a homologue,
this special case of a DAM is termed a compensated pathogenic deviation, a
CPD.
Understanding the evolution of disease-associated mutations (DAMs) is facilitated
by exploration of the structural context which allows for these mutations to appear,
and propagate through generations. Thus CPDs provide valuable insights in the
evolution of disease-associated mutations and proteins in general, through epistatic
selection.
3.1.2 Compensated pathogenic deviations
Compensated pathogenic deviations are disease-associated mutations in a protein of
one species (usually human), which occur as the wild-type in a functionally-equivalent
protein, FEP, of another species. Functionally-equivalent proteins have previously
been defined in Section 2.1.5. This phenomenon was first discussed by Kimura (1985)
who initially called them ‘compensatory neutral mutations’; the term ‘compensated
pathogenic deviations’ was introduced later by Kondrashov (2002). Throughout this
chapter, disease-associated mutations have been divided into two datasets based on
the presence or absence of the observed compensation: where compensation has oc-
curred mutations are called compensated pathogenic deviations, CPDs, and where
no compensation was found mutations are simply termed pathogenic deviations,
PDs.
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Classification of a human missense mutation as a CPD is based on a multiple
sequence alignment of the mutation-containing human protein and its
functionally-equivalent homologues. Consider the multiple sequence alignment of
the antithrombin-III protein shown in Figure 3.1. Mutations Ala416→Pro1 and
Ala416→Ser2, both cause susceptibility to trombophilia owing to antithrombin-III
deficiency in the human antithrombin-III protein (UniProtKB/Swiss-Prot:P01008).
Since position 416 is fully conserved and neither proline nor serine appear as
wild-type residues among functionally-equivalent homologues of ANT3 HUMAN,
these two mutations are classified as PDs. On the contrary, Ala419→Val3 is a
CPD, because native valine occurs in bovine and sheep sequences in the same
sequence position. Positions 416 and 419 in Figure 3.1 refer to the residue
numbering in the UniProtKB/Swiss-Prot sequence; according to the OMIM residue
numbering these are positions 384 and 387, respectively. For the details of the
OMIM-to-UniProtKB/Swiss-Prot mapping, see Figure 2.5.
Figure 3.1: A CPD example in the human antithrombin-III protein aligned to its non-
human FEPs (obtained from FOSTA).
Ala416→Pro and Ala416→Ser are PDs, Ala419→Val is a CPD; all three cause
antithrombin-III deficiency. The CPD is shown in green, the disease-associated
amino acid type found as native in non-human FEP in grey, the PD in blue
and the putative compensatory mutations in purple.
1OMIM:107300.0007 (Barbui et al., 1983)
2OMIM:107300.0027 (Harper et al., 1991)
3OMIM:107300.0042 (White et al., 1992)
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3.1.3 Compensatory mutations
The pathogenic effect of a CPD is assumed to be neutralized in the non-human FEP
through epistatic interaction(s) with other mutation(s), occurring within the same
protein (intragenic compensation), or in an interacting partner (intergenic compen-
sation) (Poon et al., 2005). This neutralising mutation is hereafter termed a ‘com-
pensatory mutation’, since its epistatic effect with a CPD results in a loss of the dele-
terious phenotype, and ultimately simultaneous fixation of the mutation pair.
The simplest (and easiest to identify) form of compensation is ‘one-on-one’ compen-
sation, where a SAAP fully neutralises the negative effect a DAM has on the fitness.
The other, more likely scenario is ‘sphere compensation’ where the effects of a se-
ries of small variations, usually among residues surrounding the DAM in the protein
structure (thus the name), add up to fully neutralise the pathogenicity of a DAM.
When modelling the average number of suppressor mutations4, Poon et al. (2005)
achieved the best fit using an L-shaped gamma distribution, with an average of 11.8
compensatory mutations for a compensated mutation. Furthermore, they estimated
78% of compensatory events were intragenic, with somewhat more intergenic com-
pensatory events in viruses than in prokaryotes and eukaryotes. This trend is not
surprising: viruses have a significantly smaller pool of proteins owing to the small
genome, providing fewer positions for the intragenic compensation to emerge.
While sphere compensation is more widespread, the one-on-one compensation is eas-
ier to identify, and is not uncommon (Kondrashov et al., 2002; Ferrer-Costa et al.,
2002). Four examples of one-on-one compensation are presented in Sections 3.3.4.3–
3.3.4.6. In the case of the model CPD from Figure 3.1, Ala419→Val, neighbouring
residues which have diverged in sequence have been shown in purple in Figure 3.1:
these are the likely compensatory sites provided the compensation is local for this
mutation. There is no experimental evidence5 whether this mutation is neutralised
4which are, in fact, a synonym for compensatory mutations
5usually obtained through mutagenesis screening
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by the additive effect of all of these nearby substitutions, or only one of them is
sufficient for the full fitness reversal.
3.1.4 Evolution of CPDs
Evolutionary processes are often explained in terms of fitness landscapes (Wright,
1932), where peaks represent genotypes with high fitness, and valleys represent less
fit genotypes. Data on fitness landscapes are limited by the availability of genetic
sequences: the wild-type sequences and low-penetrance SNP data (for example, from
dbSNP) correspond to landscape peaks, while disease-associated mutations from
OMIM and LSMDBs6 represent valleys. Almost all possible genetic sequences are
unfit, so for a protein to evolve over time, only a discrete series of rare, fit sequences
may be used as steps in the evolutionary journey (Kondrashov et al., 2002). One
of the ways to traverse between adjacent peaks in the fitness landscape is through
CPDs: individually pathogenic mutations become fixed in the population through
epistatic selection with compensatory mutations.
The unusually high fixation rate of what were predicted to be pathogenic phenotypes
was first observed in in silico modelled RNA evolution by Cowperthwaite et al. (2006).
They also found that the overall fitness did not decrease as fast as expected from
the accumulation of detrimental changes. Rather, more than half of the originally
pathogenic mutations encountered fitness reversals as a result of accumulation of
compensatory mutations, often occurring after the initial pathogenic mutation.
Povolotskaya and Kondrashov (2010) presented a model of unidirectional evolution
of proteins in sequence space in which CPDs play the main role. They found that
proteins have not reached their limit in divergence from one another, and they are
still sampling protein sequence space. Further, they suggest that for a protein se-
quence, 2% of possible missense mutations are not forbidden and are thus available
6some of which have been incorporated into SAAPdb, see Table 2.1
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for travelling along the fitness landscape. Let’s consider a protein consisting of 100
amino acids, where each position can adopt 19 different missense changes: only 38
of these combinations (2% of 19 × 100) are allowed, at any given moment. After
the first mutation, the sequence and the structural context for epistasis change, but
again 38 missense mutations are ‘allowed’, one of which is the reverse mutation. In
other words, there is 1:38 chance for that protein to revert to the original form, and
a 97.4% chance for the protein to increase the distance (in terms of sequence simi-
larity) from the original, indicating a strong tendency for previously unseen protein
sequence combinations to be sampled.
3.1.4.1 Timeline of occurrence of the compensatory and compensated
mutations
As previously mentioned, a CPD (P ) is deleterious, and without the existence of a
compensatory mutation (C), it will not be fixed in a wild-type non-human sequence.
In one of their models, DePristo et al. (2005) proposed a simultaneous occurrence of
a P–C pair in the same organism. That scenario is highly improbable as it would
require a high mutation rate. It is more likely that the compensatory mutation
evolved slightly earlier and is present in a population in low frequency, enabling the
CPD to occur without causing detrimental consequences. Another option is, provided
the mutation rate is sufficiently high, for the compensatory mutation to appear soon
after CPD emergence (similar to the scenario Cowperthwaite et al. observed in RNA
in silico evolution mentioned above), presuming P exists in the population in low
copy numbers. At that point, the P–C pair undergoes epistatic selection and is
ultimately fixed in the population.
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3.1.4.2 Effect of CPDs on the organismal fitness
Focusing on the co-occurrence of CPDs and compensatory mutations, DePristo et
al. (2005) proposed two hypotheses of CPD evolution based on models of biophysical
properties. In the first scenario, a compensatory mutation C is phenotypically neutral
and stable, thus fixing itself quickly in the population. A pathogenic mutation P is
unstable, and can become fixed only if it occurs after the compensatory mutation C,
resulting in a CPD (the P–C pair) which has higher fitness owing to epistasis.
In the second model, both P and C are individually deleterious, but together have
a neutral effect, giving rise to a fitness peak. It is known that small frequencies of
low-fitness mutations exist in large populations, an effect termed ‘population delo-
calisation’ (DePristo et al., 2005). Consequently, if P occurs in the same individual
before detrimental C has been eliminated, it is possible for the P–C genotype to
become fixed within the population, while neither of the deleterious intermediates
would be fixed on their own. Again, a less likely but possible scenario is that both
C and P occur simultaneously.
3.1.4.3 Frequency of compensation among deleterious mutations
Initial studies of CPDs by Kondrashov et al. (2002) in the human genome and
Kulathinal et al. (2004) in the Drosophila genome indicated a fairly constant
ratio of compensation among the disease-associated mutations. More recently,
as more analyses appeared, a correlation seems to have emerged between the
frequency of compensation and the minimum sequence identity threshold used
to filter out distantly related homologues: 0.14%, 0.4%, 12.5% and 17.8%7 for
human/chimpanzee/neanderthal (Zhang et al., 2010), dipteran-only proteins
(Kulathinal et al., 2004), proteins of all species with > 50% sequence identity
(Kondrashov et al., 2002) and > 10% sequence identity (Ferrer-Costa et al., 2007),
7exact counts can be found in Table 3.1
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respectively. Although the authors above used very different methodology making
it unreasonable to calculate a correlation coefficient from these scores, there is a
noticeable increase in CPD frequency with the decrease in evolutionary distance.
The dependency of the CPDs on the method used to obtain the mutation datasets
will be discussed further in Section 3.3.1.5.
3.1.5 Structural features of CPDs
In a recent study, Ferrer-Costa et al. (2007) demonstrated that both the structural
environment and the nature of the substitution play an important role for the develop-
ment of compensatory mutations facilitating a CPD. Their results show statistically
significant differences in the solvent accessibility of CPD residues as well as intrin-
sic properties of the mutation (change in amino acid volume, hydrophobicity and
BLOSUM62 scores (Henikoff and Henikoff, 1992)) when compared with the control
dataset - pathogenic deviations. They suggested that (i) CPDs are more often found
on or close to the protein surface, (ii) mutations to residues making a large number
of contacts are more difficult to compensate than those making few contacts, and
(iii) CPDs are, on average, more conservative substitutions than PDs.
3.2 Methods
In order to gather a comprehensive dataset of well-annotated compensated muta-
tions, missense mutations were gathered from OMIM (McKusick, 2000; Amberger
et al., 2009) (April 2008 release), mapped to sequence data, and then mapped to
available protein structures. Successfully mapped mutations were then divided into
two datasets, each mutation being sorted either as a ‘PD’ or a ‘CPD’. Three aspects
of the CPDs were examined: (i) preferences for amino acid types in Section 3.2.2,
(ii) properties of the residues surrounding a CPD/PD in the protein structure, partic-
ularly solvent-accessibility and sequence conservation, described in Section 3.2.3, and
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(iii) types of local structural effects, using 14 structural explanations implemented in
SAAPdb (Hurst et al., 2008), presented in Section 3.2.5.
3.2.1 Obtaining the dataset
All mutations analysed in this chapter were missense mutations (from one standard
amino acid type to another) - neither native nor mutated codon was allowed to be a
stop-codon. A distinct mutation (a CPD or a PD) was defined as a unique combina-
tion of four parameters, as shown in Figure 1.4 where the information about the pro-
tein’s accession number, the native and the mutated amino acid type originated from
OMIM, and the residue position was obtained from OMIM-to-UniProtKB/Swiss-
Prot mapping (to match UniProtKB/Swiss-Prot residue numbering), as described
below.
3.2.1.1 Mapping OMIM mutations to sequence
As previously mentioned, OMIM provides mapping of SAAPs to protein
sequence which does not necessarily correspond to the latest sequence data
in the UniProtKB/Swiss-Prot. A method to verify or correct the sequence
position of every missense mutation provided by the OMIM database was
described in Section 2.2.2. Hereafter mutations are reported with respect to the
UniProtKB/Swiss-Prot residue numbering, and where it differs from OMIM
numbering, both sequence positions are stated for easier reference.
3.2.1.2 Mapping OMIM mutations to structure
After being correctly mapped to a residue in an up-to-date UniProtKB/Swiss-Prot se-
quence, every mutation was mapped to a residue in a PDB structure using PDBSWS
(introduced in Section 2.1.4). A given sequence may have been mapped to multiple
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PDB crystal structures, the optimal structure was chosen on the basis first of se-
quence identity with the UniProtKB/Swiss-Prot sequence, second of resolution and
third of R-factor.
3.2.1.3 Multiple sequence alignments of mutation-containing human pro-
teins
In order to identify which OMIM mutations were found to be compensated, multiple
sequence alignments were built, one for every mutation-containing human protein.
Every alignment contained the human UniProtKB/Swiss-Prot sequence, and the
UniProtKB/Swiss-Prot sequences of all reliable (not containing ‘hypothetical’,
‘probable’, ‘putative’, ‘-like’ or ‘homolog’ in UniProtKB/Swiss-Prot
description field) functionally-equivalent proteins identified by the FOSTA
method (for more details, see Section 2.1.5 and McMillan and Martin (2008)).
Once a list of FEPs was obtained, the alignment was created using ClustalW8
(Thompson et al., 1994), with default parameters.
3.2.1.4 Classification into compensated and uncompensated
mutations
Upon successful mapping to at least one residue in a protein structure and aligning
the mutation-containing sequence to at least one functionally-equivalent protein, each
mutation was assigned as a compensated mutation (CPD) or an uncompensated
mutation (PD). This algorithm is presented in Figure 3.2.
Columns from the multiple sequence alignment containing disease-associated muta-
tions in the human protein were identified. If any of the non-human residues in these
columns (aligned to the human pathogenic mutation) matched the amino acid causing
8introduced in Section 2.2.4.1
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Figure 3.2: Creating CPD and PD datasets from the mutation data, the structural and
sequence data and data about functionally-equivalent proteins (FEPs). Where
not stated otherwise, numbers in parentheses denote counts of mutations.
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the disease in humans, that mutation was sorted into the CPD dataset. An example
of a CPD defined in this way was introduced in Section 3.1.2 and Figure 3.1.
3.2.2 Amino acid content of CPDs
The tendency for certain amino acid types to occur preferentially as the native or
mutated amino acid among CPDs was based on the frequency of that amino acid
type in the CPD dataset. The frequency of every amino acid type among CPDs as
the native residue was calculated as follows:
Fnative(X) =
Nnative(X)
Ntotal
(3.1)
where X is one of the 20 standard amino acid types, Nnative(X) is the number of
CPDs having that amino acid type as the native residue, and Ntotal is the total count
of native residues among CPDs (i.e. the number of CPDs processed). Similarly, the
frequency of amino acid types among mutant residues in the CPD dataset was defined
as:
Fmutant(X) =
Nmutant(X)
Ntotal
(3.2)
Now two sets of propensities have been calculated: ‘CPDs-native’ and
‘CPDs-mutant’:
Prnative(X) = ln(
Fnative(X)
Fbackground(X)
);Prmutant(X) = ln(
Fmutant(X)
Fbackground(X)
) (3.3)
where Fbackground(X) is the frequency of amino acid type X in the background dataset
of sequences. The background dataset comprised the full sequences of 245 human
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proteins containing all OMIM mutations successfully mapped to a protein structure
in the Section 3.2.1.2.
The same procedure was repeated for the PDs, resulting in another two sets of propen-
sity scores.
3.2.3 Conservation within an 8A˚ sphere around mutations
Residues spatially surrounding a compensated mutation were investigated for po-
tential compensatory mutations. The method used for identification of likely com-
pensatory mutation sites based on sequence conservation of spatially neighbouring
residues is described below, using the sequence alignment shown in Figure 3.3.
Figure 3.3: A CPD example in the human antithrombin-III protein aligned to its non-
human FEPs.
The Ala419Val CPD mutation is assigned two C/T ratios shown in grey, one
for each CPD-containing sequence (ANT3 BOVIN and ANT3 SHEEP), while
for the Ala416Pro PD mutation, four C/T ratios were calculated, one for every
FEP sequence (also shown in grey).
After identifying the Ala419→Val mutation in human sequence P01008 as a CPD
because P41361 and P32262 (cow and sheep FEPs, respectively) contained a native
valine at position 419, the best-quality crystal structure (PDB ID: 2B5T) mapped to
the human protein (P01008) was examined for all residues having at least one atom
within 8A˚ of Ala419 (the CPD residue). These ‘in range’ residues were then mapped
back onto the alignment and ‘in range’ alignment columns were checked for sequence
divergence from the human sequence in the P41361 and P32262 sequences (the two
sequences which showed a native Val419). This algorithm is summarised in Figure 3.4.
Here an approximation was made that, having identified residues within 8A˚ of the
mutation in the human structure, the equivalent residues in non-human sequences
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are assumed also to be within 8A˚ of the CPD residue in their respective structures.
Thus all ‘in range’ differences in both of the FEP sequences compared with the human
sequence were considered to be potential local compensatory mutations.
Figure 3.4: The number of mutated residues within 8A˚ of a CPD/PD mutation was
counted.
A C/T ratio was calculated for each of the CPD-containing FEP sequences (P41361
and P32262), where C was the number of local (potential compensatory) mutations
and T was the total number of ‘in range’ columns checked for that sequence. In
other words, the C/T ratio was the fraction of spatially neighbouring residues which
were mutated. The ratio was recorded together with the overall pairwise sequence
identity: pairwise sequence identity indicated the average expected C/T ratio for
that protein pair (human and CPD-containing FEP).
Figure 3.3 also contains a pathogenic deviation (PD). At column 416, a mutation to
proline was shown to be deleterious, and no proline was identified at this location
in the FEPs from other species. For PDs, the C/T ratios were calculated for every
non-human sequence aligned to the PD-containing human sequence and recorded
with the pairwise sequence identity. This counting procedure was repeated for every
alignment of sequences, examining both CPDs and PDs.
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3.2.3.1 Linear model of ‘in sphere’ sequence conservation
C/T ratios were tested to see whether they could be approximated with a linear
model. Regression showed that data could indeed be appropriately described by a
linear equation (Pearson correlation coefficient was −0.79 for CPDs and −0.82 for
PDs). Constrained linear regression was performed on each of the datasets, using
the lm test implemented in R. The constraint used was to force lines of best fit to
pass through the (100, 0) point, as further discussed in Section 3.3.3.1. Lines of best
fit describing the CPD and PD datasets were tested: t-test was used on the line
slope estimators using the null-hypothesis that the slopes of these two lines are not
significantly different.
3.2.4 Division into buried and surface mutations
Every structurally-mapped mutation was evaluated in terms of relative solvent ac-
cessibility, using a local implementation of the Lee and Richards algorithm (Lee and
Richards, 1971) on ATOM records in PDB files (for more details of the algorithm,
see Section 2.2.1). According to criteria by Miller et al. (1987), all residues with rel-
ative solvent-accessibility greater than 5% were considered surface residues, whereas
residues with rASAc ≤ 5% were termed buried residues.
3.2.5 SAAPdb analysis of CPDs
The disease-associated mutation was labeled by the SAAPdb pipeline as having or
not having each of the likely structural effects presented in Table 2.2. It is worth
noting that one mutation can be assigned multiple likely structural effects, and that
the sequence conservation category was not used in this chapter, as the focus was on
the structural effects of compensated mutations.
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The fraction of CPDs (or PDs) determined to cause a structural effect, Fcat, was
calculated as:
Fcat = Ncat/Tcat (3.4)
where cat is one of the SAAPdb categories of structural effects, Ncat is the number of
CPDs (or PDs) annotated by the SAAPdb as resulting in that structural effect, and
Tcat is the total number of mutations in the CPD (or PD) dataset. The difference
between calculated fractions of the two datasets was tested by a two-tailed Fisher’s
exact test9 for statistical significance in each structural category. Two significance
thresholds were used to identify categories with significantly different frequencies in
CPD and PD datasets: p < 0.01 and p < 0.05.
Next, each SAAPdb category was assessed for significance after the correction for
multiple testing was applied. The method was introduced in Section 2.3.3; in brief,
the obtained p-values above had to be multiplied by 14 in order to be greater than
0.01 and 0.05 and therefore significant, since Fisher’s exact test was repeated 14 times
on the same dataset10.
3.2.5.1 Monte Carlo simulations
Because of the division of data into PDs and CPDs via a negative observation, a
Monte Carlo simulation (Kroese et al., 2011) was used to test how likely it is to
obtain the same significance values by chance.
9introduced in Section 2.3.2
10the 15th category, ‘explained’, is calculated as a combination of all 14 structural categories and
is therefore not an independent analysis
CHAPTER 3. COMPENSATED PATHOGENIC DEVIATIONS 94
The dataset contained 447 CPDs and 1753 PDs found in SAAPdb11; these data
points were merged and 447 mutations were chosen at random to create set A, the
remaining 1753 being set B. For each of the structural explanation categories, a p-
value was calculated (as before, using the Fisher’s exact test) based on this random
division of the data. The random division and calculation of p-values was repeated
10000 times and, for each structural explanation, the fraction of ‘random p-values’
that were lower than the observed p-value was recorded.
3.2.6 Potential compensatory mutation examples
The four compensation examples presented in Figures 3.12–3.15 were created using
RasMol (Sayle and Milner-White, 1995). Simple modelled structures shown in sub-
figures C and D of each figure were obtained using mutmodel (Martin et al., 2002),
each time replacing a single sidechain using the minimum perturbation protocol (Shih
et al., 1985), where the sidechain’s torsion angles are rotated to find the optimum
orientation.
3.3 Results and discussion
This project expands previously mentioned studies by carefully selecting
the largest presently known CPD dataset, described in Section 3.3.1.
Section 3.3.1.1 compares and contrasts properties of the dataset introduced
here, CPDAB, and other publicly available datasets of CPDs. In order
to verify the quality of the dataset, Sections 3.3.1.2–3.3.1.4 summarise
the spread of CPDs over human protein space, protein family space and
within protein families, respectively. Section 3.3.1.5 discusses the frequency
of compensated mutations among deleterious mutations, followed by an
11the remaining 9 CPDs and 97 PDs were lost owing to different OMIM versions between the
version used in this work and the one used previously when SAAPdb was built
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analysis of preferences for amino acid types among both CPDs and PDs in
Section 3.3.2.
The main goal of this project was to examine the location of compensatory mutations
within protein structure, and the nature of pathogenic mutations which can be com-
pensated. More precisely, it provides a structural context to the CPDs by answering
the following questions: (i) in Section 3.3.3.1, how conserved are their structural
surroundings, (ii) in Section 3.3.3.2, where in the protein structures are CPDs preva-
lently found, and finally (iii) in Section 3.3.4, which effects these mutations have on
protein structures.
3.3.1 The CPD dataset
2328 disease-associated mutations from OMIM (McKusick, 2000; Amberger et al.,
2009) occurring in 245 human proteins were successfully mapped both to a residue
in a UniProtKB/Swiss-Prot (Boeckmann et al., 2003) sequence and to a struc-
ture in the Protein Databank (PDB) (Berman et al., 2000). Of these, 453 muta-
tions (19.46%) were found as a native residue in at least one non-human aligned
functionally-equivalent protein sequence and thus annotated as CPDs. The remain-
ing 1875 mutations (80.54%) were labelled as PDs. This dataset of CPDs and PDs
will hereafter be referred to as CPDAB. Considering that the PD dataset was based
on negative observation, it is possible that, with expansion of known sequence and
structural space, some PDs will become CPDs. On a similar note, according to Daw-
son et al. (2010), sequence quality must be considered, thus some of the CPDs might
have been false positives owing to experimental errors.
In the last decade, there have been several analyses of CPDs (Kondrashov et al.,
2002; Kulathinal et al., 2004; Poon et al., 2005; Ferrer-Costa et al., 2007; Zhang et
al., 2010; Baresˇic´ et al., 2010). All methods obtain a dataset of DAMs, decide on the
homologues to be searched for compensated mutations, align these homologues to the
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Table 3.1: Datasets of compensated pathogenic deviations described in the literature.
Table obtained from Baresˇic´ and Martin (2011).
Dataset Species Identity cut-off Alignment
method
Human◦
proteins
#
DAMs
#CPDs
Kondrashov Any CLUSTALW 32 4880+ 608
mammals† > 50% 3 20
Kulathinal Diptera 475◦ 1527 6
Ferrer-Costa∗ Any ≥ 10% (> 60%) Pfam 287 (24) 9334 1658 (52)
mammals 184 847
Baresˇic´ Any None ? MUSCLE 245 2328 453
Zhang-missense Human, ANFO 2628 44348 62
neanderthal,
chimpanzee
Poon Set-A Any 43‡ 115 88
Poon Set-B Any 17‡ 59 49
The Poon Set-A includes mutations brought about by mutagenic agents while Set-B does
not.
+ Precise numbers are somewhat unclear. They report 608 CPDs and that this is approx-
imately 10% of DAMs. In table 1 of their paper (Kondrashov et al., 2002), there are 4272
‘known missense’ mutations which are most likely PDs since the last row of the table has
more CPDs than ‘known missense’ mutations. This makes a total of 4880 (4272+608) DAMs.
† Kondrashov tested all found orthologues (with no sequence identity threshold) for CPDs
and then switched to mammalian-only orthologues to identify compensatory mutations
◦ In the Kulathinal dataset (Kulathinal et al., 2004), the reference species is D. melanogaster
∗ Numbers in parentheses refer to the CPDs used for structural analysis (Ferrer-Costa et al.,
2007)
? Functional-equivalence among homologues used instead of a sequence identity threshold
(Baresˇic´ et al., 2010)
 Dataset originates from Zhang et al. (2010)
‡ There is no reference species in the work of Poon et al. (2005)
DAM-containing sequence and finally, identify compensated mutations. As already
mentioned in Section 3.1.4.3, despite all the authors using a very similar definition
of CPDs, the methodology implementing the steps listed above differs significantly.
Therefore the review by Baresˇic´ and Martin (2011) attempts to compare and contrast
all published CPD datasets, and Table 3.1, reproduced from that review, is presented
here and referred to throughout this chapter.
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3.3.1.1 The use of functionally-equivalent proteins instead of close ho-
mologues
The most important difference in building CPDAB is the use of
functionally-equivalent proteins (FEPs) rather than orthologues derived from
Pfam (Finn et al., 2006) (as used by Ferrer-Costa), or from BLAST (as used
by Kondrashov). In both papers, orthologues had to satisfy sequence identity
thresholds to ensure that diverged homologues were not used for the CPD
identification: Ferrer-Costa used protein families defined in Pfam and removed
homologues with < 10% sequence identity with the human sequence, and
Kondrashov used only human proteins that can be aligned to a minimum of three
sequences with > 50% sequence identity each. Some of these orthologues could
have diverged in function and, where they have, key functional residues were, by
definition, subjected to mutation (McMillan and Martin, 2008). While the broader
sets of sequences used in other work have lead to identification of additional CPDs,
using more restricted sets of FEPs obtained from the FOSTA database (McMillan
and Martin, 2008) ensured that this situation will not arise. Finally, this project
set out to compare compensated an uncompensated SAAPs in the broadest sense
possible, and for that the accuracy of the PD subset was crucial: limiting ourselves
to CPDs restricted to recently evolved homologues would hinder this attempt.
Ferrer-Costa et al. (2007) identified a significantly larger set of 811 human proteins
containing mutations (compared with 245 in CPDAB). Many of these mapped only
to homologues of high sequence identity (Table 3.1), whereas the CPDAB dataset
included only mutations mapped to structure. In addition, they extracted mutation
data from UniProtKB/Swiss-Prot annotations, resulting in a different set of muta-
tions from those identified from OMIM here. 35% of the larger (sequence-based)
Ferrer-Costa disease-associated protein dataset contained at least one CPD location,
but the relative accessibility analysis was based on only 24 proteins with available
protein structures.
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All other CPD datasets listed in Table 3.1 either focused on the recently diverged ho-
mologues when searching for CPDs (Kulathinal and Zhang datasets), or provided no
new structural features of gathered CPDs (Kondrashov). Moreover, CPD detection
by Kondrashov and colleagues was based on a small number of proteins reported to
have large numbers of pathogenic deviations (at least 50 per protein). As a result,
the percentage of human proteins containing a CPD in the Kondrashov dataset was
significantly higher than in the CPDAB and Ferrer-Costa datasets, at the same time
adding bias towards protein families with many reported DAMs. The Poon (2005)
dataset is removed from further consideration as a significant fraction of this dataset
belongs to artificially induced mutation, and thus is not suitable for discussion of nat-
ural emergence of compensated mutations. To conclude, so far the CPDAB seemed
the best compromise among publicly available datasets of CPDs, and as such was
suitable for comparing with uncompensated deleterious mutations.
3.3.1.2 Redundancy of CPD-containing human proteins
2328 OMIM mutations, successfully mapped to a protein structure, were found in 245
human proteins. 85 of these proteins contained at least one CPD. The distribution
of these 85 proteins over the human sequence space was tested, in order to identify
whether CPDAB dataset is biased towards a small number of redundant human
proteins.
The sequence identity over the whole pairwise alignment length was calculated for
every pair of CPD-containing human proteins by an in-house implementation of the
Needleman & Wunsch algorithm (1970), and was used as a measure of sequence
redundancy. The distribution of these 85 × 84/2 = 2570 sequence identity values is
shown in Figure 3.5. With the mean sequence identity of 6.79% between two CPD-
containing human proteins, CPDAB is not only an extensive dataset, but it also
shows very little redundancy.
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CPD−containing human proteins
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Figure 3.5: Diversity of CPD-containing human proteins.
Diversity was calculated as the mean pairwise sequence identity of each pair of
human protein sequences. Mean standard sequence identity (average of 2570
data points) was 6.79%, with standard deviation of 4.92%.
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Figure 3.6: Diversity of FEP families containing PDs (264) and CPDs (85).
Some families may occur in both datasets. The histogram is normalized such
that the total height of the bars is the same between the two sets. Diversity
was calculated as the mean pairwise sequence identity within the family.
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3.3.1.3 Redundancy within FOSTA families
In order to identify whether there was any bias in alignments used to identify CPDs,
all FOSTA families were examined in terms of their sequence redundancy. Again,
redundancy was measured as an averaged pairwise sequence identity, but this time
for all the sequence pairs within one FOSTA family (a mutation-containing human
sequence and all functionally-equivalent sequences).
Mean family sequence identities are shown in Figure 3.6. First, both CPD and PD
datasets presented in this study were evenly spread across families with different
levels of diversity. Second, while compensatory events were more common in more
diverse families (i.e. those which, on average, contain more distantly related mem-
bers), they occurred even in families which show very low diversity. In summary,
FOSTA alignments sufficiently cover families of FEPs with both ancient and recent
common ancestors.
3.3.1.4 Sequence identity distribution over human-FEP pairs
As previously mentioned, earlier work on CPDs mainly focused on mutations found
compensated in relatively close homologues (Kondrashov et al., 2002; Kulathinal et
al., 2004; Zhang et al., 2010). Since there was no sequence similarity threshold im-
posed during the CPDAB dataset build, the question arose of what the distances
were between the human sequence containing disease-associated mutations, and the
functionally-equivalent homologue in which the mutated residue type was found as
native. A distance from the human sequence, in terms of pairwise sequence iden-
tity, was measured for every CPD-containing FEP sequence, e.g. ANT3 BOVIN and
ANT3 SHEEP in Figure 3.1, and pairwise sequence identity was recorded, yielding
3218 human-FEP pairs for 453 CPDs, shown in Figure 3.7.
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This graph shows that there is a significant number of CPDs within moderately
and highly sequence-diverged homologues, which have probably been excluded from
the previous studies. In addition, three peaks in the human-FEP distribution (Fig-
ure 3.7) are suggested (∼ 85%, ∼ 70% and ∼ 45% possibly corresponding to mam-
malian, other-eukaryotic and prokaryotic homologues (Kondrashov, personal com-
munication)).
3.3.1.5 Prevalence of compensation among disease-associated
mutations
To summarise the comparison of the datasets presented above, there are several ad-
vantages of the algorithm utilised in creation of the CPDAB dataset. First, there
were no assumptions made about the distance of the homologue from the human
sequence, and the sequence features of the homologue; all restrictions were based
on functional annotation. Second, there were no restrictions imposed on the num-
ber of sequences in the multiple sequence alignment, or the number of compen-
sated mutations observed in the alignment. Third, by choosing mutations from a
widely used resource like OMIM, it was ensured that mutations occurred in proteins
that were often sufficiently interesting for protein structure to have been solved.
In turn, this guaranteed a high level of cross-referencing between sequence and
structure, thus enabling structural characterisation of the large fraction of muta-
tions.
Similar to the Ferrer-Costa dataset of CPDs12, CPDAB had 19.5% compensated
mutations. While some of the CPDs presented in this work may be false positives,
detected in distant homologues and possibly resulting from poorly built alignments
in highly variable regions, it will be interesting to follow the change in compensation
frequency as more sequences become available from high-throughput sequencing, and
as FOSTA grows in terms of family number and sizes. The current projection is that,
12where 18% (1658/9334) of the larger, sequence-based dataset of mutations were found to be
compensated
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Figure 3.7: Distance between the human sequence and FEP sequence containing mutated
residue type as native.
It should be noted here that several homologues could have been identified for
a unique disease-associated mutation.
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Figure 3.8: Amino acid propensities in PDs and CPDs.
Amino acid types have been ordered by ascending hydrophobicity on the Kyte
& Doolittle scale (introduced in Section 4.1), from left to right.
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when no sequence similarity cut-offs are imposed on the orthologues, compensation
occurs once for every five DAMs.
3.3.2 Distribution of amino acid types among mutations
Both CPDs and PDs were considered in terms of their native and mutated amino
acid type preferences, as shown in Figure 3.8. A positive value, e.g. H in ‘CPDs-
native’, denotes that the histidine was overrepresented as a native residue among
CPDs, when compared with the frequency of histidines among human proteins from
which the mutations were extracted from. In other words, mutations from histidine
to another amino acid were more common than expected among CPDs.
These propensities are interesting to analyse in the light of amino acid ‘age’. Accord-
ing to Jordan et al. (2005), amino acid types can be divided into ancient ones (P, A,
G and E) and the more recently emerged ones (F, C, M, H and S). Furthermore, since
the recent ones had less time to evolve and sample their roles in different positions in
the proteins, it is to be expected that protein sequences get depleted in the ancient
amino acid types, at the account of more recent ones13. Indeed, both PDs and CPDs
mostly follow this trend, with some exceptions. There are fewer methionines and
histidines in ‘CPDs-mutant’ than in ‘CPDs-native’: presumably these amino acids
are involved in functions or interactions for which it is hard to compensate using an-
other amino acid. Additionally, proline should be less common among mutant than
among native residues; among PDs the opposite was observed, indicating that the
introduction of proline is often pathogenic, and probably requires complex and/or
multiple changes fully to compensate for its effect on protein fitness.
While no clear trends emerged in this survey, it will be interesting to repeat this
analysis when SAAPdb has been updated, and both the PD and CPD datasets
increase.
13where this substitution is not detrimental to the protein
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3.3.3 CPD localisation in the protein structure
3.3.3.1 Sequence conservation within the sphere
This analysis compared frequencies of mutations occurring in the residues surround-
ing a CPD or a PD in the structure, i.e. it is set to search for the ‘sphere compensa-
tion’. In common with Kondrashov et al. (2002), it hypothesizes that compensatory
mutations, neutralizing a CPD’s pathogenicity, are likely to be physically close to a
CPD and, more precisely, participate in short-range interactions with the compen-
sated mutation. To define residues making a one-residue-wide sphere around the
mutated residue in the protein structure, all residues with any atoms within 8A˚ dis-
tance from any atoms in the CPD residue, based on PDB atom coordinates, were
considered ‘in sphere’ residues.
Figure 3.9 shows the distribution of sequence variability in residues surrounding a
CPD, compared with PDs. C/T ratios (where C was the number of local potentially
compensatory mutations and T was the total number of ‘in range’ columns in the
alignment checked for that sequence, see Section 3.2.3) represent the fraction of in-
range residues that are mutated. Ratios were also taken for PDs in order to control
for sequence variability. Owing to the great number of points on the graph, and in
order to see if there is any major difference between the two datasets, C/T ratios
were averaged for each dataset in 1% sequence identity bins, as shown in Figure 3.10.
Indeed averaged C/T ratios indicated an increased sequence variability around CPDs,
when compared with spheres around the PDs.
Restrained linear regression was performed on the full datasets to obtain lines of
best fit, the restraint being the biologically obvious condition that both lines have to
pass through 0 mutations when the sequence identity is 100%. The line equations
show a significant increase in the slope for the CPD dataset (Z-statistic=7.860, with
p < 0.05). When the restraint was removed and the linear model was built again, the
Z-statistic increased, indicating still significantly different ‘in sphere’ conservation
CHAPTER 3. COMPENSATED PATHOGENIC DEVIATIONS 105
20 40 60 80 100
0 .
0
0 .
2
0 .
4
0 .
6
0 .
8
1 .
0
Frequency of observed mutations within 8A sphere
Sequence identity in %
C o
m
p e
n s
a t
o r
y  
m
u t
a t
i o
n s
 /  
c o
u n
t e
d  
r e
s i
d u
e s
CPDs
PDs
Figure 3.9: Dependency of the local mutation ratio on sequence identity.
The C/T ratio for residues within an 8A˚ sphere of each mutation is plotted
against pairwise sequence identity for both CPDs and PDs.
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Figure 3.10: Dependency of the local mutation ratio on sequence identity.
The line of best fit, obtained by linear regression with a (100, 0) constraint for
both complete datasets (i.e. the data shown in a): 3138 data points for CPDs
and 74429 data points for PDs) is shown together with the average C/T ratio
for each 1% sequence identity bin to illustrate the trends in the data.
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trends between CPDs and PDs. This increase in the number of diverged residues in
the structural neighbourhood of CPDs strongly supports the hypothesis that com-
pensation is commonly a local effect, as previously suggested by Kondrashov et al.
(2002).
Now let’s consider the values of the slopes obtained by linear modelling. For the CPDs
in Figure 3.10, the best-fit line had a slope of −1.007. Considering that the −1.00
slope corresponds to random mutation events happening at the rate proportional to
the average sequence identity for the two sequences in question, it is obvious that
CPDs reflect a set of random mutational events, i.e. they are the direct result of
the random genetic drift. In contrast, the lower slope of the PD linear model (-
0.9) points to spheres with higher conservation than expected by random drift (for
structural or functional reasons), meaning that compensation is less likely to occur
within these spheres. In other words, if the environment of a residue is conserved
through evolution owing to some functional or structural constraints, a mutation is
less likely to be easily compensatable. This decreased likelihood of compensation in
more conserved regions corresponds to previous conclusions made by Ferrer-Costa et
al. (2007) about CPDs occurring in less structurally constrained locations, provided
the residues are assumed to be conserved owing to structural, and not functional
constraints.
3.3.3.2 Buried vs. surface mutations
An average relative solvent accessibility was calculated for all compensated and un-
compensated mutations in CPDAB. With the mean rASA = 43.4 ± 28.0% for the
CPDs and mean rASA = 26.9 ± 27.2% for the PDs, the CPDs presented higher
propensity for solvent-exposed residues in the protein structure. Again, this analysis
confirmed, on a significantly larger dataset, previous results by Ferrer-Costa et al.
(2007) indicating that CPDs prefer more solvent-accessible positions. In the case of
a surface residue, it is reasonable to assume that compensation may appear through
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interaction with other mutated molecules, although Poon et al. (2005) claim intra-
chain compensation is a lot more common.
In order to test whether the average ‘in sphere’ conservation differs between buried
and surface residues, CPDs and PDs were divided based on solvent accessibility, as de-
scribed in Section 3.2.4. Lines of best fit were then modelled for buried/surface CPDs
and buried/surface PDs. The same procedure was repeated with two buried/surface
thresholds: rASA = 5% and rASA = 10% 14.
Table 3.2: Linear models of conservation in buried and surface CPDs and PDs.
Best-fit line slope Best-fit line r2 b Correlation coeff.c
CPDs all −1.007× 10−2 90.5% -0.79
CPDs buried (≤5%)a −1.040× 10−2 96.0% -0.81
CPDs buried (≤10%) −1.025× 10−2 95.7% -0.79
CPDs surface (>5%) −0.999× 10−2 89.1% -0.78
CPDs surface (>10%) −1.001× 10−2 88.9% -0.78
PDs all −0.900× 10−2 84.5% -0.82
PDs buried (≤5%) −0.894× 10−2 89.7% -0.86
PDs buried (≤10%) −0.892× 10−2 89.4% -0.86
PDs surface (>5%) −0.906× 10−2 85.1% -0.82
PDs surface (>10%) −0.909× 10−2 84.5% -0.82
aNumbers in brackets indicate which rASA values were used as a cut-off value
badjusted r2 from lm test implemented in R
cPearson correlation coefficient
The Pearson correlation coefficient between the linear model and data was cal-
culated for every combination; high correlation coefficients obtained justified the
approximation of C/T ratios with a linear correlation, see Table 3.2, fourth col-
umn. As shown in the second column of Table 3.2, the slopes of the lines of
best fit for all buried/surface cases were almost indistinguishable from the equiv-
alent lines in the full datasets, with CPD slopes close to −1.00 and somewhat
lower PD slopes. The only notable difference was that CPDs showed a slight in-
crease in slope being −1.025 or −1.040 when only buried CPDs were taken into
account. These values suggest that, when CPDs occur in the protein core, they
14rASA ≤ 5% or rASA ≤ 10% classified as buried, and rASA > 5% or rASA > 10% classified as
surface
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are accompanied by a somewhat higher than random local mutation rate. The
changes in PD slopes when only buried or surface PDs were considered were neg-
ligible.
3.3.4 Structural analysis of the effects of CPDs
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Figure 3.11: Relative frequencies of predicted structural effects for CPDs and PDs.
Values are indicated at the top of each bar. Significantly different bars
(Fisher’s exact test, see Table 3.2) after application of the Bonferroni cor-
rection for multiple testing are indicated (* p < 0.05, ** p < 0.01). Each
bar represents Fcat, as defined in Section 3.2.5. The ‘struc explained’ bar is a
summary representing explanation by any of the other structural tests shown
in this figure. In the case of this category, no correction was applied giving
p = 6.71× 10−14.
Fractions of PDs and CPDs for which structural effects have been identified in
SAAPdb are shown in Figure 3.11, grouped by classes and divided into categories of
likely structural effects. Analysis of relative frequencies in fourteen categories covered
four classes of disrupting effects: protein interface, binding properties, protein folding
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and stability. These categories were briefly described in Table 2.2 and have been ex-
plained in detail by Hurst et al. (2008). Differences between the two datasets give an
insight into which types of structural disruptions are more likely to be compensated,
showing that the compensation of pathogenic mutations is highly dependent on the
nature of the mutation’s effect on the structure.
3.3.4.1 Testing each SAAPdb category for CPD-PD difference
After mapping each OMIM mutation to the most reliable protein structure, as de-
scribed in Section 3.2.1.2, SAAPdb was queried for each mutation, and structural
effects likely to be caused by that mutation were extracted. 447 CPDs and 1753 PDs
were found processed in the latest version of SAAPdb. For each structural category
presented in Table 2.2, the fraction of the CPDs and PDs observed causing that
structural effect has been listed in Figure 3.11, and the Bonferroni-corrected p-values
from a Fisher’s exact test have been listed in Table 3.3.
In order to compensate for the multiple testing on the same dataset which increases
the probability of observing significant PD-to-CPD difference by chance, observed
p-values were adjusted using rigorous Bonferonni correction. It should be noted here
that, instead of evaluating which p-values are smaller than corrected α values, 0.01/14
and 0.05/14 respectively, all p-values were multiplied with 14. This is to facilitate
data interpretation, as a person is likely automatically to evaluate presented p-values
by comparing them with α = 0.01 and α = 0.05. Even after correcting for full
dependence between SAAPdb categories, although these are at best only partially
dependent, the dataset presented here clearly shows different trends in CPDs and PDs
in categories: binding, UniProtKB/Swiss-Prot features, proline, clash and buried
charge, as shown in Table 3.3. These results are further discussed for each class in
Sections 3.3.4.3–3.3.4.6.
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Table 3.3: Difference in frequencies in structural effect categories observed between CPDs
and PDs, raw frequencies, and after correcting for multiple testing.
p-values refer to a two-tailed Fisher’s exact test (d.f. = 1); Bonferroni-corrected
p-values are uncorrected p-values multiplied by 14, to allow them to be compared
with conventional α values of 0.05 and 0.01. Significance levels are marked as:
* p < 0.05, ** p < 0.01. The mc-value shows the result of a Monte Carlo
simulation and is the fraction of random divisions of the data which obtain the
observed uncorrected p-value or better (see text).
Structural Uncorrected Uncorrected Corrected Corrected
category p-value significance p-value significance mc-value
PQSa 0.86 1† 0.81
bindingb 1.09× 10−4 ** 1.5× 10−3 ** 0.00
MMDBb 0.32 1† 0.31
sprotFTb 6.46× 10−6 ** 9.04× 10−5 ** 0.00
prolinec 1.57× 10−6 ** 2.20× 10−5 ** 0.00
glycinec 7.05× 10−2 9.87× 10−1 0.07
clashc 5.68× 10−13 ** 7.95× 10−12 ** 0.00
cisprolinec 1 1† 0.36
hbondingd 1.99× 10−3 ** 2.79× 10−2 * 0.00
voidd 5.16× 10−2 7.22× 10−1 0.05
corephilicd 1.32× 10−3 ** 1.85× 10−2 * 0.08
surfacephobicd 0.10 1† 0.09
buriedcharged 4.62× 10−10 ** 6.47× 10−9 ** 0.00
SSgeometryd 1.31× 10−3 ** 1.83× 10−2 * 0.00
aInterface explanations
bFunctional explanations
cFolding (fold-preventing) explanations
dInstability (destabilizing) explanations
1† indicates corrected p-value was greater than 1
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3.3.4.2 Confirming results with Monte Carlo simulations
Assignment of mutations as PDs or CPDs is based on a negative observation, i.e. that
this mutation, known to cause disease in humans, has not been observed as the native
residue in a FEP from another species. Consequently, the number of CPDs may be
an under-estimate simply because FEPs have not yet been observed demonstrating
that compensation can take place.
In order to test that the significance of the results observed above was not a result of
random partitioning of the data, a 10000-iteration Monte Carlo simulation was run
as described in Section 3.2.5.1. The results shown in Table 3.3, indicate that where
the observed (Bonferroni-corrected) p-value was < 0.01, the probability of seeing this
p-value by chance was zero (i.e. mc-value = 0.00 when p < 0.01). Where p < 0.05,
there was a > 91.7% probability that the results were not obtained by chance (i.e.
mc-value ≤ 0.083 when p < 0.05).
To conclude, even when using very stringent Bonferonni correction, some statistically
significant differences between CPDs and PDs in terms of SAAPdb structural cate-
gories have been identified. The same trends have also been observed as significant
during Monte Carlo simulations. In other words, random partitioning of the muta-
tion data failed to replicate observed differences in frequencies between CPDs and
PDs for some SAAPdb categories: these features are indeed specific for compensated
missense mutations. Therefore, these results show compelling evidence that compen-
sated and uncompensated mutations have different effects on the protein structure.
The following four sections will cover the main classes of structural effects represented
in SAAPdb, providing one example for every effect class: interface, binding, folding
and stability.
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3.3.4.3 Interface disrupting effects
Interface residues have been defined as surface residues in the monomer which undergo
a change in relative accessibility of ≥10% on complex formation. 26.5% of CPDs and
26.1% of PDs occurred in interface residues found in PQS files (Henrick and Thornton,
1998). This is the only structural category for which the frequency of CPDs is the
same, or greater than, the frequency of PDs. This finding was in agreement with the
recent observations that CPDs are often found in residues having fewer intra-protein
interactions (Ferrer-Costa et al., 2007) (and hence have fewer structural constraints),
indicating that it might be relatively easy to compensate for the detrimental effects
of interface residues. An example of a compensated mutation in a protein interface
is shown in Figure 3.12.
Figure 3.12: Potential compensation of a mutation affecting an interface residue.
a) The position of Arg249→Ser is shown on the human GTP cyclohydrolase
pentamer structure, PDB ID: 1FB1. This CPD occurs at an interface in the
pentamer and causes dopa-responsive dystonia. b) Detail of Arg249 and its
interaction with Ser250 from a neighbouring monomer. Multiple non-bond
interactions between Arg249 and Ser250 contribute to pentamer stability. c)
The Arg249→Ser mutation causes the loss of function in GCH1 HUMAN by
losing multiple non-bonded interactions (modelled structure shown) and hence
destabilizing its structure. d) The Rickettsia bellii FEP has compensated for
the Ser249 lost contacts by introducing Lys250 (modelled structure).
3.3.4.4 Mutations affecting binding
A significantly greater fraction of PDs than CPDs was assigned as making specific
binding interactions (hydrogen bonds defined according to the rules of Baker and
Hubbard (1984), or non-bonded contacts) to a ligand or another protein chain (Fig-
ure 3.11, category ‘binding’). Using data from the MMDBBIND database (Bader et
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al., 2001) to identify binding residues rather than the PDB data, also showed a greater
fraction of PDs than CPDs, but the difference was not statistically significant.
It is not surprising that, owing to the specific properties required for H-bonds or
interactions at interfaces, these results showed compensating for a mutation at a
specific binding residue is usually difficult. An example of a potential compensated
mutation at a binding residue is shown in Figure 3.13.
Figure 3.13: Potential compensation of a mutation affecting a binding residue.
a) Asn34→Ser position is shown on the human UDP-glucose 4-epimerase
structure, PDB ID: 1EK6. This CPD occurs in a binding site and in a PQS
interface and causes epimerase-deficiency galactosemia. b) Detail of Asn34
and its interaction with NAD+. c) The Asn34→Ser mutation causes the loss
of hydrogen bond with the exogenous NAD+, needed for the normal function
of the human protein (modelled structure). d) The Streptococcus thermophilus
and Streptococcus mutans FEPs have compensated for the Ser34 by introduc-
ing Asn107, which in turn stabilizes protein-ligand interaction, shown on the
modelled structure.
3.3.4.5 Folding disruption effects
This class of structural effects describes cases where the mutation is likely to prevent
correct folding of the protein and is represented by (i) mutations from cis-proline,
to proline and from glycine (where backbone torsion angles are unfavourable for
the replacement residue), and (ii) introduction of a bulkier, clash-causing residue.
Mutations from cis-proline were very rare in CPDAB, and were not considered fur-
ther.
Mutations from another amino acid to proline are expected to be damaging to
protein structure when the native residue has a backbone conformation disallowed
by proline’s cyclic sidechain. Previously shown results on amino acid propensities
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additionally confirmed that prolines were rare among CPD-mutant residues, obvi-
ously the complexity of the required compensation is large enough to overturn the
trend of accumulation of proline in recent protein sequences, for more details see
Section 3.3.2.
Substitution to a clash-causing residue was extremely rare among CPDs compared
with PDs. This is not surprising as compensating for a clashing residue would proba-
bly need several, chronologically earlier, cascading compensatory mutation events to
create a void large enough to accommodate the clashing residue; such a void would
itself be destabilizing. A rare example of a clash compensation is observed in human
triosephosphate isomerase FEPs, as shown in Figure 3.14.
Figure 3.14: Potential compensation of a mutation affecting a folding residue.
a) The position of Gly122→Arg is shown on the human triosephosphate iso-
merase dimer structure, PDB ID:1WYI. This CPD causes a clash and a buried
charge, and increases thermo-sensitivity of the human protein. b) Detailed po-
sition of Gly122 and Trp90. c) The Gly122→Arg mutation causes atom clash,
indicated by the arrow, between larger sidechain of Arg122 and native Trp90
(modelled structure). d) Substituting Trp90 with a smaller Lys compensates
for the introduction of the Arg122 in several bacterial FEPs (Aquifex aeoli-
cus, Coxiella burnetii, Mycoplasma gallisepticum, Treponema pallidum, Xylella
fastidiosa, Chromohalobacter salexigens), shown on the modelled structure.
3.3.4.6 Mutations affecting protein stability
Mutations affecting protein stability introduce no physical barriers to prevent
correct folding, but reduce the stability of the correctly folded form below that
of unfolded or misfolded states (Hurst et al., 2008). Disruption of hydrogen
bonding, creation of voids, misplaced charges, hydrophillics, or hydrophobics,
and disruption of disulphides all fall into this category. Such mutations may
be temperature-sensitive (such as the Val143→Ala mutation in p53 (Martin
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et al., 2002)) and are the main category of interest in ‘rescuing’ protein
function (Bullock and Fersht, 2001; Friedler et al., 2003; Friedler et al.,
2002).
Very few cases of disruption of disulphides were observed, and this category was not
considered further.
Mutations that affect hydrogen-bonding were identified in SAAPdb according to the
method of Cuff et al. (2006). Considering the fact that hydrogen bonds have a
strong effect on protein stability (Cuff et al., 2006) and that precise geometries are
involved, it is not surprising that mutations affecting hydrogen-bonding were found
very commonly in both datasets. The high frequencies in both datasets, 8.17% of
CPDs and 13.44% of PDs, indicated a common occurrence of both mutation types
in hydrogen bonding residues, although there are significantly fewer hydrogen-bond
disrupting CPDs than PDs. This suggests that it is difficult to make compensatory
mutations which counteract the disruption of the intricate hydrogen-bonding network
in the protein core.
The creation of voids of volume > 275A˚3 did not show a significant difference be-
tween the CPD and PD datasets. The Cuff void calculation method (Cuff and Martin,
2004) calculates the volume of voids assuming that no movements occur in the pro-
tein structure. In reality it is likely that several small movements of sidechains and
backbone will occur to fill the void (at least partially). Only if these movements are
too great will the stability and function of the protein be disrupted. It appears that
in the CPDs, voids can be compensated for by replacing one or more local sidechains
with a larger residue. A number of small changes can compensate as effectively as
a single larger change and these may be accommodated more easily if, in evolution,
they occur before the CPD. Figure 3.15 shows an example of a compensated void
mutation in glucose-6-phosphate dehydrogenase.
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Figure 3.15: Potential compensation of a stability-reducing mutation.
a) The Phe173→Leu is shown on the human glucose 6 phosphate dehydroge-
nase structure, PDB ID:2BH9. This CPD creates a void and causes neonatal
jaundice. b) Detail of Phe173 and its relative position to Val169. c) Substi-
tution of aromatic Phe173 with a smaller leucine creates an enlarged ‘void2’
in the protein core, indicated by the arrow (modelled structure). d) Sev-
eral bacterial FEPs have compensated for the void creation by substituting
Val169 with a larger residue: Leu, Ile or Met. The compensatory effect of
Val169→Ile in Buchnera aphidicola subsp. Schizaphis graminum and subsp.
Baizongia pistacia FEPs, shown here on a modelled structure. Introducing a
larger isoleucine reduces the ‘void1’ size, increases the distance between the
two voids, and in turn stabilizes the structure (indicated by an arrow). In
b)–d), only the two residues of interest are shown. The small spheres fill
buried voids surrounding the residues and bounded by the rest of the protein
structure.
Introducing a hydrophilic residue or an unsatisfied charge in the protein core (Hurst
et al., 2008) were significantly less likely to be compensated for, again, showing the
great complexity of interactions among tightly packed buried residues. Compensat-
ing for a buried hydrophilic or charge would require introduction of a compensatory
hydrophilic or charged residue (which, by itself, would be destabilizing) in a pre-
cise orientation in the core. The observation that such events are rare argues for
the first DePristo hypothesis described in Section 3.1.4.2, in which phenotypically
neutral compensatory mutations are introduced before the compensated mutation.
Introducing a hydrophobic residue on the surface seems to be easier to compensate
for, although a detailed analysis of multi-chain proteins and complexes with ligands
would be required in order to explain these mechanisms fully.
In summary, frequencies of structural effects in both datasets presented here were
quite similar to PD frequencies presented by Hurst et al. (2008). The differences
in frequencies between overall counts per category (CPDs+PDs), and PD counts in
that earlier work are a result of that PD dataset including other mutation sources
CHAPTER 3. COMPENSATED PATHOGENIC DEVIATIONS 117
in addition to OMIM. However, some categories typical for buried residues (such
as introducing a hydrophilic residue, buried charge, clash and SS-geometry) show a
striking difference between PDs and CPDs, indicating these effects are less likely to
be compensated for.
3.4 Conclusions
The results presented here have three main novel aspects: (i) the orthologous pro-
teins have been chosen on the basis of functional equivalence rather than sequence
identity thresholds, (ii) CPDs have been surveyed in a structural context on a much
larger scale than previous work and (iii) the range of surveyed effects of CPDs on
protein structure is greater than in previous work. The SAAPdb database (Hurst et
al., 2008) was utilised to analyze the specific structural effects of CPDs in a range
of structural categories, comparing them with PDs. The reliability of the analyses
was increased by using data on functionally-equivalent proteins for the multiple se-
quence alignments, because even relatively similar sequences can diverge in function
(McMillan and Martin, 2008). The large size of the dataset and its wide spread
across different protein families appears sufficient for a broad structural analysis of
human disease-associated single amino acid mutations and cases where these have
been compensated in other species.
Compensation of disease-associated mutations is fairly common and should not
be neglected when protein evolution and/or disease-associated mutations are
researched. Compensation through epistatic interactions with compensatory
mutation(s) is mostly intragenic (Poon et al., 2005). The complexity of
compensatory events ranges from the simple one-on-one scenario (which is less
common, although several examples have been introduced throughout this chapter)
to a series of compensatory events, usually in close spatial vicinity to the pathogenic
mutation.
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The ratio of the pathogenic mutations for which compensation has been observed is
very methodology-dependent. In particular, it seems to increase when the conditions
for homologues included in the alignments are relaxed, and based on the CPDAB
dataset and other datasets presented in Table 3.1, it is estimated that up to 20% of
DAMs encounter full fitness reversal.
Obviously the quality of the dataset presented in this chapter could be further im-
proved: an update of the presented set of analyses is planned once SAAPdb is up-
dated with the recent mutation data and protein sequences (yielding more accurate
FOSTA annotations and sequence-to-structure mappings). In addition, in an age
when there is mass production of genomic data owing to the recent advances in se-
quencing technologies, one should exercise caution when analysing any mutation data
and make sure falsely annotated mutations, which are actually the results of errors in
the sequencing technology, are identified, and filtered out as false positive data.
In terms of their structural features, CPDs obtained in this project prefer protein
surfaces, and in general, less conserved and structurally constrained areas. The anal-
ysis of structural surroundings of compensated mutations indicated that the variation
and potential compensatory mutations occur mostly through random genetic drift,
while uncompensatable pathogenic mutations tend to occur in more conserved pro-
tein structure segments. This preference of PDs for the more conserved environments
is a novel finding, however, it is in agreement with preferential localisation of PDs
in more buried residues: PDs often have more intraprotein interactions, and thus
have more complicated structural restrictions. Moreover, this analysis confirmed
that compensation is predominantly a local effect.
Structural analysis by the SAAPdb pipeline, which indicates the likely local struc-
tural effects of a mutation, showed important features of the CPD dataset. First,
CPDs in humans were less often assigned any likely structural effect, suggesting again
that they cause less significant disruption of local structure. This confirmed results
by Ferrer-Costa et al. (2007), suggesting that CPDs cause ‘milder’ changes than PDs
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in physico-chemical properties. Second, CPDs often occur in interfaces. According
to the first evolutionary model proposed by DePristo et al. (2005), introduction of
phenotypically neutral mutations (which are then able to compensate for a CPD)
is a necessary first step before a CPD mutation can occur. Previously a high oc-
currence of neutral mutations in interface residues was shown (Hurst et al., 2008),
and this may create an amenable environment for CPD occurrence. Thus it was
not surprising to find the PQS-interface category being the only structural category
having a slightly higher frequency of assigned CPDs than PDs (Figure 3.11). In con-
trast, disease-associated mutations were less likely to be compensated for when the
residue had more complex intra-protein interactions (i.e. in the protein core), which
would often require multiple compensatory events. Furthermore, based on struc-
tural categories as defined by SAAPdb, CPDs are more likely to be found among
surface residues, with the exception of specific binding residues which make key
hydrogen-bonding or van der Waals interactions across an interface. It is also pos-
sible that other factors may result in compensation such as changes in expression
levels.
In conclusion, this chapter presents a detailed structural comparison of the oc-
currence of compensated pathogenic deviations. This analysis set out to confirm
and expand the work done by Ferrer-Costa and colleagues, in which they have
found CPDs to be preferentially located on the surface, on average in positions
with less severe structural changes (in terms of amino acid volume and hydropho-
bicity change, and BLOSUM62 scores), and on average fewer structural restric-
tions than PDs. The analysis presented in this chapter, using an order of mag-
nitude larger dataset of CPDs (for more details on datasets, see Table 3.1), con-
firmed aforementioned structural trends, and expanded them on a larger set of
SAAPdb features than three utilised by Ferrer-Costa et al. (2007). Through a
large-scale structural analysis, this analysis further confirmed the hypothesis that
compensation tends to be a local effect, since local sequence variation around a
CPD was greater than around sites of PDs in functionally-equivalent proteins of
the same sequence identity. Thus we have begun to differentiate compensated and
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uncompensated mutations on the basis of their effects on protein structure. This
gives us insights into evolutionary mechanisms and may shed light on pathogenicity
in humans.
In the future, research on the coevolution of compensated and compensatory muta-
tions will most likely focus on two main areas: (i) elucidating the exact mechanisms
used by individuals to travel along the ridges of the fitness landscape and (ii) de-
velopment of compensation prediction tools, mainly to be used for pharmaceutical
purposes. The former task has so far been limited by the availability of high-quality
protein sequence and structure data. With the recent popularisation of genome-
wide association studies, much attention has turned to identification of so-called
‘cluster-reference triplets’ and identifying compensatory trends from only three, re-
cently diverged sequences, e.g. Zhang et al. (2010) and Povolotskaya and Kondrashov
(2010). The latter task of compensation prediction is interesting from the aspect of
targeted reversal of known DAMs. Recently, the first Critical Assessment of Genome
Interpretation (CAGI) challenge was held (Callaway, 2010). This series of challenges
sets out to evaluate state-of-the-art mutation phenotype prediction tools in a trans-
parent way. One of the datasets containing p53 mutations15 evaluates potential
function-rescue compensatory mutations for a list of known mutations deactivating
this tumour-suppressor protein, adding a more practical and clinical aspect to this
phenomenon.
15http://genomeinterpretation.org.content/p53/
Chapter 4
Characteristics of Protein
Interfaces
The underlying motivation behind the project presented in this and
the next chapter is to improve the coverage of single amino acid polymor-
phisms in SAAPdb with protein-protein interface information, currently
limited by the availability of data on protein-protein interface structures.
In short, this chapter gathers protein-protein interface data and sur-
veys a range of chemical, structural and family-specific features, compar-
ing them to the rest of the protein surface. In other words, a dataset of
surface segments and a list of features were prepared, to be used in the
next chapter to build a predictor of putative interfaces on protein surfaces.
This predictor will enhance the annotation of neutral and pathogenic
SAAPs located in protein-protein interfaces, when added to the SAAPdb
pipeline.
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4.1 Introduction
Protein-protein interactions are fundamental for a range of cellular functions, e.g.
cell cycle regulation, apoptosis, cellular motors, pathogen recognition, communica-
tion among cells, etc. Proteins vary greatly in the numbers of interactions they make
with other proteins, from ‘loners’ with one interacting partner to ‘hubs’ interact-
ing with dozens of other proteins, sometimes reusing the same interface for several
binding partners over time (Keskin et al., 2008). Comparative analysis of human in-
teraction databases shows that the number of complexes greatly exceeds the number
of interacting proteins, in humans (Futschik et al., 2007) as well as in other species
(Missiuro et al., 2009); Bork et al. (2004) estimated an average of 3–10 interacting
partners per yeast protein. Typically, the more advanced the species is on the evolu-
tionary scale, the more connected the protein network is, indicating advancement in
regulation of processes (Keskin et al., 2008).
Unfortunately, the number of protein complexes deposited in the PDB (Berman et
al., 2000) is not representative of this great diversity, mainly owing to various exper-
imental complications in co-crystallization of multichain protein complexes. Protein-
protein complexes constitute only 50% of protein structures in the PDB1, the remain-
der are monomers and proteins in complexes with nucleotide chains, small peptide
chains and ligand molecules.
At the moment, the part of the SAAPdb pipeline identifying mutations in protein-
protein interfaces consists of three analyses, all relying on the structural data available
in the Protein Data Bank; SAAPdb structural effects of mutations have been defined
in Section 2.1.7.2. 30% of mutations deposited in the current version of SAAPdb2 are
recognised by the pqs category. The interface category of SAAPdb is considered
unreliable: it relies on PDB annotation of interacting residues in complexes, many
of which are non-biological crystal contacts. Finally the binding category recognises
1as of October 2010
296954 mutations distributed over 2042 protein structures
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residues involved in specific binding interactions with another protein chain or ligand.
For more details on definitions of SAAPdb structural categories see Hurst et al.
(2008).
In this chapter, sections 4.1.1–4.1.3 define an interface, and review approaches to in-
terface identification, interface types, size and topology. Next, methods to build
and analyse a novel dataset of protein-protein interfaces are presented, followed
by Section 4.3.1 presenting the dataset of interfaces gathered and filtered for non-
redundancy and high-quality structural data. Last, Section 4.3.2 reviews trends ob-
tained for eight features on the aforementioned dataset of interfaces, comparing them
with previously published results based on other datasets. This chapter concludes
with a list of features validated as interface predictors, to be used by the machine
learning tools to build a predictor in Chapter 5.
4.1.1 What is an interface?
An interface in general, defines the area of contact between two molecules in a com-
plex. In the case of protein-protein interfaces, it is a subset of residues or atoms on
the surfaces of both chains that participate in hydrogen bonds, van der Waals or elec-
trostatic interactions with the interacting protein chain. Protein complexes display a
wide range of binding affinities, from micromolar to nanomolar, thus corresponding
to a change of free energy in the range of −6 to −19 kcal/mol upon complexation
(Keskin et al., 2008), and life spans from seconds to days (Janin et al., 2008).
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4.1.2 Identifying protein-protein interfaces
There are two prevailing approaches to identification of interface residues (or atoms)
on the protein surface, both based on structural information available for the com-
plex.
(1) Distance-based methods employ a distance threshold, e.g. 0.5 − 2A˚ (Janin et
al., 2008) or vdW +1A˚ (Negi and Braun, 2007), where vdW denotes the sum of
the van der Waals radii of the two atoms being examined. Any atom within the
defined distance of any atom in the interacting partner is labelled as an interface
atom. In the case of residue-based analyses, this annotation is extended to
complete residues containing at least one interface atom.
(2) Solvent-accessibility-based interface detection defines a cutoff for the decrease
in relative solvent-accessibility upon complexation e.g. Jones and Thornton
(1997).
The two methods are considered to be equally reliable, since most of the applied
thresholds manage to detect the same interfaces. However, even a small change
in distance or ASA cutoff can change the average size of interfaces detected, their
boundaries, and the ratio to non-interface surface. This is one of the main causes of
data inconsistency among interface analyses, and seriously complicates comparison of
different, previously published methods (de Vries and Bonvin, 2008). Furthermore,
some of the features analysed, like sequence conservation, are particularly sensitive
to variations in interface definition (de Vries and Bonvin, 2008). The work presented
here is based on interface residues defined using relative solvent-accessibility decrease
upon binding, for details see Section 4.2.1.3.
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4.1.3 The main properties of interfaces
4.1.3.1 Types of protein-protein interfaces
Protein-protein interfaces can be characterised in several ways. The simplest case is
where two or more protein chains constitute a complex fold: if they fold cooperatively
and are never found as stable monomers, these complexes are considered obligate
complexes3. If constituents of a complex fold independently and can be isolated
as functional proteins in both bound and unbound states, they are termed non-
obligate or three-state folders4. Based on the reversibility of complexation, non-
obligate complexes can be both transient and permanent in nature (Nooren and
Thornton, 2003), while obligate complexes are by definition permanent. Furthermore,
transient complexes can be divided based on the strength of binding, as shown in
Figure 4.1. Finally, a distinction can be made based on the similarity among chains
constituting a protein complex (usually presented in terms of sequence identity). For
a complex of, for example two chains, a homodimer will consist of two identical chains,
while a heterodimer will consist of chains of different sequence. For examples of
homo/hetero-dimers and -trimers, see Figure 1.6 in introduction on mutations.
Figure 4.1: Interface types shown overlapping on a scale of binding affinities and dissocia-
tion constants.
Figure obtained from Perkins et al. (2010), with permission from the authors.
3also termed two-state complexes, observed either in unbound and unfolded, or folded and bound
form
4three states correspond to unfolded, folded unbound and folded bound
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Figure 4.1 presents a summary of interface types, showing that all previously men-
tioned interface types actually form a continuum over a wide range of binding affinities
(Perkins et al., 2010).
4.1.3.2 Interface size
A typical protein-protein interface is a continuous patch of surface residues with an
average area of 1600 ± 400A˚2, ∼ 800A˚2 on each subunit surface (Lo Conte et al.,
1999). Homodimeric interfaces are larger (Bahadur et al., 2003), with an interface
surface of ∼ 1940A˚2 (Yan et al., 2008). When less stringent criteria for interface
residues were employed, some authors obtained an average transient interface area
of ∼ 2100 ± 1250A˚2, e.g. Headd et al. (2007). Most complexes have one continuous
interface surface, or less often, one standard-sized patch and several adjacent smaller
patches (Chakrabarti and Janin, 2002).
4.1.3.3 Solvent-accessibility of an interface
Interface residues, when unbound, are on average more solvent-accessible than the
rest of the protein surface (Chen and Zhou, 2005). Porollo and Meller presented
substantial differences between predicted relative solvent-accessibility values (as cal-
culated by Lee & Richards (1971)) for interface residues and observed rASA in high-
quality structural data (Porollo and Meller, 2007). Surprisingly, they further showed
on several datasets using both support vector machines and neural networks, that
the difference between predicted and observed values outperformed rASA values as
predictors for interface residues. While this evidence clearly indicated a correlation
between interface residues and solvent accessibility, this feature was left out of the
list of predictors, under suspicion that it might not be an independent predictor of
interfaces5. Whether this is really true, or adding rASA as a predictor improves
5classification of residues into surface or interface, introduced in detail in Section 4.2.1.3, is based
on the difference between rASA in complex and monomeric form
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accuracy of interface prediction is to be tested in the next chapter, when ASA-based
interface predictor is benchmarked against the dataset of interfaces defined using the
drop in solvent-accessibility criterion (for more details see Section 5.3.5.2).
4.1.3.4 Topology: core and rim model
In terms of topology, an interface in a complex is viewed as a core of solvent-
inaccessible residues, surrounded by the rim of residues somewhat accessible to sol-
vent (Chakrabarti and Janin, 2002). This exclusion of water molecules from the space
of an interface core facilitates van der Waals contacts across the contact surface of
two interacting chains. In order for the core to occur, an interface is required to
have a minimum size of 600A˚2 (Bogan and Thorn, 1998). Distribution of amino acid
types in the interface core is similar to the composition of protein core residues, while
rim residues resemble the rest of the protein surface (Chakrabarti and Janin, 2002).
Note that the ratio of core to rim surface, and consequently the size of the average
interface, often depends on the choice of solvent-accessibility threshold to separate
rim residues from non-interface residues.
Alanine-scanning mutagenesis has shown an uneven distribution of free energy across
the core: only certain core residues, termed interface hot spots, significantly con-
tribute to the binding free energy change, while mutations in the other core residues
have less of an impact on binding affinity (Bogan and Thorn, 1998). Usually, a
minimum of 2.0 kcal/mol increase in binding free energy upon mutation to alanine
is used to define hot spots (Bogan and Thorn, 1998; Moreira et al., 2007); these
residues have distinctive amino acid composition with high propensities for (often
highly conserved) polar amino acids (Hu et al., 2000; Porollo and Meller, 2007). Li
et al. (2004) showed that hot spots often occur in pockets on the protein surface,
visible even in the protein’s unbound state, hence providing a recognition pattern
for the interacting partner. Thus it is now widely accepted that these electrostatic
interactions are crucial for recognition between interacting partners (i.e. specificity),
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whereas the hydrophobic effect contributes to the stability of the bound complex
(Moreira et al., 2007).
4.1.3.5 Previously identified interface-specific characteristics
Throughout the last two decades, there have been numerous attempts to characterise
a typical protein-protein interface. All approaches have been based on a similar idea:
if an interface displayed a property uncommon on the protein surface, filtering seg-
ments of protein surfaces for that property could yield previously unidentified inter-
face regions, even when the interacting partner and/or the orientation of molecules
during interaction were unknown. The first analyses were performed on a limited
number of protein structures available at that time in the Protein Data Bank (Jones
and Thornton, 1997; Lo Conte et al., 1999; Chakrabarti and Janin, 2002; Bahadur
et al., 2003). However, when sufficient datasets of interface-containing structures
became available, common physico-chemical features of interfaces started to emerge
(Neuvirth et al., 2004; Bradford and Westhead, 2005; Yan et al., 2008). No property
has strong enough predictive power to be used as a successful predictor of inter-
faces on its own (Bradford and Westhead, 2005). The following sections review the
most commonly cited interface properties, provided they have been mentioned (and
similarly defined) in more than one protein-protein interface analysis.
All surveyed interface features can be grouped into three types:
Sequence-based features can be calculated from amino acid sequence alone. This
includes amino acid propensities and hydrophobicity.
Structure-based features require structural data for that complex. Coordinates of
atoms are used to calculate planarity, protrusion, hydrogen bonding, disulphide
bridges and secondary structure elements. By definition, classification into an
interface or non-interface surface atom or residue is a structure-based feature;
for different approaches to interface definition see Section 4.2.1.3.
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Profile-based features require information on homologues or
functionally-equivalent proteins (FEPs (McMillan and Martin, 2008)). These
homologues or FEPs are aligned to the interface-containing protein, providing
family-specific interface properties, here: two sequence conservation scores,
based on all homologues identified by a BLAST search and FEPs, respectively.
4.2 Methods
While there is a decent amount of accumulated knowledge on the topic of protein-
protein interfaces, several common pitfalls were identified from the literature, some
of which have been mentioned in Section 4.1.3.5. Without repeating these, the aim
was:
• to obtain a thoroughly curated up-to-date dataset of protein chains and their
interface segments (Section 4.2.1)
• to explore a range of sequence- and structure-based protein properties, to find
interface-determining features (Sections 4.2.2–4.2.4)
Technical aspects of these procedures, and tools and resources used in the process
are described hereafter.
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4.2.1 Obtaining the dataset
4.2.1.1 Obtaining interface-containing structures
The first task when analysing interfaces was to obtain an extensive, well-annotated
and up-to-date dataset of protein structures containing only biologically-relevant
protein-protein contacts. In order to avoid inclusion of crystal contacts among in-
terfaces, rather than using raw structural data, biological units from the Protein
Quaternary Structure (PQS) resource (Henrick and Thornton, 1998) were used to
identify and analyse protein-protein interfaces. All 58397 protein structures stored
in PQS as of March 2009 in the form of their biological units were extracted from
ftp://ftp.ebi.ac.uk/pub/databases/msd/pqs/BIOLIST, and termed the PQSall
dataset.
4.2.1.2 Filtering for high-quality multichain structures
PQSall was filtered to eliminate viral capsids, NMR entries, low resolution, high
R-factor and monomeric entries, resulting in the PQSfiltered dataset of proteins,
as shown in Figure 4.2. Structures of viral capsids were eliminated because these
complexes are considered exceptions in terms of interface properties: each subunit
has contact surfaces with multiple other subunits; there is limited knowledge on the
number of chains in biological units; and the mechanism of the capsid assembly is
still poorly understood (Zlotnick, 2005).
For a structure to have been classified as a protein-protein complex, the final require-
ment was that the complex consisted of at least two amino acid chains, both with a
minimum length of 30 amino acids. Chains with fewer than 30 residues were labelled
as peptide chains and were discarded during filtering.
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PQSall (58397 proteins)
Keyword SKIP,
MONOMERIC, VIRUS filter
NMR filter
Resolution filter (r > 3.00)
R-factor filter (R > 30.00)
Monomer filter (min.
2 protein chains
in the structure)
PQSfiltered (25876 pro-
teins with 87738 chains)
Figure 4.2: Preparation of protein-protein interfaces dataset.
PQSall contains a list of biological units for all PQS files (March 2009). The fiters
shown in blue specify what they eliminated from the dataset: monomers, viral capsids,
NMR structures, high resolution, low model quality structures and peptide chains,
respectively.
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When the coverage of total protein space is considered, the PDB is biased towards
proteins which are easier to crystallize, and towards protein families which are cur-
rent hot-topics in structural biology, e.g. cancer-related proteins and proteins related
to widely-spread severe diseases. To remove this bias, all PQSfiltered chains were
clustered based on sequence similarity and one chain was chosen from each cluster,
resulting in a set of non-redundant chains, PQSnr. Clustering was performed us-
ing the PISCES6 (Wang and Dunbrack, 2005) server with a 25% sequence similarity
threshold, culling ‘by chain’ and with all other parameters set to default values. The
representative chain was selected from each of the 4345 clusters based on the highest
structure resolution and then if tied, the lowest R-values.
4.2.1.3 Identifying buried, surface and interface residues
All residues in PQSnr were tested for localisation in the three-dimensional structure
of the complex, based on solvent-accessibility. Relative solvent-accessibility of each
residue in the complex (rASAc) and in monomeric chain (rASAm) was precalcu-
lated and stored in XMAS format, as explained in Section 2.1.1.2. If a residue had
rASAm > 5 it was classified as surface, otherwise it was a buried residue7. Surface
residues were further divided into interface and non-interface, based on the differ-
ence in relative solvent-accessibility between monomeric and complex form. More
precisely, interface residues needed to satisfy:
rASAm − rASAc ≥ 10 (4.1)
6http://dunbrack.fccc.edu/Guoli/PISCES_InputB.php
7a criterion introduced by Miller et al. (1987)
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4.2.2 Sequence-based properties of interfaces
Hydrophobicity and amino acid propensities do not need anything but sequence in-
formation on protein chains to be calculated, hence these are termed sequence-based
interface properties.
4.2.2.1 Amino acid propensities
20 standard amino acid types were examined for preferential occurrence in inter-
faces, or on non-interface surface using the method of Liang et al. (2006). To start
with, background fractions of monomeric solvent-accessible surface area (ASAm) oc-
cupied by each amino acid type among observed interface residues were calculated
as follows:
Fintf (X) =
ASAtotal(X)
ASAtotal(intf)
(4.2)
where X was one of the 20 amino acid types, Fintf (X) was the ASA-based percentage
of residues of typeX among the interface residues, ASAtotal(X) was the sum ofASAm
for all residues of type X in the interface dataset, and ASAtotal(intf) was the sum
of ASAm for all residues in the interface dataset. By analogy,
Fsurf (X) =
ASAtotal(X)
ASAtotal(surf)
(4.3)
was the percentage of residues of type X in the non-interface surface dataset. Addi-
tionally, ASAsurf (X) was the average ASAm value for all residues of type X found in
the surface dataset. Propensity for a residue of type X to be in an interface, Pr(X),
was defined as:
CHAPTER 4. CHARACTERISTICS OF PROTEIN INTERFACES 134
Pr(X) =
(
ln
Fintf (X)
Fsurf (X)
)
× ASA
m(X)
ASAsurf (X)
(4.4)
where ASAm(X) was the empirically obtained monomeric ASA for that residue.
The method by Liang et al. (2006) was chosen as the most appropriate for two rea-
sons. First, it is ASA-based, taking into account the contribution of sidechain sizes:
larger amino acids will, on average, account for larger fractions of interface surface
than residues with small sidechains. Additionally, ASA(X) incorporates empirical
information into the propensity calculation; an improvement over previously used for-
mulae, e.g. by Dong et al. (2007) where every residue of a given type was considered
to have the same, average contribution:
Pr(X) = ln
Cintf (X)
Cintf
Csurf (X)
Csurf
(4.5)
where Cintf and Csurf are total counts (rather than ASA-contributions) of interface
and surface residues, respectively, and Cintf (X) and Csurf (X) are counts of interface
and surface residues or residue type X, respectively. This generalisation has two
dangerous consequences: each residue of a type X is assumed to contribute equally
to the interface/surface, and all residues (irrespective of their size) are treated equally
likely to be observed in an interface, resulting in an overestimation of bulky residues
in both interface and surface datasets.
Since the scale of Pr(X) is logarithmic, a positive Pr(X) value means residue type X
is more often found in the interface than the non-interface dataset, while a negative
Pr(X) indicates a residue type underrepresented in interfaces.
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4.2.2.2 Hydrophobicity
Numerous hydrophobicity scales have been developed tailored for various experimen-
tal problems, for a review see Cornette et al. (1987). Here, Kyte and Doolittle scale
was chosen (Kyte and Doolittle, 1982): it combines several previously developed
methods in a dimensionless range from −4.5 for a hydrophillic arginine to 4.5 for
hydrophobic isoleucine:
Table 4.1: Kyte & Doolittle hydrophobicity scale.
Amino acid R K D E N Q H P Y W
Hydrophobicity -4.5 -3.9 -3.5 -3.5 -3.5 -3.5 -3.2 -1.6 -1.3 -0.9
Amino acid (cont.) S T G A M C F L V I
Hydrophobicity -0.8 -0.7 -0.4 1.8 1.9 2.5 2.8 3.8 4.2 4.5
4.2.3 Structural properties of interfaces
Properties such as shape identifiers (planarity and protrusion), interactions among
spatially close residues or atoms (hydrogen and disulphide bonds) and organisation
of residues in secondary structure elements require information on the coordinates of
atoms in a protein chain in the folded state.
4.2.3.1 Planarity
Planarity of each residue was calculated using PRINCIP (included in the SURFNET
package (Laskowski, 1995)). This algorithm calculates the best-fitting plane through
a set of residues, and then provides the root mean squared error8 from that plane
as a measure of planarity9. In order to define a plane for a residue, its coordinates
were used along with the coordinates of the 7 closest residues on the protein surface
(based on the distance between Cα atoms).
8defined in Section 5.1.1.4
9the lower the error rate, more planar the set of residues are
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4.2.3.2 Preparing the Benchmark 4.0 dataset for protrusion
analysis
The protrusion of chain residues into the solvent should not be calculated on the
PQS chains just separated into monomers, without prior application of some kind
of surface smoothing algorithm, for more details see Section 4.3.2.4. Therefore, a
set of protein-protein complexes, with solved structures in both bound and unbound
form were obtained from the Benchmark 4.0 dataset10 (Hwang et al., 2010). First
NMR structures and chains which did not exist in PQS were eliminated. Then each
bound chain was annotated with interface and non-interface surface residues, using
the same method as in Section 4.2.1.3. Mapping these residues to equivalent residues
on the unbound chains was performed using PDBSWS (Martin, 2005); for more
details see Section 2.1.4. A residue on an unbound chain was mapped to a residue
on a bound chain, via the equivalent residue in the UniProtKB/Swiss-Prot protein
sequence. As a result, interface and surface residues from bound chains were mapped
across to surface residues on 199 unbound chains, and prepared for further protrusion
analysis.
4.2.3.3 Protrusion
Average residue protrusion was calculated by PROTRUDER (Simon Hubbard, 1994,
unpublished), as a numerical score in the range of 0.0 − 9.0, as originally used by
Jones and Thornton (1997). Protrusion was calculated on 199 unbound chains from
the Benchmark 4.0 dataset (Hwang et al., 2010), prepared as described above.
10http://zlab.umassmed.edu/benchmark/
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4.2.3.4 Secondary structure elements
Secondary structure was calculated per-residue by an in-house implementation of the
SSTRUC program (Smith and Thornton, 1989) and stored in XMAS format. SSTRUC is
an improvement of well known DSSP algorithm (Kabsch and Sander, 1983). Secondary
structure elements, according to Kabsch and Sander, are presented in Table 4.2.
SSTRUC uses the same annotation, adding lower-case categories for residues at the
ends of secondary structure elements, relaxing hydrogen bonding requirements for
these residues.
Table 4.2: Kabsch & Sander secondary structure elements.
Category Description
H α-helix
B A single bridge displaying β-structure-
characteristic hydrogen bonds
E Multiple consecutive bridges (i.e. β-strand)
G 310-helix
I pi-helix
T Hydrogen-bonded turn
S Bend (based on backbone angle of segments
upstream and downstream of residue in ques-
tion)
4.2.3.5 Disulphide bonds
Residues were searched for intrachain disulphide bonds based on the distance between
Sγ atoms of neighbouring cysteines. An in-house script checks for pairs of cysteines
in the same protein chain with Sγ atoms less than 2.25A˚ apart, labels them as par-
ticipating in disulphide bonding, and stores this information in the XMAS file. The
2.25A˚ threshold is chosen based on the average distance between disulphide sulphurs
of 2.03A˚ determined by Hazes and Dijkstra (1988), adding ∼ 10% for inconsistencies
in structural data.
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4.2.3.6 Hydrogen bonds
Similarly to disulphide bonds, hydrogen donors and acceptors were identified as de-
fined by Baker and Hubbard (1984) and stored during XMAS file preprocessing.
Briefly, if the hydrogen atoms have known positions (i.e. their coordinates can be
calculated), the distance between the hydrogen and the hydrogen-acceptor must be
not greater than 2.5A˚ with the donor-hydrogen-acceptor angle between 90◦ and 180◦,
for the hydrogen bond to be assigned. In case the hydrogen atom is not defined, a hy-
drogen bond is assigned when the donor-acceptor distance is not greater than 3.35A˚
and the angle is again between 90◦ and 180◦. These rules correspond to the definition
of hydrogen bond introduced by Cuff et al. (2006) in their Figure 1, with the excep-
tion of reducing donor-acceptor distance from 3.5A˚ to 3.35A˚, as the former condition
was found to be too liberal.
4.2.4 Profile-based properties of interfaces
Profile-based amino acid propensities and sequence conservation scores both require
sequence information from the homologues of the interface-containing chain, in the
form of multiple sequence alignments. To that end, two types of alignments were cre-
ated for every chain in PQSnr: FOSTA alignments contained fewer homologues, while
having restrictive criterion of functional-equivalence for each homologue, whereas
BLAST alignments contained more homologues at the same time increasing the
chance of functionally-diverged homologues being included in the alignments. In
both cases, for the alignment to be created, the minimum size was the query se-
quence plus four homologues, and the maximum size was 200 homologues, creating
alignments with 5-201 sequences aligned, respectively.
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4.2.4.1 Multiple sequence alignments
First, families of functionally-equivalent homologues were extracted from FOSTA11
(McMillan and Martin, 2008). All non-redundant PQS chains were mapped to
UniProtKB/Swiss-Prot chains using PDBSWS (Martin, 2005). Then families con-
taining the mapped UniProtKB/Swiss-Prot chain, and at least four functionally-
equivalent homologous chains were aligned using Muscle3.712 (Edgar, 2004c) with
default parameters.
The second alignment dataset was extracted by using BLAST13 (Altschul et al., 1990)
to identify homologues of the PQS chain sequence in the UniProtKB/Swiss-Prot
database, using all default parameters, filtering out low-complexity regions and all
homologues with E > 0.01. All remaining homologues containing terms ‘putative’,
‘predicted’, or ‘hypothetical’ in their descriptions were removed as unreliable.
Finally if the list of homologues had more than 200 sequences, it was reduced to
the 200 sequences containing the lowest E-values. Families passing the minimum
alignment size criterion were aligned with the homologues using Muscle3.7 with
default parameters.
4.2.4.2 Sequence conservation
The conservation score of each residue was calculated using the Valdar01 method
implemented in scorecons (Valdar, 2002) with the substitution matrix normalised
so all matches have the highest score of 1 (Karlin and Brocchieri, 1996). Thus each
residue was assigned two scorecons scores, provided both alignments were successfully
created for that protein chain.
11introduced in Section 2.1.5
12introduced in Section 2.2.4.3
13see Section 2.2.3
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4.3 Results and discussion
4.3.1 Dataset of interfaces in protein-protein complexes
Contrary to the work published in the 1990s when the number of structures in the
PDB was too low to obtain a comprehensive dataset, structural data nowadays suffi-
ciently cover various interface types and offer enough data for solid statistical analysis.
There have been numerous sets of interfaces used in recent years (reviewed for exam-
ple by de Vries and Bonvin (2008)), none of which successfully passed the following
tests: (i) crystal contacts were removed, (ii) complexes were culled using all filters
from Figure 4.2, (iii) peptide chains and protein-ligand interfaces were removed, and
finally (iv) redundant interfaces (based on sequence homology) were removed. There-
fore, to the best of the author’s knowledge, PQSnr is, at the time of writing, the most
extensive dataset of non-redundant, high-quality structures of protein-protein com-
plexes, including both obligate and non-obligate interfaces.
The PQSnr dataset consisted of 4345 non-redundant protein chains from 4014 protein
complexes. These chains were spread across 37/40 (93%) of CATH architectures,
and 860/1233 (70%) of CATH folds (topology level of the hierarchy)14. The broad
coverage of CATH entries indicates not only that PQSnr contains exclusively high-
quality structural data, it provides a representative sample of protein chain space
(and, by analogy, of protein-protein interfaces space).
Each chain was interacting with at least one other protein chain within the same PQS
complex thus providing a protein-protein interface site, and on average had 23.5%
buried residues and 76.5% surface residues. 20.4% of residues found on the protein
surface were labelled as interface, the rest comprised non-interface surface control
cases – hereafter referred to as the ‘surface dataset’. These chains were further
employed for parameter space analysis and, in the following chapter, patch building,
classifier training and testing.
14based on the CATH v3.4, for more details on the methodology see Cuff et al. (2011)
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As shown in Figure 4.3, both interface and surface residues spread over the whole
range of solvent-accessibility values, with a slight enrichment in interface residues
among higher ASA values.
4.3.2 Identifying interface-specific features
Each of the following sections (4.3.2.1–4.3.2.7) analyses a feature presumed to have
some predictive power in interface classification. Each feature (a property) is anal-
ysed on the PQSnr dataset, compared to previously identified trends, and finally, a
conclusion is given whether it is likely to be useful in the next chapter when a pre-
dicting model is built. For the summary of trends observed in this extensive analysis,
see Table 4.3.
4.3.2.1 Amino acid propensities
The simplest way to differentiate a dataset of interfaces from the rest of the pro-
tein surface is to compare the amino acid composition. All previous surveys found
that interfaces differed from the surface amino acid type distribution (Jones and
Thornton, 1996; Chakrabarti and Janin, 2002; Liang et al., 2006; Yan et al., 2008),
sometimes reporting different patterns in amino acid preferences, probably owing to
variations in methodology. The results presented below are ASA-based rather than
residue-count-based, and corrected for the ASA of that residue position, as defined
in Section 4.2.2.
Initial analysis on a limited dataset of 70 proteins showed an abundance of aromatic
and aliphatic residues in interfaces, and a lower frequency of all charged residues,
except arginine (Chakrabarti and Janin, 2002). On a larger dataset, Yan et al. (2008)
observed that aliphatic and polar residues (except arginine) were underrepresented
in interfaces, and confirmed a high frequency of aromatic and hydrophobic amino
acid types. Arginine was found overrepresented in some datasets (Zhou and Shan,
CHAPTER 4. CHARACTERISTICS OF PROTEIN INTERFACES 142
5 15 25 35 45 55 65 75 85 95
Distribution of solvent accessibility in surface and interface residues
Relative solvent accessibility
F r
a c
t i o
n  
o f
 r e
s i d
u e
s
0
0 .
0 2
0 .
0 4
0 .
0 6
0 .
0 8
0 .
1
0 .
1 2
0 .
1 4
0 .
1 6
0 .
1 8
0 .
2
Interface residues (124330)
Surface residues (482757)
Figure 4.3: Relative solvent accessibility of surface and interface residues.
There was a significant difference in rASA values between interface (M = 52.82,
SD = 23.26) and surface residues (M = 39.49, SD = 25.43), t(df =
207473.6) = 176.7002, p-value < 2.2e − 16, when two-tailed Welch two-sample
t-test was performed. Total counts of residues per category are shown in the
legend in brackets. All 187471 buried residues would, by definition, fit into the
first bin, not shown here. Residues with rASA > 100 values are shown in the
last bin. For core-surface sorting criterion, see Section 4.2.1.3.
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Figure 4.4: Propensities of amino acid types in interface residues.
Propensity value was calculated using Equation (4.4). Residue types are ordered
by ascending hydrophobicity value according to Kyte & Doolittle scale, see
Table 4.1.
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2001; Chakrabarti and Janin, 2002; Ofran and Rost, 2003; Bahadur et al., 2004; Liang
et al., 2006; Yan et al., 2008), although another recent analysis questioned this trend,
showing no difference from the rest of the surface (Neuvirth et al., 2004).
Contributions of each amino acid type in terms of solvent-accessible surface for PQSnr
are shown in Figure 4.4, revealing clear trends for some amino acid types to prefer
or avoid interfaces, when compared with the rest of the protein surface. Similarly to
previously identified propensities mentioned above, interfaces are depleted in polar
and charged amino acid types (except arginine and histidine), and enriched in aro-
matic and aliphatic residues (except glycine and alanine). It is worth noting that
arginine was again found to be overrepresented in interfaces – a feature first shown on
smaller interface datasets and then dismissed by Neuvirth et al. (2004), using amino
acid counts rather than fractions of solvent-accessible surface. Overall, patterns in
amino acid propensities are likely to contribute strongly to the predictive power when
an interface prediction classifier is trained.
4.3.2.2 Hydrophobicity
As expected from the difference in amino acid composition, interfaces, especially
their cores, have been found to be more hydrophobic than the rest of the protein
surface (Chakrabarti and Janin, 2002; Ofran and Rost, 2003; Yan et al., 2008). Fur-
thermore, the comparison of different types of complexes revealed that homomeric
complexes have higher average interface hydrophobicity than heterocomplexes, ow-
ing to larger interface size and thus, higher core-to-rim ratio (Headd et al., 2007).
Homomeric complexes are mostly obligate (Ofran and Rost, 2003) and, as discussed
in Section 4.1.3.1, complexation occurs at the same time as protein folding so these
residues can be considered as the protein core.
Figure 4.4 shows residue types ordered by hydrophobicity values, from hydrophillic
ones on the left, towards hydrophobic amino acids on the right. Excluding arginine,
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histidine and aromatic residues (these have been discussed above), there is a notable
preference for hydrophobic residues in the interfaces, and less hydrophobic ones on the
rest of the protein surface. It can therefore be concluded hydrophobicity is a predictor
of interfaces, and it is not completely overlapping with amino acid propensities, thus
justifying its use in addition to propensities while training the model.
4.3.2.3 Planarity
The interfaces of homomeric complexes have better shape complementarity and
tighter packing with fewer water molecules than heteromeric complexes. There have
been several attempts to describe the shape of an interface formally, most commonly
through assigning a planarity value to the interface residue and its neighbours, or to a
patch. Planarity is quantified as the RMSE for the best-fitting plane for a patch (see
Jones and Thornton (1997) and references therein). It has been suggested that inter-
faces are more planar than the average surface patch (Jones and Thornton, 1997), the
effect being more distinctive when only heterodimers were considered (Chakrabarti
and Janin, 2002). In accordance, a significantly lower planarity score was observed
for interfaces when compared to surface residues, shown in Figure 4.5.
4.3.2.4 Protrusion
Several other shape quantifiers were introduced besides planarity, i.e. protrusion
(Jones and Thornton, 1997), shape index and curvedness (Bradford et al., 2006),
concavity and “rufness” [sic] (Pettit et al., 2007). These properties varied in defi-
nition, and with the exception of protrusion, none was used again after the initial
introduction in a single publication. It was therefore decided that protrusion would
be tested as the second shape attribute, potentially adding new structural patterns
to the learning process.
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Figure 4.5: Planarity values for interface and surface residues. There was a significant
difference in planarity values between interface (M = 2.12, SD = 0.38) and
surface residues (M = 2.14, SD = 0.40), t(df = 223562.5) = −19.5522, p-value
< 2.2e − 16, when two-tailed Welch two-sample t-test was performed. Total
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Figure 4.6: Average protrusion indexes, for interface and surface residues in Benchmark 4.0
There was a significant difference in protrusion values between 3076 interface
(M = 4.45, SD = 2.86) and 19569 surface residues (M = 5.12, SD = 2.66),
t(df = 3959.994) = −12.2799, p-value < 2.2e − 16, when a two-tailed Welch
two-sample t-test was performed.
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Protrusion index was calculated by PROTRUDER, reproducing the protrusion index
from Jones and Thornton (1997). It has been argued that monomeric structures
obtained by merely separating chains from a complex can have misleading posi-
tions of interface atoms15, thus artificially increasing local protrusion indexes. These
monomeric structures will show interfacial atoms in energetically unfavourable con-
formations sticking out unnaturally into the solvent; these interactions are stabilised
via interactions with the other chain in the complex state. In order to obtain a more
realistic interface surface, one should run energy minimisation on each monomer after
separation, taking into account interactions of interface atoms with solvent molecules.
Implementing this step requires too much computer time for calculation of protrusion
as a predictor of interfaces.
Alternatively, one can utilise structures where both single chains and the complex
form have been solved in separate experiments, and deposited in the PDB. Such
triplets of PDB entries (one bound and two unbound structures) have been period-
ically published in a gold-standard dataset created for protein docking simulations
(Hwang et al., 2010). The latest version, Benchmark 4.0, contains 176 triplets16.
After filtering chains with different chain identifiers in PDB and PQS files, NMR
structures, and chains for which PDBSWS does not map the same UniProtKB/Swiss-
Prot accession number to both bound and unbound chain, 199 chains comprised the
Benchmark 4.0 dataset of interface and surface residues.
Preliminary analysis of average protrusion index for interface and surface residues
on the Benchmark 4.0 data, shown in Figure 4.6 indicates that interfaces adopt less
protruding positions. However, this dataset is not extensive: when redundant chains
were removed it covered only 139 chains, only 3% of the PQSnr dataset used to survey
all other physico-chemical predictors. Furthermore, this trend was less extensive than
the decrease in planarity score17, so planarity is considered to be a better indicator of
interface shape. Since extending the protrusion calculation to the full PQSnr dataset
15personal communication with Prof. David T. Jones, UCL
16http://zlab.umassmed.edu/benchmark/
17concluded from smaller absolute value of the t-statistic
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is a non-trivial computational task, protrusion index was excluded from the list of
features used in the prediction step and was given a low predictive power value in
Table 4.3. However elimination of protrusion might have been unjust: protrusion
index should be revisited once more structures become available in both bound and
unbound forms.
4.3.2.5 Secondary structure elements
Initially, Neuvirth et al. (2004) showed a slight enrichment in β-strands and long
loops in interfaces. In a more recent study, same authors argued that there was
no clear preference for secondary structure in interfaces (Neuvirth et al., 2007);
the trends changed depending on which methodology was used to define secondary
structure.
All residues were tested for secondary structure, using a method introduced in Sec-
tion 4.2.3.4. Residues labelled with ‘h’ or ‘H’ by SSTRUC were considered to be helix
residues. Likewise, residues labelled with ‘e’ or ‘E’ belonged to β-strands. Other
SSTRUC categories were sorted as C (for coil), effectively covering all non-α, non-β
residues.
Contrary to the previous work by Neuvirth et al. (2004), PQSnr displays significant
depletion in β-strands and significant enrichment in α-helices in the interfaces (see
Figure 4.7). While findings on the PQSnr dataset do not confirm previous analyses,
secondary structure was still employed as a predictor, to be potentially removed by a
classifier if it should display dependencies on other interface features. Consequently,
it has been labelled as a medium predictor in Table 4.3.
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Figure 4.7: Disulphide bonds, hydrogen bonds and secondary structure elements in inter-
face and surface residues.
Secondary structure elements are β, α or else, labelled with E, H and C, re-
spectively. Frequency of disulphide bonds among residues is shown on a scale
shown on the left, while the scale for hydrogen bonds and secondary structure
fractions is shown on the right side of the graph. All categories show statis-
tically significant difference between interface and surface categories (χ2 test,
p < 0.01), even after Bonferroni correction for multiple testing was applied.
4.3.2.6 Disulphide bonds and hydrogen bonding
The frequencies of hydrogen bonds, disulphide bonds and electrostatic interactions
per interface and per area unit are highly dependent on the definition of the interface
surface and the quality of structural data. Charged residues were found to be depleted
in the analysis of interfaces in the PQSnr dataset, and it was shown that electrostatic
interactions are crucial for specificity rather than being often found as energetic hot
spots (Moreira et al., 2007) (see Section 4.1.3.4). Therefore it made no sense to
use electrostatic interactions as a predictor, and the focus was shifted to intrachain
hydrogen and intrachain disulphide bonds.
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On average, hydrogen bonds were found to occur once every ∼ 190A˚2 in Chakrabarti
and Janin’s analysis of transient heterocomplexes (Chakrabarti and Janin, 2002), one
hydrogen bond was observed every 230A˚2 in transient homocomplexes and one every
210A˚2 in obligate homodimers (for review see Table 2 in Janin et al. (2008)). In
PQSnr, both disulphide bonds and hydrogen bonds were more likely to occur among
surface residues and depleted among interface residues, as presented in Figure 4.7.
Disulphide bridges were two orders of magnitude less common than hydrogen bonds
in PQSnr, but unlike charged residues, cysteines were overrepresented among inter-
face residues (as previously shown in Figure 4.4), making a decreased frequency of
disulphide and/or hydrogen bonds potentially useful when building a predictor.
4.3.2.7 Sequence conservation
Using sequence conservation scores to identify protein-protein interfaces is somewhat
controversial. Several studies indicate that interfaces are more conserved in terms of
protein sequence than the non-interface surface residues (Valdar and Thornton, 2001;
Zhou and Shan, 2001; Ofran and Rost, 2003; Neuvirth et al., 2004), with heteromeric
complexes exhibiting higher conservation scores than homomeric complexes (Yan et
al., 2008). Additionally, Guharoy and Chakrabarti (2005) showed that biologically
relevant interfaces have more conserved residues in the core than in the rim, while
nonspecific crystal contacts do not present that trend. Therefore, the topology of
conservation in a putative protein-protein interface can be used to discriminate crystal
contacts from biological interfaces.
On the other hand, sequence-based classification into interface and non-interface
residues (or atoms) has no way of diversifying between buried and surface residues (or
atoms) without using input from structural data. In that way the non-interface cat-
egory has significantly more data points than the interface category, thus inevitably
losing specificity (many are false positives) (de Vries and Bonvin, 2008). Therefore
sequence-based interface prediction methods still exhibit poorer performance than
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most of the structural predictors (Kufareva et al., 2007), some recent work even
questioning sequence conservation as a relevant factor for protein interface recogni-
tion (Caffrey et al., 2004; Neuvirth et al., 2007).
This project revolved around protein-protein interfaces with available structural data.
Sequence conservation score is merely an additional attribute, and it will be viewed as
a (potentially improving) modifier to the structure-based interface prediction.
Interface sequence conservation analysis was performed twice, using two different
types of multiple sequence alignments. First, conservation score was based on FOSTA
families of functionally-equivalent proteins (McMillan and Martin, 2008). While
FOSTA ensures that every interface-containing protein chain is aligned exclusively
with chains having the same function, the availability of such families is low: only
866 chains (∼ 20%) from PQSnr had four or more FEPs available for the alignment.
In contrast, the second conservation score obtained homologues using BLAST, with
an E-value cutoff of 0.01. There were 3122 chains (∼ 72%) with BLAST-based
conservation scores.
Both conservation scores confirmed that interface residues are significantly more con-
served than other surface residues. As expected, FOSTA alignments displayed more
conserved interfaces, however, it is worth keeping in mind that this dataset of in-
terfaces was severely reduced, potentially affecting classifier training. Additionally,
comparison of FOSTA- and BLAST-based conservation in Figures 4.8 and 4.9 re-
spectively, displays both conservation scores have a bimodal distribution, one peak
around 0.5 and the other towards a sequence conservation of 1.0. There is a slight
difference: BLAST data have a higher 0.5 peak, while FOSTA data have more almost-
perfectly-conserved sequence positions, both among interfaces and non-interface sur-
face residues.
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Figure 4.8: FOSTA-based sequence conservation in interface and surface residues.
There was a significant difference in conservation values between interface
(M = 0.66, SD = 0.6) and surface residues (M = 0.61, SD = 0.26),
t(df = 38544.01) = 30.8154, p-value < 2.2e − 16, when two-tailed Welch two-
sample t-test was performed.
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Figure 4.9: BLAST-based sequence conservation in interface and surface residues.
There was a significant difference in conservation values between interface
(M = 0.58, SD = 0.25) and surface residues (M = 0.53, SD = 0.23),
t(df = 123168.8) = 52.7088, p-value < 2.2e − 16, when two-tailed Welch two-
sample t-test was performed.
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4.3.2.8 An ideal interface
Ideally a search for a protein-protein interface on a surface of a single protein chain
should yield a single contiguous surface segment of 800 − 1000A˚2, with higher than
average planarity (manifested confusingly as lower planarity score) and hydropho-
bicity, and depleted in charged residues. When amino acid types are examined in
spatially neighbouring residues on the same chain, the interface will have fewer than
average disulphide and hydrogen bonds, and have overrepresented α-helices and un-
derrepresented β-strands. Furthermore, a typical interface will have an O-ring shaped
topology, with more conserved residues in the centre; these highly conserved residues
are likely to be polar amino acids (Hu et al., 2000). Finally, this patch will have
residues with higher solvent-accessibility than other patches on the surface of the
queried protein. The set of consensus features has been shown in Table 4.3, com-
paring previously listed trends with patterns observed within PQSnr dataset, thus
providing guidelines for the prediction step introduced in the next chapter.
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4.4 Conclusions
This chapter examines protein-protein interfaces in terms of their chemical, struc-
tural and evolutionary properties, using a carefully selected dataset of high-quality
structures of protein complexes. Interfaces presented features consistent with previ-
ous findings on mostly smaller datasets, and some new methodological issues were
identified in the process.
First, it is crucial to ensure that only biological interfaces are used, devoid of crystal
contacts which are an inevitable consequence of solving protein structures using X-
ray crystallography. The work presented here, similar to many recently developed
methods, uses Protein Quaternary Structure (Henrick and Thornton, 1998) as a
source of modelled biological units. PQS was recently discontinued, and substituted
with more reliable automated PISA-modelled (Krissinel and Henrick, 2007) biological
units. However, it is unclear whether one should use PISA-modelled quaternary
structures (provided for all PDB structures) or manually curated, inevitably more
correct, PiQSi (Levy, 2007) biological units (covering ∼ 25% of currently available
structures).
Second, some complexes are less appropriate for this type of analysis (for example,
viral capsid complexes, discussed in Section 4.2.1.2), as their nature could hamper
the detection of interface-specific features. In particular, antigen-antibody complexes
have a specific evolutionary mechanism (Liang et al., 2006) (a high frequency of
somatic mutations to optimise binding to the antigen), and could have therefore
resulted in misleading multiple sequence alignments in Section 4.2.4.1. Moreover,
transmembrane proteins display structural features which impose strict restrictions
on amino acid composition and structural features, adding unnecessary bias to the
dataset (Nugent and Jones, 2009). Removing both these types of interfaces from the
PQSall dataset might in the future provide more general interface features.
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The classification of residues on the surface of a protein into interface or non-interface
is based on incomplete information. Since the PDB provides structural information
for a fraction of complexes, it is likely that many of the proteins used here have alter-
native, previously unobserved interfaces, besides the one used to define an interface
in this chapter. Indeed, the goal of this project is to build a model predicting these
previously (experimentally) unproven interfaces. Thus defining all residues on the
surface of a protein not participating in interaction with an observed binding partner
as non-interface is based on negative information, and is far from ideal. However, as
the coverage of the total space of biological interfaces is increased by adding structures
into the PDB, the models should have more information from which to learn, and
ultimately result in more reliable prediction of protein-protein interfaces. Bearing
this in mind, special care was dedicated to obtaining and carefully filtering interface
data to be provided to the classifiers.
This survey started with a minimal set of attributes: there was no ambition to provide
an extensive set of interface-specific characteristics. The aim was to cover previously
identified chemical and structural patterns in protein-protein interfaces, and test
whether sequence data on homologues provides any additional information when
identifying likely interfaces. Sequence data raised special interest owing to conflicting
reports ranging from full uselessness to claims that sequence information alone is
sufficient for successful interface prediction. Amino acid propensities, hydrophobicity,
planarity, hydrogen and disulphide bonds are all expected to perform well in the
next chapter as strong predictors of protein-protein interfaces. Secondary structure
elements might aid the prediction, but have lower predictive power, and protrusion
as a surface shape indicator has been eliminated owing to the lack of appropriate
interface data (see Section 4.3.2.4). Sequence conservation is expected to improve
model’s performance: less the BLAST-based, and more when adding the FOSTA-
based conservation. These two conservation scores should be tested separately, and
as a combination of two predictors.
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When used to train various types of classifiers, this range of parameters should be
sufficient to provide a reasonable prediction of putative interface patches on the
surface of a protein chain. Once the appropriate type of machine learning model
is identified for this classification problem and this dataset, the range of interface
attributes could be revisited to be optimised (e.g. by combining potentially dependent
attributes into a single score) and/or expanded in order to enhance the model’s
performance. Potentially at that stage, protrusion could be re-tested, hopefully on a
larger dataset of bound structures, for which unbound monomeric structures are also
available.
Throughout this chapter, the χ2-test and t-test have been used to test whether inter-
face residues displayed significantly different trends from other surface residues. Both
of these tests might overemphasize the difference in frequencies or means because they
were calculated using very large datasets – both categories consisted of thousands of
points. While all interface properties displayed a significant difference in frequencies
or means, this was taken as a starting guideline for the final choice of attributes; once
the models are built they will provide true measures of attribute importance, and
the list of final properties used for prediction can be adjusted accordingly.
Chapter 5
Protein-Protein Interface
Prediction
The extensive interface data analysis and feature detection in the last
chapter was performed with the aim of building a protein-protein inter-
face prediction tool, to complement interface detection algorithms already
developed within the SAAPdb pipeline. SAAPdb currently provides anal-
ysis of mutations in interfaces in complexes deposited in the PDB; an ob-
vious enhancement was to expand the range of SAAPdb structural effects
to predicted interfaces.
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5.1 Introduction
There is a sizeable gap between the number of available monomeric and complex
structures in the Protein Data Bank. In order to accommodate this gap, and fa-
cilitated by the constant decrease in costs of computation time, numerous methods
predicting likely interface regions in monomeric structures have emerged over the last
decade. Typically, prediction methods identify a dataset of known interfaces, analyse
this dataset to obtain a list of features discriminating interfaces from the rest of the
protein surface, and then separate the known complexes into monomers to be used as
training and testing examples. Training is used to obtain the optimal set of features
and to learn a model based on the selected features, ultimately producing the best
prediction performance on a remaining test set.
This introductory section will start with a short review of machine learning in Sec-
tion 5.1.1, covering basic principles of data handling and referring to two methods
utilised in this chapter. Next, an overview of the commonly used publicly-available
machine-learning-based interface prediction tools is provided in Section 5.1.2, focus-
ing on the two methods chosen to be developed here, and compared to previously
published work in Section 5.3.4. There are numerous published protein-protein in-
teraction analyses as this is one of the central problems of structural bioinformatics.
The literature review below does not aim to present all of them; rather it focuses
on the methods suitable for the specific modelling task at hand: predictions to be
incorporated into the SAAPdb structural analysis1, and the efficacy of the surveyed
methods. Additionally, only methods where the training datasets were publicly avail-
able, performance measures were clearly stated, and predictors were available for
benchmarking purposes were considered.
1assigning SAAPs to likely interface sites, where the structure of the complex is unknown
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5.1.1 Introduction to machine learning
We live in an age when data accumulates faster than ever. While data storage is
becoming cheaper by the day, thus encouraging tracking of all kinds of naturally-
occurring processes and results of human activity, one has to remember that, as
Albert Einstein is supposed to have said “information is not knowledge”. We have to
make sense of these data and learn from them, rather than just gather them in their
raw form. Unfortunately, our potential to analyse large amounts of information does
not keep up with data accumulation (Witten and Frank, 2005).
Machine learning is a computer science field addressing exactly this issue - it tries
to identify structure in given data, in an automated or semi-automated way through
a process called data mining. The purpose of data mining is threefold, according
to Witten and Frank (2005): it aims better to understand, explain (in ‘human-
readable’ terms) or predict features of data. More formally, Mitchell called this
process learning, and defined it as follows (Mitchell, 1997):
“A computer program is said to learn from experience E with respect to
some class of tasks T and performance measure P, if its performance at
tasks in T, as measured by P, improves with experience E.”
Using Mitchell’s terminology, the class of tasks (i.e. the aim of the learning process) is
termed the concept description. Experience comes in the form of some examples,
also called data points, training examples or instances (all three terms will be used
interchangeably henceforth). Each instance usually has a unique identifier, followed
by a set of measured attributes (also termed features). The choice of attributes is
based on the experimenter’s suspicion that they may contribute new knowledge to
the concept description. Each instance will have a value assigned for each attribute.
Based on the value type, attributes are numerical if they can be expressed on a
numerical scale, or categorical, if the attribute description is defined as a finite
set of mutually exclusive categories. These categories can also be numerical, but
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not continuous (for example, binary attributes with possible outcomes of 0 or 1),
or expressed as some kind of non-numeric description (e.g. times of day: morning,
noon, afternoon, evening) and termed nominal attributes.
5.1.1.1 Different machine learning approaches
There are two main types of machine learning: supervised and unsupervised learning.
In supervised learning, the aim of the model is to predict how the combinations
of values of input attributes affect the outcome, also expressed in the form of an
attribute. If the output is categorical, the machine learning process is called clas-
sification and the attribute predicted by this model is termed the class attribute
- all models built hereafter are of this type. On the other hand, if the outcome
of a prediction can be expressed on a continuous numerical scale, and the model
can be formalized as a numerical function of input variables, the model is called a
regression model.
The learning process, when building a classifier, starts by accessing a set of instances
with known attribute and class values (a training dataset). Modelling then pro-
duces a set of rules2 the efficiency of which is tested on a dataset of instances with
known attribute values, but lacking the class value (a testing dataset). Alpaydin
(2009) defines classification as learning the mapping function g(·) from the input
space X to the output space Y :
y = g(x|Θ) (5.1)
by optimising the set of parameters Θ in order to minimise the error on the training
set. In this thesis, only binary classification will be considered predicting the presence
or absence of a single feature: y in that case can adopt only two values 1 or 0,
2the methodology used to obtain the rules and their format differ between different supervised
classifiers
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corresponding to ‘class feature exists’ and ‘class feature does not exist’ for the given
instance, respectively.
Unsupervised learning occurs when a learning concept focuses on relationships
between the attributes, rather than trying to predict an outcome. In this case, there
is no testing set, and the model outputs training instances grouped used some simi-
larity measure. The main types of unsupervised methods are association learning
where any structure among attributes is sought; and clustering where generating
groups (clusters) of instances is the goal, without necessarily identifying the under-
lying structure common for instances in the same group.
Several other categories of learning exist, like semi-supervised learning (learning on
a mixture of labelled and unlabelled instances) and reinforcement learning (where no
training instances are provided) which are outside the scope of this thesis. For more
details on these concepts, see for example Mitchell (1997) or Alpaydin (2009).
5.1.1.2 Data sampling
The central problem of machine learning is the quality of the data used for the
learning step: mainly its size and how representative it is of the variety of features
in the full population that is modelled. The relative size of the sample cannot be
affected by the experimentalist: data are always limited or we would not have the
need to model a system, we would simply observe it as a whole.
The gathered data (with known attribute values and class value) have to be divided
into training data and testing data. If too many data points are used for training, one
might build an excellent model, but the testing dataset might not be representative,
thus misleadingly presenting low performance during evaluation. In the opposite case,
the model will not be robust owing to the lack of training data, but the evaluation
step will be very thorough. The optimal balance is achieved by iteratively using all
instances for both training and testing: a process called cross-validation. N folds
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are chosen (usually 3, 5, or 10), and data are divided into N non-overlapping subsets
of equal size. Then N models are built, each time using a different fold for testing,
and all other folds merged for training. Evaluation of cross-validation is reported as
averaged scores from each iteration.
An extreme case of cross-validation is the leave-one-out validation (also knows as
‘jackknifing’), where the number of iterations (folds) equals to the number of data
points: in each step all but one instance are used for model building, and tested on
one data point. However this procedure is very resource-heavy so it makes sense to
use it only when a very limited sample is available.
Both cross-validation and leave-one-out validation are data sampling without replace-
ment, i.e. once an instance is sampled from the pool of instances, it is removed, and
cannot be sampled again. In contrast, data sampling with replacement, also called
bootstrapping, during sampling always leaves the instance in the original pool,
and just copies it to the testing dataset. In this way, each sampled instance is chosen
from the original N instances, which allows repeated sampling of the same instance.
In fact, if sampling with replacement is performed N times from the dataset of N
instances to be included in the testing set, typically 63.2% of instances will be cho-
sen (obviously, some more than once), leaving 36.8% of instances for the out-of-bag
(OOB) testing set. To use a simple example, sampling without replacement would be
dividing a group of children in two football teams, whereas sampling with replacement
would be drawing the names of children winning a prize from a hat, and returning
the name back to the hat, so the same child can win more than one prize.
The other important issue during classification is the ratio of data points with each of
the classes. This ratio has to be maintained throughout all the partitions of training
and testing data, in order to avoid creating unbalanced models. For example, if by
random data partitioning all instances with one class value were in the test set, and
the training set had only values with the other class value, the model will simply
predict the latter class value in 100% of the cases. The common method used to
CHAPTER 5. PROTEIN-PROTEIN INTERFACE PREDICTION 163
avoid this issue is to stratify both training and testing dataset, i.e. make sure the
ratio of data points with each class value is maintained while randomly sampling
data points for each fold in cross-validation, and the testing dataset.
Finally, provided with a limited sample, the model should perform equally well on
the entire population being modelled3, even if some of the patterns present in the
population are not present in the training data. Alternatively, if the classifier is
overfitted: it will present misleadingly high performance during training, but when
tested on slightly different instances, it will prove inadequate. The only true test
against overfitting is testing on a completely new set of instances, that have not been
included in any phase of modelling (for more details see Section 5.1.1.5).
5.1.1.3 Handling missing data
Often some gathered data points do not have known values for all attributes used
in the modelling process. There are various causes for missing values: for exam-
ple an error could have occurred during the measuring process (e.g. an instrument
malfunctioned), or it made no sense to perform the measurement for a certain data
point (e.g. a patient’s condition was too severe to perform an expensive test which
would have not aided his treatment). In any case, the experimenter building a model
usually does not have a possibility of repeating the measurement, so the modelling
has to proceed with missing values.
There are three main strategies for handling missing data: (i) removing a data point,
(ii) creating a new category, provided the feature is nominal or, (iii) imputing the
value from data points with known values for that attribute. For more details see
Witten and Frank (2005) or Saar-Tsechansky and Provost (2007), and references
therein. Removing data points makes sense if the remaining dataset is not so small
to seriously affect the model’s performance. Indeed, training data used throughout
3performance is measured during training, but we really want the model to be a good predictor
of the future data
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this chapter were abundant enough to utilise this procedure (for details on the dataset
like its size, see Sections 5.3.1–5.3.2). Next, when the attribute for which the value is
missing is nominal, one can create a novel attribute category ‘missing value’, provided
this is not adding severe bias by equating all the instances with the lacking value.
Finally, there are several ways of predicting what would be the most likely value for
the instance. For the review on missing data imputation, see for example Jerez et al.
(2010).
5.1.1.4 Model evaluation
The aim of classification is to build a model based on some known data, which will
successfully sort new instances into the right class. Consider the possible outcomes of
a binary classification for a data point. The test instance, by definition, has a known
true class value (positive or negative), and a predicted class value (again, positive
or negative). The four combinations are presented in Table 5.1. An instance with a
positive class value can correctly be classified as true positive, TP, or erroneously as
a false negative, FN. Vice-versa, an instance with the negative measured class value
can correctly be classified as true negative, TN, or erroneously be labelled as false
positive, FP.
Table 5.1: Outcomes of a two-class prediction, also termed confusion matrix.
Predicted class
Positive Negative
Actual Positive TP FN
class Negative FP TN
The ‘success’ or how ‘correct’ the classification is, is a relative term and depends
on the purpose of the model. For example, when used as a diagnostic tool, missing
a likely positive should be avoided at all costs, while falsely predicted positives are
acceptable. In contrast, in the case of protein-protein interface prediction problem
presented here, the predicted interface should always correspond to a true interface;
at the same time it is more acceptable that a (small) fraction of true interfaces
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are missed. Consequently, there are different measures of model performance, and
Table 5.2 surveys the ones used for binary classification evaluation, also listing the
ranges of values the measures can adopt.
Table 5.2: Binary classification performance measures.
Name Formula Range of values
Accuracy TP+TNTP+FP+FN+TN [0, 1]
Precision? TPTP+FP [0, 1]
Sensitivity† TPTP+FN [0, 1]
Specificity◦ TNTN+FP [0, 1]
False positive rate FPFP+TN = 1−specificity [0, 1]
False negative rate FNFN+TP = 1−sensitivity [0, 1]
F-measure 2TP2TP+FN+FP [0, 1]
Matthews correlation
coefficient
TP×TN−FP×FN√
(TP+FP )(TP+FN)(FP+TN)(FN+TN)
[−1, 1]
Root mean squared er-
ror
√∑n
i=1 (xˆi−xi)2
n (
∗) N/A‡
Mean absolute error
∑n
i=1 |xˆi−xi|
n N/A
? positive predictive value (PPV)
† true positive rate (TPR), coverage or recall
◦ true negative rate (TNR)
(∗) xˆi and xi are the predicted and the actual class values for the i-th instance,
respectively
‡ the scale of values depends on the scale of the numerical class value
Accuracy, also termed ‘overall success rate’, measures the fraction of correctly pre-
dicted cases, compared to all cases considered. The opposite is error rate, defined
as 1−accuracy. Precision indicates how many instances predicted to be positive
really are so, in other words this indicates how likely the model is falsely to annotate
a hit as positive. In the case of interface prediction, this is particularly important.
False positives in SAAPdb are erroneously annotated as structurally-damaging, thus
failing sensibly to narrow down the list of potentially interesting mutations for the
database user testing candidate mutations. Sensitivity, on the other hand, indicates
how many true positives were missed, a crucial feature to avoid when using models
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in medicine4. Specificity indicates for true negatives the same thing sensitivity does
for true positives.
The F-measure is the harmonic mean between precision and sensitivity:
usually used with an equally weighted contribution of these two. While being
a more general measure of accuracy than the first four listed here, it neglects
the TN . Therefore the more appropriate general performance indicator is the
Matthews correlation coefficient, MCC: it shows how well the predicted
class correlates with the actual class (from -1 for anti-correlation, through 0
meaning no correlation, to 1 for the perfect correlation). Further, the MCC is
the only evaluation metric including all four counts from Table 5.1 into a single
value.
In general, the model is better the higher the values in the upper part of Table 5.2 are,
and the lower the error rates are (provided output is a continuous numerical value,
and error measures are applicable). However, during model optimisation, usually
one has to trade one performance, to increase the other. This is achieved by trying
out various attribute combinations and adjusting the model’s parameters until the
desired correctness is achieved.
For models with numerical outputs (like neural networks), in contrast to binary clas-
sifiers (e.g. random forests), three more performance measures can be applied: root
mean squared error (RMSE), mean absolute error (MAE) and area under the curve
(AUC), the ‘curve’ being the receiver operating characteristic (ROC) curve.
Root mean squared error is a square-root of variance of the residual5. In
other words, the difference between the expected and observed value for each
data point is first squared, then averaged, and then a square-root is taken.
Mean absolute error is the averaged sum of absolute errors, each obtained
4missing an existing disease could have fatal consequences, whereas over-predicting diseased
states, however traumatising for the patient, can be rectified at a later time
5variance of residuals is also called mean squared error
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as the absolute difference between predicted and observed class value for a data
point.
There is one more performance measure, provided a classifier ranks the outcome,
or assigns probabilities, or confidence values: the receiver operating characteristic
(ROC) curve, and the corresponding area under the curve (AUC). Plotting true
positive rate against false positive rate, the learned model can be compared with
the performance of a random model, i.e. a predictor randomly outputting a class
value, irrespective of the input values. As presented in Figure 5.1, a random model
has AUC = 0.50 (the curve ‘A’). A perfect predictor with zero error rate would have
AUC = 1.00 (curve ‘D’ is the closest to this ideal scenario), reaching a TPR value of 1
for all FPR values. However, there have been some recent doubts expressed by Hand
(2009) about comparing different classifiers by using AUC since each ROC curve is
a result of a different misclassification metric. Therefore a mixture of performance
characteristics should be used when evaluating a model, paying special attention to
which suboptimal behaviour of the model could be tolerated when it is applied in
practice.
Figure 5.1: Receiver operating characteristic curve.
A is a random model, B, C and D show improvement over random predic-
tion, in ascending order. Figure obtained from http://www5e.biglobe.ne.
jp/~tbs-i/psy/tsd/node3.html, with minor modifications.
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5.1.1.5 Benchmarking
To sum up data sampling and evaluation strategies, it is important to focus on the
future performance of the model, while training and testing on a limited set of present
instances. Benchmarking assumes independent and transparent testing (usually sev-
eral similar models) on data never ‘seen’ by the model(s). While considered absolutely
neccessary, especially to prove that one method outperforms another one without any
doubt, it is rarely performed as it requires a great deal of effort, computing time, and
(most scarce) data appropriate for the task modelled, that have not yet been utilised
for that problem.
Two types of classifiers have been built in this chapter, and a short introduction to
their methodology is presented in more detail hereafter.
5.1.1.6 Neural networks
The multilayer perceptron is a type of feedforward6 neural network building the class-
prediction function using backpropagation to minimise the errors during learning by
adjusting the weights of the connections between the network’s nodes (Rumelhart et
al., 1986).
In short, the multilayer perceptron is a model which can be represented minimally as
three layers of interconnected nodes (also termed neurons, neurodes or perceptrons),
with weights on all connections. As presented in Figure 5.2, the architecture of the
model is divided into the input layer (one neuron for every attribute7), the (usually
single) hidden layer with a user-defined number of hidden nodes, and the output layer
with a node for every class category. The term ‘hidden’ refers to the fact that, unlike
the input and the output layer, hidden nodes do not represent an observable property.
Indeed, one of the downsides of multilayer perceptrons is that the data structure
6nodes connected in a non-circular fashion
7in the case of a neural network, these are exclusively numerical
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they learn, although highly efficient at prediction, is not always easily transferable to
human-readable terms. In other words, it can be used as a ‘black box’ for prediction,
but unlike trees comprising rules it is not trivial to visualise.
Figure 5.2: Multilayer perceptron schema.
Nodes are organised in three types of layers: input, hidden, and output layer,
and the weights on the connections between the nodes are optimised. Figure
obtained from http://en.wikipedia.org/wiki/File:Artificial_neural_
network.svg under Creative Commons license.
Using mathematical terminology, a multilayer perceptron is a function mapping input
values to the class value. Every node transforms the input using a nonlinear activation
function, and the final output value is a linear combination of the outputs of weighted
hidden layer nodes. The aim of the model is iteratively to learn the weights which
will minimise the error rate on the presented instances, i.e. the training set. This
error minimisation is often referred to as ‘gradient descent’, because in every iteration
error is reduced in a stepwise fashion, hopefully reaching a global (rather than local)
error rate minimum. Another way to avoid finding a local minimum is by introducing
‘momentum’, i.e. a small amount of random noise introduced into the system in every
epoch. Finding the appropriate ratio of learning rate8 and the momentum is the key
to model optimisation to achieve sufficient generalisation and specialisation.
The user specifies the ending conditions for the learning process: either by defining
the number of epochs, or by the defining a stopping condition when the learning rate
has not changed for the last n epochs. While the number of iterations could be very
high, allowing the model to sample error space finely around the achieved minimum,
8the ‘size’ of the error decrease in every step
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the learning process is usually stopped soon after the learning rate change plateaus in
order to avoid overfitting the model to the training data (especially when the training
set is of a limited size), a process also known as ‘early stopping’.
5.1.1.7 Random forest
When a classification model is required for a dataset containing many attributes,
often a dimensionality-reduction needs to be employed because many commonly used
models display suboptimal performance when highly interdependent or irrelevant
attributes are mixed with the informative ones. This attribute-optimisation step is
resource-demanding, and the standard way to avoid it is to resort to decision trees:
the preferred model of choice for high-dimension modelling tasks.
A decision tree algorithm in every iteration, surveys all the possible splits of all
attribute values, determining the split condition which maximises the information
gain (Witten and Frank, 2005). This procedure is recursively repeated for every
node created by the split, until no information gain can be achieved, or until the
maximum tree size is reached.
Unfortunately, while robust in respect to high-dimensional data, a single decision
tree often lacks accuracy when trained on a limited dataset. Several authors recently
proposed an obvious improvement of this model by building a set of T trees (con-
veniently termed a forest), instead of a single tree. In this case, the final predicted
classification of an example is a combination9 of predictions made by every tree, gen-
erally outperforming decision trees (Svetnik et al., 2003). The most efficient method
for learning a solution to a problem using an ensemble of T trees is the random
forest, introduced by Breiman (2001).
A random forest builds a user-specified number of trees, each trained and evaluated
on a bootstrap sample of the same dataset, with the remaining 1/3 of instances
9often simply a majority vote
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comprising the ‘out-of-bag’ test set; for more details on bootstrap sampling see Sec-
tion 5.1.1.2. The number of trees is limited by the computer power; in practice,
the more trees a model produces, the better the performance. Moreover, using the
Law of Large Numbers, Breiman (2001) proved that there is an upper bound for
the generalisation error, therefore adding trees to the random forest does not lead to
overfitting.
While building a tree, a split of a node is calculated based on a randomly chosen
subset of mtry attributes: this type of tree building is sometimes referred to as the
random tree algorithm. In this respect the random forest resembles the bagging
algorithm (Breiman, 1996), where a split is based on all p available attributes, with
an obvious gain in speed when mtry < p. The tree is then built until there are no more
information-gaining splits and no pruning is performed. Finally, the model is applied
to out-of-bag instances, and the performance on them is reported as the ‘out-of-bag
error’ (OOB error), which refers to 1-accuracy on the OOB set of instances.
According to Breiman (2001), a low mtry means a low correlation between the trees,
but at the same time, each individual tree in the model will be less informative
(as it covers a narrow range of provided attributes in every split). Increasing mtry
will yield more similar trees, and each tree will provide more accurate prediction.
Consequently, optimal performance of random forests lies within medium mtry and
T values, and some optimisation of these two parameters should be utilized (Svetnik
et al., 2003). In fact, Svetnik claims that as long as mtry is not 1 or p, this parameter
does not significantly influence the method’s performance, at the same time providing
great improvement in speed over bagging, and even over some decision trees.
Svetnik et al. (2003) have shown that random forests have several advantages over
decision trees: (i) in every tree-splitting step they use a subset of parameters signifi-
cantly reducing the tree-building time, (ii) the time-consuming cross-validation step
is avoided by bootstrapping and evaluating the method on the OOB dataset (usually
∼ 1/3 of the training dataset) and (iii) complexity of the tree-building step is reduced
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by omitting the pruning step. Moreover, while being very resource-efficient for large
datasets with many attributes, random forest shows comparable performance to
boosting (Meyer et al., 2003) and decision forests (Tong et al., 2003) and outperforms
bagging. Finally it is a straightforward method to use ‘off-the shelf’ with only two
parameters: the number of attributes tested while building a tree m, and the number
of trees T which should be set to as high as the computational resources permit.
Another convenient feature of this classifier is that it provides a measure of impor-
tance of each attribute used for training. After each tree is built, a misclassification
rate for a feature on the OOB set can be calculated when that attribute’s values are
randomized (Breiman, 2001). The difference between that misclassification rate, and
the OOB error is termed the raw importance measure of an attribute. It is worth not-
ing here that, while culling the attributes with the highest importance scores removes
the less informative attributes, this parameter optimisation does not guarantee the
highest scoring attributes are not mutually highly dependent.
5.1.2 Predicting protein-protein interfaces from structural
data
When building interface prediction models, authors have used numerous datasets,
reviewed in great detail by de Vries and Bonvin (2008); it is often simply the most
recent version of the Protein Data Bank (Berman et al., 2000), filtered to eliminate
noise from the structural data (i.e. low-quality structural data and redundant struc-
tures). Interestingly, despite being intensively researched in recent years, there is
no consensus dataset of protein-protein interfaces, and there is still a fair amount of
disagreement over typical interface-distinguishing features.
Additionally, as described in Section 4.1.2, there is no unique definition of an interface:
some use a distance threshold from residues on the interacting chain, others use the
decrease in solvent-accessibility upon complexation. When sequence conservation is
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added as a property, one gets to choose from a plethora of conservation scores (e.g. as
reviewed by Valdar (2002)). Finally, different authors use the same predictor names
for differently defined predictors, i.e. amino acid propensities can be defined at the
patch-level (Jones and Thornton, 1997) or residue-level (Dong et al., 2007), yet the
same terminology is used in both cases. These inconsistencies complicate comparison
of methods and their performance, as will be discussed in Section 5.3.5.
Several recently-developed methods showing promising protein-protein interface pre-
diction performance are reviewed in Table 5.3, with the accuracy and coverage (sen-
sitivity) values as listed in the original papers. Most of these methods are patch-
based rather than residue-based, use a combination of structural, evolutionary and
sequence-based predictors, and report overall success rates (during cross-validation)
up to ∼ 75% (Keskin et al., 2008).
The most successful interface prediction methods are based on both physical and
chemical features, with optional evolutionary data; Kufareva et al. (2007) argued
that while family alignment profiles marginally increase performance for some pro-
teins, when alignments contain small numbers of sequences, or the interface has
to adapt easily to several interacting partners, removing evolutionary information
might increase the robustness of the interface prediction. Moreover, considering all
the methods listed in Table 5.3 and (by extension) others listed in Table S1 in the
review by de Vries and Bonvin (2008), it seems that analysing interfaces by sampling
patches on the protein surface is superior to methods assigning a score/probability
for individual surface residues.
In terms of machine learning methods, this project focused on two: neural networks
and random forests. These two were chosen because the former has been ubiquitously
used for this purpose, and the latter has recently shown great potential in modelling
similar bioinformatics problems, and moreover, these two methods cover the opposite
spectra of classification methodology: numerical and tree-based categorical classifi-
cation.
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5.1.2.1 Neural networks developed for protein-protein interface predic-
tion
Several groups have utilised neural networks for interface prediction in the last decade.
Promising performance was achieved by Fariselli et al. (2002). Using a sequence pro-
file for an 11-residue patch (the predicted residue and 10 closest spatial neighbours)
in three-fold cross-validation, they reported 72% accuracy, 56% sensitivity and a cor-
relation coefficient of 0.43 for the interface class. However, this performance was later
claimed to be an overestimate, when tested by Porollo and Meller (2007), owing to
the redundancy of the dataset. The neural network built by Ofran and Rost (2003)
relies solely on sequence information achieving poor sensitivity (not reported in the
original publication, rather estimated by de Vries and Bonvin (2008)) and was con-
sequently removed from further comparison with methods built on structural data.
Another neural network, actually a consensus of several models, cons-PPISP (Chen
and Zhou, 2005) was trained and tested on interfaces inferred from PDB structures,
thus allowing bias towards crystal contacts. Initially displaying high accuracy (86%),
but low sensitivity (17-19%), it was further refined to achieve improved performance
on their test set. Although that goal was eventually achieved by combining several
neural networks, optimisation on the specific (and fairly limited in size) test set,
apparently lead to overfitting, as Zhou and Qin (2007) reported significantly lower
performance during their benchmarking procedure.
Porollo and Meller (2007) used SABLE, a previously developed predictor of relative
solvent-accessibility, as one of the interface-specific features. They noticed that this
tool, when predicting solvent-accessibility of a residue, corresponds better to the
values in the bound rather than the unbound state. Therefore, when utilised on
monomeric chains, some surface residues have unexpectedly low predicted relative
solvent-accessibility, and these residues frequently correspond to interface residues.
Consequently they built SPPIDER, a multilayer perceptron combining conservation,
structural attributes and rASA values, outperforming the Fariselli model mentioned
above. They claimed SPPIDER had high sensitivity and specificity (presented in
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Table 5.3), however Zhou and Qin (2007), when presenting novel interface instances,
achieved a specificity of 47% with 43% sensitivity, with even lower performance on
the CAPRI25 dataset.
5.1.2.2 Random forests aimed at interface prediction
Random forest is a binary classifier, based on the majority-voted prediction of several
random trees. It was chosen for several favourable features: (i) convenience for
datasets with a large number of (potentially overlapping) attributes, (ii) no tendency
towards overfitting, (iii) it calculates fewer parameters requiring less CPU time than
other models with a similar dataset, (iv) since it is a tree-based method, it has an
easy-to-visualize model structure (at least single trees do), and finally, (v) it provides
principal-component-like attribute importance, which can be used for dimensionality
reduction.
Sˇikic´ et al. (2009) have used random forests to build both sequence-only based and
combined sequence- and structure-based interface predictors with 80% precision and
25% recall and 76% precision and 38% recall during 10-fold cross-validation, respec-
tively. Unfortunately, they do not provide their classifier, nor have they benchmarked
it against other interface datasets omitted from the training procedure. However,
random forests are becoming increasingly popular (Breiman, 2001): they have shown
great potential in prediction of biological problems such as activity prediction from
chemical structure (Svetnik et al., 2003), renal tumour classification (Shi et al., 2005)
and genome-wide association studies and detection of multiple-sclerosis-linked gene
candidates (Goldstein et al., 2010).
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The comparative analysis of several datasets using different machine learning meth-
ods, summarised in Table 5.4, showed that although all the methods display high
accuracies measured during cross-validation, their performance deteriorates severely
when new data are used (Zhou and Qin, 2007). There is an obvious potential for im-
provement, and hopefully, careful data extraction and feature selection will improve
the models, regardless of the choice of test set (used during benchmarking).
Table 5.4: The benchmarking of several interface-prediction methods on the two datasets
(Zhou and Qin, 2007).
For the dataset of 35 enzyme-inhibitor complexes (Enz35), accuracy was mea-
sured at a coverage of 50%, and for 25 CAPRI targets accuracy was measured
at 30% coverage.
Datasets PPI-
Pred
SPPIDER cons-
PPISP
ProMate PINUP meta-
PPISP
Enz35 27% 33% 36% 38% 48% 50%
CAPRI25 23% 25% 26% 26% 28% 31%
To that end, this project set out to develop a novel protein-protein interface classifier,
optimised for the residue-level prediction within SAAPdb.
5.2 Methods
This section lists methods used to perform data preparation, utilising and optimising
several machine learning methods to build an interface predictor, and finally bench-
marking against similar previously published methods on an independent dataset of
interfaces, upon which none of the methods was trained. The technical aspects of
the above mentioned procedures, and tools and resources used in the process, are
described in Sections 5.2.1–5.2.6, and they all refer to the PQSnr dataset prepared
and presented in the previous chapter.
CHAPTER 5. PROTEIN-PROTEIN INTERFACE PREDICTION 178
5.2.1 Preparing patches of various sizes
In order to sample parts of the protein surface and test for a certain combination
of physico-chemical properties indicating a likely interface, the surface had to be
fragmented. These fragments, hereafter termed surface patches, were built to be
continuous with a fixed maximum patch radius, approximately circular in shape, and
include at least one highly solvent-accessible residue, called the patch centre.
The PQSnr dataset contained 4345 protein chains containing protein-protein inter-
faces, residues sorted into buried and surface residues, the latter further divided
into interface and non-interface residues. When separating surface residues into in-
terface and non-interface, an additional set of markedly solvent-accessible residues
(rASAm > 25) was collected, each representing a patch centre, i.e. a starting point
when building a patch.
Before presenting the algorithm developed to build surface patches, several terms
need to be introduced:
Geometry vector is a Euclidean vector, defined for a residue. Its initial point is
the Cα atom of the residue in question, and the terminal point is the centre of
geometry of the 10 spatially closest neighbours of that residue (calculated by
averaging Cα atom coordinates).
Solvent vector is defined for a residue as the opposite vector to the geometry
vector. More precisely, its initial point is also the Cα atom of the residue; it
has the same length but the opposite direction to the geometry vector.
Solvent angle, defined for two residues, is an angle between the solvent vectors of
the two residues.
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Contact radius is defined for a pair of atoms, as the sum of the van der Waals radii
of the two atoms, plus a tolerance distance (here set as 0.2A˚). Two atoms are
in contact if the distance between these atom centres is less than the contact
radius.
Once a patch radius had been specified, the algorithm builds a patch iteratively
from each patch centre in PQSnr. The algorithm was:
i Determine all surface residues with at least one atom centre within the
patch radius from the patch centre. These are candidate residues for that
patch, and their atoms are added to the set of unlabelled atoms U.
ii Label the highest ASAm atom in the patch centre residue as belonging to
that surface patch.
iii For each labelled atom L, test if any of the unlabelled candidate atoms
(U) are within the contact radius. If L and U are in contact, and if the
solvent angle between L and U is less than 120◦, label U.
iv Repeat step iii until no new candidate atoms are labelled.
The 120◦ angle check was used similarly to previous work by Jones and Thornton
(1997) and Pettit et al. (2007), in order to eliminate opposite sides of a deep pocket
being merged into one patch, which would result in discontinuous (and biologically
meaningless) patches.
The only tuning parameter when building a patch was the patch radius. Three kinds
of input for the classifiers were prepared using three patch sizes from PQSnr, shown
in Table 5.5. Each was a set of surface patches on all chains and three patch sizes
were chosen: single-residue, patch radius 9A˚ and 14A˚ and were named Pnr res, Pnr 9
and Pnr 14, respectively. For more details, see discussion in Section 5.3.2.
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Table 5.5: A range of patch sizes.
Patch area is calculated using patch radius and formula for the area of the
circle: r2pi. Counts of residues were obtained by building all patches with certain
radius using PQSnr and the aforementioned algorithm, and calculating the mean
number of residues in patches.
Radius (A˚) Area (A˚2) Residues Corresponds to:
r=9 254 7 Smallest observed biologically relevant interfaces
(Section 5.3.2)
r=14 616 20 Minimal interface size to obtain a hydrophobic core
(Bogan and Thorn, 1998)
r=16 804 26 Average interface size by Lo Conte et al. (1999)
5.2.2 Preprocessing interface attributes
5.2.2.1 Class value
A patch could adopt one of two class values: interface, I or surface (i.e. non-interface
surface), S. Let P be the set of residues in the patch under consideration, and I
is the set of interface residues for the chain to which this patch belongs, previously
identified and stored as explained in Section 4.3.1. Then rASAmP denotes the sum
of solvent-accessible surface area of all residues in a patch and by analogy, rASAmI
denotes the solvent-accessible surface area of residues within that patch, which have
previously been labelled as interface residues:
rASAmP =
∑
i∈P
rASAm(i), rASAmI =
∑
j∈I
rASAm(j) (5.2)
where rASAm(i), rASAm(j) are monomeric rASA value for residues i and j, respec-
tively10. Then
rASAo =
rASAmI
rASAmP
(5.3)
10calculated by the solv algorithm, as specified in Section 2.2.1
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represents the fraction of the surface area of a patch occupied by the atoms in interface
residues, i.e. the interface-patch overlap. If a patch overlapped with an interface in at
least half of its surface (rASAo ≥ 0.5), that patch was assigned class I. If there was
no overlap between a patch and the interface on that chain (rASAo = 0), the patch
was labelled as class S. All other patches11 remained unlabelled and were removed
from further consideration.
5.2.2.2 Training attributes
In addition to the class value, each patch had eight features assigned to it, identi-
fied as predictive of interfaces in the last chapter. For simplicity, attributes were
grouped into four combinations (sequence-based attributes are part of the STR cat-
egory):
STR Structural: propensities, hydrophobicity, planarity, disulphide bonds, hydro-
gen bonds, secondary structure
STR+F Structural + FOSTA: all structural, FOSTA-based conservation
STR+B Structural + BLAST: all structural, BLAST-based conservation
ALL Structural + FOSTA + BLAST: all structural, FOSTA-based conservation,
BLAST-based conservation
For Pnr 9 and Pnr 14 the value of a property X for a patch was calculated as the
arithmetic mean of values of X for all residues in that patch:
XP =
N∑
i=1
xi/N (5.4)
11in effect, corresponding to the rim of the interface
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where i = 1, ..., N are N residues in patch P , and xi is value of property X for residue
i. Since patches in Pnr res each comprised a single residue, patch values were identical
to that residue’s for all attributes except planarity. Planarity of a single-residue patch
was calculated based on the coordinates of that residue and the 7 spatially closest
neighbours.
The overall secondary structure type assigned to the whole patch is defined based on
the percentage of residues belonging to a secondary structure type, as proposed by
Jones and Thornton (1995):
H , if α > 20% and β < 20%,
E , if α < 20% and β > 20%,
EH , if α > 20% and β > 20%,
C , if α ≤ 20% and β ≤ 20%.
As many machine learning models support only numerical non-class attributes, the
secondary structure attribute needed to be transformed. Typically, a nominal at-
tribute H with N possible categories is transformed into N binary attributes. The
transformation from nominal secondary structure attribute SS ∈ (H,E,EH,C), into
binary attributes SS′ is shown in Equation (5.5), increasing the total number of at-
tributes by three (in the case when EH secondary structure is allowed, i.e. for r = 9
and r = 14 patches), or two (for single-residue patches) extra secondary structure
attributes.
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SS′ =

(1, 0, 0, 0), if SS = H
(0, 1, 0, 0), if SS = E
(0, 0, 1, 0), if SS = EH
(0, 0, 0, 1), if SS = C
(5.5)
Alternative encodings are also possible – see Section 5.4.
5.2.3 Building WEKA classifiers
There are numerous approaches and algorithms in machine learning, and often an
experimenter needs to try out several of them to identify the most suitable technique
for the problem in question. Built to that end, several resources such as WEKA (Hall
et al., 2009) and RapidMiner (Mierswa et al., 2006) implement a wide range of tools
and techniques, simultaneously offering a user-friendly interface to create, optimise
and evaluate machine learning experiments.
This machine learning started by trying out all available methods implemented within
the WEKA platform: an open-source, Java-based collection of machine learning al-
gorithms. All supervised classifiers implemented in WEKA3.6.3 were trained on Pnr 9,
with all default parameters. For a full list of classifiers, see Figure 5.4. Two super-
vised methods that have been tested in more detail over a wider range of parameters
and training data setups will be presented below in Sections 5.2.3.1 and 5.2.3.2.
5.2.3.1 Multilayer perceptrons
The WEKA implementation of the test (weka.classifiers.functions.
MultilayerPerceptron) was used. The model was trained on normalised attribute
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values12 using a sigmoid function, using 5 or 50 hidden nodes over 500 epochs, with
all other model variables set to WEKA’s defaults.
5.2.3.2 Random forests
The weka.classifiers.trees.RandomForest method implemented in WEKA was
used. Based on the random forest algorithm developed by Breiman (2001), this
algorithm builds unpruned random trees, without limiting the tree depth. This clas-
sifier is incapable of handling missing attribute values, it introduces an imputed
value instead: usually the mean value for continuous numerical attributes, or the
most common category for nominal attributes (other strategies for building mod-
els with some data missing have been presented in Section 5.1.1.3). This practice
was acceptable for all attributes used, except FOSTA: ∼ 80% of instances in all
patch sets were missing the FOSTA-based conservation score, mostly as a result of
lack of functionally-equivalent proteins (a minimum of 4 FEPs was required to build
a multiple sequence alignment, as presented in Section 4.3.2.7). Thus in order to
avoid building a model on many imputed values, all instances with missing FOSTA
values were removed from the training and testing datasets when this method was
used.
Let p be the total number of attributes provided for every data point (class value
excluded). For the Pnr res, p was 8/9/9/10 for STR, STR + F, STR + B and ALL
model settings, and 9/10/10/11 for Pnr 9 and Pnr 14. The default value for mtry,
introduced in Section 5.1.1.7, is
√
p, rounded to the closest integer value. In other
words, for the range of p from 8 to 11, the method’s default is mtry = 3, however a
range of values from 2 to 9 was also tested.
The common recommendation for the tree-number optimisation is to increase the
number of trees until the OOB error stops decreasing. Unfortunately, this could not
12i.e. all attribute values are adjusted to range between -1 and 1
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be achieved here; the WEKA implementation of the random forest method is pro-
hibitively memory-demanding and allocating 20G of RAM was insufficient to build
random forests with more than 150 trees for this training dataset. Therefore only a
range from 50 to 150 trees per ensemble were used. Finally, although strictly there
is no need to perform cross-validation when training a random forest13, a 10-fold
cross-validation procedure was employed here in order to obtain other performance
measures (i.e. correlation coefficient, F-measure, sensitivity, etc.), which would facil-
itate comparison with other machine learning methods.
5.2.4 Preparing the benchmarking dataset
A dataset of PQS biological units was obtained following the data-quality filtering
procedure developed for the verification of the PQSall dataset, presented in Sec-
tion 4.2.1.2. The PQS server was discontinued in August 2009, and it stopped au-
tomatically updating the list of biological units by including new PDB structures in
early 2010. This last release of PQS containing 61265 structures was downloaded, and
filtered to eliminate low-quality data and monomeric structures. As previously men-
tioned in Section 4.2.1.1, the PQSall dataset consisted of protein-protein complexes
gathered from PQS, not later than March 2009. Therefore removing all complexes
present in PQSall from complexes obtained from the 61265 structures, yielded a
complementary dataset termed PQSbench, including only complexes released by PQS
after March 2009 and before it ceased.
13OOB error, introduced in Section 5.1.1.7, is calculated on instances omitted during the training
step, equalling to 1-accuracy (the error rate) during cross-validation
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5.2.5 Preparing interface predictions from other classifiers
Several previously published protein-protein interface prediction tools were used to
obtain predictions of likely interfaces for the protein chains in the PQSbench dataset:
PPI-Pred is currently unavailable for testing, ProMate was accessed through the
web page for batch queries14 using the default combination of scores and extracting
amino acids coloured according to their probability of comprising an interface (by
setting the temperature factor in the PDB file to this value). SPPIDER predictions
were obtained from http://sppider.cchmc.org/, using the SPPIDER II classifier.
PIER predictions were obtained from http://abagyan.ucsd.edu/PIER/pier.cgi
as downloadable comma-separated value files. meta-PPISP (and PINUP scores used
within) were obtained from http://pipe.scs.fsu.edu/meta-ppisp.html.
5.2.6 Benchmarking
Each surveyed classifier provided residue-level predictions as numerical values.
Thresholds identical to the ones used in the original papers were chosen for all the
methods to indicate a positive prediction (residue predicted as interface): p > 70 for
ProMate, predicted by minimum of 5 neural networks for SPPIDER, minimum
score of 30 for PIER and p > 0.34 for meta-PPISP. In the case of PINUP, the
original classification was based on clustered patches, but since meta-PPISP’s
output provides only raw PINUP scores (scaled to 0.0 to 1.0 range), a 0.5 cut-off
was chosen to differentiate interface from non-interface residue.
14http://bioinfo.weizmann.ac.il/promate/
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5.3 Results and discussion
After careful consideration, it was decided that none of the available methods sur-
veyed in Section 5.1.2 was suitable for the task at hand, and an in-house interface
prediction method should be developed to be added to the SAAPdb pipeline, for
both methodological and technical reasons.
In terms of methodology several common weaknesses were identified, in particular
training on one type of interface (transient in Neuvirth et al. (2004) and obligate
in Bradford et al. (2006)); optimising models for lower specificity in order to obtain
higher sensitivity, thus increasing the false positive rate, e.g. Chen and Zhou (2005);
and finally, using only sequence data to obtain a more diverse training set. All
sequence-only predictors (such as Res et al. (2005), Ofran and Rost (2003; 2007))
were eliminated; as SAAPdb focuses on structural effects and thus all residues that
will be modelled for putative interface sites are, by definition, mapped to available
protein structure. Consequently, ignoring structural information to widen the range
of proteins on which the model is trained makes no sense in the context of this project.
For references and further discussion on the sequence-only interface prediction, see
Section 4.3.2.7.
While inconsistencies in methodologies presented above were considered suboptimal,
the prevailing reason for developing a novel prediction was its availability, and in-
surance of future maintenance. The majority of surveyed methods provided access
through a web page, however none of the methods that performed well in predict-
ing interfaces not used during the cross-validation step had freely accessible source
code.
The previous chapter describes in detail how an extensive and up-to-date dataset
of interfaces was built, and which features were chosen as predictors of interface
regions on the surface of protein structures, based on that dataset and previously
published literature. This chapter reports how these features were transformed into
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a machine-readable format, followed by testing of various prediction approaches, fi-
nally presenting a comparison of developed models to existing predictors on a novel
benchmarking dataset of complexes. This prediction method was built in order to
predict likely interfaces at the residue-level as a part of the SAAPdb pipeline, ulti-
mately compensating for the sparse interface-damaging SAAPs owing to the lack of
protein-protein interface data in the PDB.
5.3.1 Protein-protein interface data
The robustness of a model learned by a classifier, and its ability to generalise and
perform on new testing examples, is greatly influenced by the size and quality of
the training dataset. At the same time, interface data are limited and there is no
gold-standard dataset to train and test models, in a way easily comparable with
other publicly-available methods. Ideally, one should have three mutually indepen-
dent subsets of a dataset of interfaces, each sufficiently large and representative in
respect of features of the full dataset. These three subsets would then be used for
parameter evaluation (choosing the minimal set of features to be used for classifica-
tion purposes), training the classifier, and testing the performance of the classifier,
respectively. In reality, this is rarely possible and the widely accepted compromise is
to choose parameters based on the whole dataset, followed by cross-validation, where
the whole dataset is divided into training and testing subsets several times in order
to maximise the size of the training set, without adding bias to it. For more details
on data sampling, see Section 5.1.1.2.
At the same time, performance of similar methods is often reported based on the
testing set during the cross-validation. Considering each method uses a slightly
different definition of the interface and different, often partially overlapping datasets,
comparing methodologies from various authors is very difficult. Indeed, so far there
has only been one attempt to compare different interface-prediction tools on a dataset
of protein-protein complexes on which no method was trained (Zhou and Qin, 2007).
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First, they showed that testing on an independent set of interfaces (25 CAPRI targets)
none of which was included in cross-validation, yielded significantly lower sensitivity
and specificity than reported in the original publications introducing these methods.
This result, along with impaired performance when tested by de Vries and Bonvin
(2008) (marked by “this work” in their Table 3), strongly indicates that comparing
sensitivity and specificity scores obtained from methods’ original publications (unless
these have been trained on the same data) should be avoided as unreliable.
Further, Zhou and Qin (2007) compared performance of the same methods on two
datasets: CAPRI and Enz35, the latter containing several interfaces on which some
methods used in benchmarking were trained. Figure 1 in Zhou and Qin (2007) indi-
cates that choosing a single sensitivity value and ordering methods by their specificity
is dataset-specific and consequently should not be used to compare performance: or-
der of tools in terms of accuracy stayed the same when they compared Enz35 at
coverage 50% and CAPRI at coverage 30%. However if both are observed at cover-
age 50%, the order of methods is different.
Both arguments served as an incentive to build a novel benchmarking dataset, to be
used for an extensive methodology comparison presented in Section 5.3.5. Lastly, to
ensure a dataset of interfaces no other method was trained on (including the method
presented in this chapter) for benchmarking, the PQSnr dataset was based on a
slightly out-of-date version of the PQS list of biological units. This allowed the accu-
mulation of newly solved structures of complexes, then used during the benchmarking
step.
5.3.2 Choosing patch sizes
The surface of the protein is fragmented and each segment is then assigned to the
interface or non-interface class. While the majority of methods use patches of surface
residues (Jones and Thornton, 1997; Chakrabarti and Janin, 2002; Bahadur et al.,
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2003; Neuvirth et al., 2004; Caffrey et al., 2004; Bradford and Westhead, 2005),
there is no consensus on the optimal patch definition or size; for a review of patch-
based methods see de Vries and Bonvin (2008). Typically, patches are continuous
in nature, often mutually overlapping, consisting of adjacent residues on the surface
of the same protein chain. The size of structure-based patches can be defined based
on an empirical interface size (Jones and Thornton (1997) define the patch size for
every complex to be equal to the observed interface size in that complex), fraction of
the protein surface (Bradford and Westhead (2005) define patch size as a circle with
6 − 8% of the surface area in a complex), or based on a fixed sphere radius of e.g.
10A˚ (Neuvirth et al., 2004) around patch centres (usually uniformly distributed over
the surface of a complex). Non-patch-based methods usually identify features on a
residue- or atom-level. This approach can, in effect be viewed as a special case of
minimal patch size – each residue is a disjoint patch; for examples of non-patch-based
interface predictors, check Liang et al. (2006) and Qin and Zhou (2007).
The way the surface of a protein is sampled from fragments influences their classifi-
cation into surface or interface fragments. The advantage of using small fragments,
(i.e. patches with one residue at a time) is the lack of overlap between neighbouring
patches, and an unambiguous classification of training examples into interface or sur-
face classes15. Larger patches on the other hand, overlap to some extent with other
patches and with the interface. This requires a ranking system for patches predicted
to be in the interface: there are bound to be several patches labelled as interface and
a metric has to be introduced to distinguish more likely hits among them. Also, to
label the training examples, a (somewhat arbitrary) threshold has to be introduced
defining which patches will be labelled as interface in the training phase: here a 50%
surface overlap with the known interface was used. The advantage of larger patches is
that some kind of shape property can be defined, providing more signal from which
the classifier can learn. All points considered, it made sense to survey a range of
patch sizes when searching for the most appropriate model.
15a one-residue patch can either be an interface residue, or be a surface residue
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The results presented in this chapter cover a range of sizes for structure-based patches,
from single-residue patches in the Pnr res, to small patches in Pnr 9 and large patches
Pnr 14. These three datasets had 500543, 398531 and 319658 patches, respectively.
None of the datasets had a minimum size of patch specified, i.e. a Pnr 14 patch could
contain examples with only one residue provided no other surface residues were found
within the 14A˚ distance. The single-residue dataset of patches contains a lot more
patches owing to the way the datasets were built: Pnr res contains a patch for every
surface residue (residues with rASAm > 5), while in Pnr 9 and Pnr 14 a patch was
created for every patch centre (residues with rASAm > 25).
Patch size was deliberately chosen to be smaller than the average interface, thus not
using the r = 16 (see Table 5.5), because the final prediction is destined to be used
at a residue level in SAAPdb; the aim was to get a decently performing predictor,
rather than perfect the prediction of the whole interface. Moreover, Pnr 9 and Pnr 14
patches resemble ‘hot regions’ (residues within 10A˚ distance), defined by Keskin et
al. (2008). Several hot regions comprise an interface; effects of mutations in residues
within a hot region are cooperative, while effects among hot regions are considered
additive. Thus, mutations within each patch can be observed as an independently
evolving unit, once interface prediction is added to the SAAPdb pipeline.
5.3.2.1 Small patches
The minimal patch size was determined empirically, based on the smallest observed
interface in the PQSnr dataset. The dataset of non-redundant chains was sorted
by the size of interfaces identified using the solvent accessibility decrease criterion
(Section 4.1.2). Each interface was then manually inspected using RASMOL (Sayle and
Milner-White, 1995), in ascending order of interface sizes, to find the minimum size
likely to present a biologically plausible contact between two protein chains, rather
than crystal contacts PQS failed to identify and remove. The smallest interfaces
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satisfying several conditions16 contained 6 or 8 amino acids, see Figure 5.3, which, if
the interface was considered to be an ideal circle on the protein surface, corresponded
to a patch radius of 9A˚. Therefore, when building small patches using the algorithm
defined in Section 5.2.1, a patch radius r = 9A˚ was used, aiming for patches which
should be smaller or the same size as the smallest interface.
Figure 5.3: Smallest observed interfaces.
Interface residues are shown in spacefill mode. A) PDB ID: 3CR3 (heterodimer)
6 and 10 interface residues in chains A and D, respectively. B) PDB ID: 1CZY
(homotrimer) 8 residues on chains A and C. C) PDB ID: 2QMS (homodimer)
8 interface residues on chains A and B.
5.3.2.2 Large patches
Large patches were created to resemble the minimum patch size needed for an inter-
face core to occur according to Bogan and Thorn (1998). This was 600A˚2 per chain,
which corresponded to a circular patch with radius of r = 14A˚.
5.3.2.3 Single-residue patches
Single-residue patches were used in the following section to characterise interface and
surface residues in PQSnr, for all properties except planarity. By definition, shape
indicators need coordinates for the set of nearby residues, to determine the local
shape of the protein surface.
16surface complementarity, tight interchain packing and literature confirmation of a biological unit
CHAPTER 5. PROTEIN-PROTEIN INTERFACE PREDICTION 193
5.3.3 Combining interface attributes
Each patch was initially assigned two types of values: a class value (interface or
surface patch, defined in Section 5.2.2) and eight attribute values each corresponding
to a sequence-, structure- or profile-based property identified in Section 4.3.2.8 to
be a valid predictor: amino acid propensity, hydrophobicity, planarity, secondary
structure, disulphide bonds, hydrogen bonds, sequence conservation based on FOSTA
alignment and sequence conservation based on BLAST alignment.
All interface properties except the class and the secondary structure were numerical
by definition; Table 5.6 summarises the ranges of patch values per attribute. Sec-
ondary structure was originally a categorical attribute with three possible outcomes
for Pnr res: helix, strand or other; or four possible values for Pnr 9 and Pnr 14: he-
lix, strand, helix/strand, or other. This attribute was transformed into three/four
binary attributes as described in Section 5.2.2.2, consequently increasing the number
of structural interface features to 8/9, respectively.
Table 5.6: Attributes used for model building.
str, F and B refer to attribute combinations, listed in the text below.
Attribute Variable type Value range
Propensity (str) Numerical (continuous) [-1.04, 2.37]
Hydrophobicity (str) Numerical (continuous) [-4.50, 4.50]
Planarity (str) Numerical (continuous) [0.00, 7.88]
Secondary structure - helix (str) Numerical (binary) (0,1)
Secondary structure - strand (str) Numerical (binary) (0,1)
Secondary structure - helix/strand ∗(str) Numerical (binary) (0,1)
Secondary structure - other (str) Numerical (binary) (0,1)
Hydrogen bonds (str) Numerical (continuous) [0.00, 1.00]
Disulphide bonds (str) Numerical (continuous) [0.00, 1.00]
FOSTA conservation (F ) Numerical (continuous) [0.00, 1.00]
BLAST conservation (B) Numerical (continuous) [0.00, 1.00]
Class Categorical (binary) (I, S)
∗ defined for patches in Pnr 9 and Pnr 14
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5.3.4 Choosing the most appropriate machine learning method
5.3.4.1 Survey of classifiers using WEKA
Before focusing on a particular machine learning method, all supervised classifiers
implemented in WEKA (Hall et al., 2009) were trained on the dataset Pnr 9 (using
ALL attributes) without changing default parameter values, to validate the choice of
the dataset and the attributes. The overall performance of unoptimised classifiers on
the Pnr 9 dataset, presented in Figure 5.4, was comparable to previously published
protein-protein interface prediction methods in Table 5.3, confirming sufficient size of
the Pnr 9 dataset and predictive power of the implemented interface attributes.
All methods displayed relatively high specificity (∼ 0.9) with somewhat lower sensi-
tivity (∼ 0.4). In other words, classifiers were more likely to miss an interface residue
than report a false positive: a favourable behaviour when the aim of the classifier is to
indicate mutations in predicted interface sites. The best single indicator of a model’s
performance is the Matthew’s correlation coefficient (MCC)17. Again, the majority
of methods have similar, albeit mediocre MCCs of ∼ 0.4, indicating the chosen pa-
rameters have some (although by no means exhaustive) predictive value. No clear
preference for numerical (regression models) versus binary classification (trees and
other rule-based models) methods was noticeable from performance measures.
Further, none of the produced models was an obvious choice significantly outper-
forming other methods used in this survey, nor the previously built methods for
protein-protein interface prediction, introduced in Section 5.1.2.
Considering that no WEKA models were particularly successful ‘off-the-shelf’,
when compared either with previously published interface predictors listed
in Table 5.3 or compared with other models built in this survey, further
17as it uses all four counts from the confusion matrix for a binary classification problem: TP , TN ,
FP and FN , for more details see definition of MCC in Section 5.1.1.4
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Figure 5.4: A survey of machine learning tests used on interface data.
All nine performance measures were defined in Section 5.1.1.4. Each presented
score for a model is an average of 10 scores obtained during 10-fold cross-
validation.
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analysis focused on optimising two learners, chosen for their different
learning methodology, and previous strengths shown on similar data mining
problems.
A multilayer perceptron was chosen as a representative of the numerical models, pro-
viding a numerical score between 0 (non-interface surface) and 1 (interface): this
method, introduced and discussed below in Section 5.3.4.2, has already proven its
efficacy in protein-protein interface prediction in SPPIDER, cons-PPISP and the
Fariselli method. A random forest was chosen as a binary classifier representative:
this method was shown to outperform decision trees, and at the same time it provides
the structure of the model in a tree-like form which is more intuitive to interpret
in a human-readable fashion (unlike the weights in the hidden layer of multilayer
perceptrons). Random forests have proven useful recently for similar structural pre-
dictions, the efficacy in prediction of protein-protein interfaces is discussed below in
Section 5.3.4.3.
5.3.4.2 Neural network prediction
Predicting protein-protein interfaces by building a neural network was investigated by
using the MultilayerPerceptron method in WEKA, with the classification cut-off set
to 0.5. Originally the model was set to have 5 hidden layer nodes (H = 5), butH = 50
was also tested with no improvement in performance, yet a 10-fold increase in the time
required to build the model. Therefore all results presented in Table 5.7 contained
five nodes in the hidden layer (for more details on the experimental setup refer to
Section 5.2.3.1), varying three patch sizes, and five combinations of attributes (the
four introduced in Section 5.3.3, plus STR+F with all missing FOSTA conservation
scores removed, hereafter referred to as STR + F ∗). The latter attribute setup was
used to test whether the lack of missing values affects performance of this neural
network; it is worth noting here that this dataset is significantly smaller, consisting
of around 20% of the patches.
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Table 5.7 presents the results of this range of models, grouped by increasing patch
size. First, the overall prediction model quality (measured by the increase in MCC, F,
AUC, and decrease of RMSE and MAE, for definitions see Section 5.1.1.4) increases
as the patch size grows. Single-residue patches had the highest specificity, at the
expense of very low sensitivity: this model highly favours outputting the ‘S’ class,
thus the significant drop in the correlation coefficient. Using current definitions of
interfaces and attributes, residue-based prediction of interfaces is not efficient.
For all three patch sizes, the best overall performance measures were achieved when
at least some evolutionary information was added: ALL, STR + B and STR + F ∗,
clearly outperformed STR. Finally, the removal of patches lacking FOSTA-based
conservation (STR + F ∗) improved MCC and AUC scores and reduced both error
rates, when compared with STR + F . In other words, modelling interfaces using a
larger training dataset where one of the attributes was often missing (FOSTA values
were missing for 79% of instances), is less profitable than eliminating the instances
with missing values, even when the MultilayerPerceptron method claims to handle
missing values18.
To conclude, the multilayer perceptrons developed here for Pnr 14 with ALL,
STR + B or STR + F ∗ attributes seemed promising candidates for benchmarking
against cons-PPISP and SPPIDER, the results of which are presented below, in
Section 5.3.5.
5.3.4.3 Random forest prediction
Random forest provides a majority vote class based on an ensemble of trees each
independently trained to predict an interface on a subsample of the training dataset.
As previously mentioned in Section 5.1.1.7, random forest has two adjustable param-
eters, which have been tested over a range of values for the Pnr 9 dataset, and results
18the input node for the attribute with the missing value will output zero for that instance
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are presented in Table 5.8. All tests in this section have been performed on signif-
icantly smaller datasets; during model building, this algorithm is unable to process
instances with missing values, so by default it would substitute missing FOSTA-
based (all ∼ 80% of them) conservation scores with the mean value for this attribute.
To avoid that, all instances with missing FOSTA values have been removed, creating
datasets with 104989, 85277, 69865 patches for Pnr res, Pnr 9 and Pnr 14, respectively.
None of the other attributes had a significant frequency of missing values to need fil-
tering. The models were built on the full datasets as well (data not shown here),
yielding 2-5% lower accuracy, specificity, precision and correlation coefficient, and a
1% increase in sensitivity with respect to the values reported in Table 5.8.
The results of the random forest parameter space search showed minor changes in
performance when the number of trees and randomly chosen attributes are varied.
Although there was an improvement when the number of trees was increased from
100 to 125 and 150, it did not justify the significantly longer time to build these
models. In terms of mtry, varying between the choice of a random 2, 3 or 4 attributes
during each split made no discernible difference, but when increased to mtry ≥ 5,
the performance deteriorated. The grey line listed twice, first in Table 5.8 and again
in Table 5.9 represents the same test, to be used as the baseline for comparison of
different parameter combinations. To conclude, the default parameters of T = 100
and mtry = 3 proved to be optimal, and were used further to test performance for
various patch sizes and attribute combinations.
For all three patch sizes in Table 5.9, random forest models show the largest oscil-
lations in performance when the list of predictors used during training is changed:
structure-only based models have the lowest prediction power, with some improve-
ment when either FOSTA- or BLAST-based conservation is added, and the best per-
formance is obtained when both conservation scores were added (the ALL attribute
setup). While there is obviously some overlap between these two conservation scores,
they complement each other19. However, contrary to the expected performance
19one reflecting long-term evolution, the other only functionally-equivalent proteins
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presented in Table 4.3, it seems the BLAST-based conservation (STR + B) is more
informative than the FOSTA-based one (STR + F ). Not surprisingly, adding two
non-orthogonal features (in ALL) improves the performance: a feature typical for
the random forest.
Single-residue models clearly favour surface over interface class, outputting many
TN and FN and not many FP and TP. Consequently, these models have low MCC
indicating almost non-existent correlation between the predicted and the real class
value. To conclude, the optimal random forest interface prediction is obtained for
large patches (Pnr 14) with one, or preferably both conservation scores added to the
structural interface features.
5.3.4.4 Random jungle
An alternative implementation of random forest algorithm called Random Jungle, RJ
(Schwarz et al., 2010) was initially tested20, but was abandoned for inferior speed
and lack of missing value handling capabilities, in comparison with the WEKA im-
plementation. However, RJ provides a list of importance measures, a convenient
feature not currently supported by WEKA’s random forest method. The importance
measure was introduced in Section 5.1.1.7: in short, it is a numerical indication of
how much performance deteriorates if that attribute were to be removed from model
building.
An RJ model was built for the Pnr 9 dataset using ALL interface features, and default
100 trees and mtry = 3. The order of interface feature importance provided by the
RJ algorithm is presented in Table 5.10:
20the main difference being WEKA RandomForest builds an ensemble of trees using RandomTree,
while RandomJungle uses the CART algorithm to create trees
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Table 5.10: Interface attributes, ordered by importance.
The higher importance score indicates more likely misclassification if that at-
tribute is randomly permuted among instances in the model.
Importance Attribute
7096 Amino acid propensities
5530 Planarity
5403 BLAST-based conservation
4704 FOSTA-based conservation
1846 Hydrophobicity
327 Hydrogen bonds
289 Secondary structure (C)
281 Secondary structure (H)
258 Secondary structure (E)
16 Disulphide bonds
To conclude on various machine learning models built above, all implemented
methods indicate that models benefit from including sequence-based, structural and
profile-based attributes. While the attribute with the highest importance is purely
sequence-based, the second most informative interface feature is planarity which
requires a high-quality protein structure to be available. Aside from hydrophobicity
and planarity, other structural features had little effect: these properties might
be poorly correlated with the appearance of interfaces, or simply not have been
appropriately defined. Further, in the current experimental setup, the performance
increases with the patch size, similarly to the work by Porollo and Meller (2007)
smoothing attribute values over spatial neighbours increases the ability to predict
protein-protein interfaces.
Contrary to conclusions reached in Chapter 4, both neural networks and random
forests show improved performance when structural data are complemented
by BLAST, when compared with STR + F . It was expected that using fewer
homologues more likely to be conserved in terms of protein function will be more
informative in context of interface prediction than broadening the alignments by less
recently diverged homologues, some of which may have evolved to have alternative
function and thus potentially display alternative evolutionary restrictions on the
contact residues.
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It turns out that the abundance of homologues in BLAST-based alignments21 com-
pensates for the introduced diversity. While for the neural networks direct comparison
cannot be made (STR+F has lots of missing values so it is not surprising STR+B
outperforms it; STR + F ∗ is trained on a much smaller dataset than STR + B), in
the case of random forests this trend is clearly discernible. While it was no surprise
that data containing information about the long-term evolution was more informa-
tive, this trend also proved to be very convenient as FOSTA data are scarce, and
regular updates (to make them more abundant) are computationally costly.
5.3.5 Comparison of interface prediction methods
The goal of this section is to compare machine learning approaches presented in
Sections 5.3.4.2–5.3.4.3 with already existing methods, in a clear and reproducible
way. As previously mentioned, virtually every experiment differs in the set of inter-
faces used, definition of interfaces and patches, attributes, and/or what constitutes a
successfully predicted instance, an independent evaluation of methods should be per-
formed using classical benchmarking, previously introduced in Section 5.1.1.5.
Further complicated by no standard datasets of protein-protein interfaces, it was not
surprising to find only one review paper (Zhou and Qin, 2007) reporting comparison
of several interface-predicting tools. In it, Zhou and Qin showed significantly lower
performance on an independent set of proteins that has not been used in the training
set in any of the methods compared: accuracy was reduced by between 4.8 and 18.2
percentage points, while coverage showed an insignificant decrease. However, both
the datasets they used were fairly small, and the larger Enz35 dataset overlapped
with some of the tested methods, thus raising questions about applicability of these
benchmark results on future structural data.
21E < 0.01, for more details on how alignments were built and which sequences they contained,
see Section 4.2.4.1
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5.3.5.1 Benchmark dataset of complexes
One approach to ensure all the complexes in the benchmarking dataset have not
been used before, is to obtain complexes added to the PDB after the last evaluated
method was published. Here, the complexes for the PQSall dataset, (defined in
Section 4.2.1.1) were obtained in March 2009, and PQS was revisited in January
2010, extracting all complexes published in the PDB and automatically added to
PQS in the meantime. This yielded 91529 chains, a 4% increase over PQSfiltered.
The same percentage increase was obtained when the chains were culled into clusters
of > 25% sequence similarity using PISCES (introduced in Section 2.2.5). This
indicates that the PDB is steadily growing in terms of new protein families.
4204 chains in 1306 novel protein complexes passed the data quality filters listed in
Figure 4.2. These chains were all used for benchmarking, i.e. no same-cluster repre-
sentative selection by PISCES was neccessary, yielding a benchmark dataset used to
test the performance of various classifiers, hereafter termed PQSbench. Conveniently,
all prediction models evaluated here precede structures included in PQSbench, ensur-
ing a truly independent test of generalisation powers for various interface-predicting
models.
5.3.5.2 Performance of various predictors
Protein-protein interface-predicting methods listed in Table 5.3 were applied to ob-
tain their predicted classes for all residues in the PQSbench dataset. The PPI-Pred
online tool was inaccessible owing to technical reasons, thus eliminating this predictor
from the analysis. Further, the PINUP website has been discontinued, allowing the
download of the stand-alone predictor. However, this method is indirectly assessed
through the meta-PPISP tool: meta-PPISP provides a linear combination of PINUP
and two other prediction models listing their scores with the consensus class.
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The results of the remaining surveyed methods: ProMate, PIER, PINUP, meta-
PPISP and SPPIDER were compared with the three best-performing neural networks
and three random forests chosen in Sections 5.3.4.2 and 5.3.4.3, respectively. Their
performance on the PQSbench dataset is listed in Table 5.11. Only residues labelled
as interface or surface by the method were considered, since PQSbench only includes
interface and non-interface surface residues.
Table 5.11: Compared performance of several interface classifiers. Previously published
methods are shown separated from classifiers developed in Sections 5.3.4.2–
5.3.4.3
ACC=accuracy, PREC=precision, SPEC=specificity, SENS=sensitivity,
MCC=Matthew’s correlation coefficient, F=F-measure. The highest and the
lowest score in every column are shown in blue and red, respectively.
Method ACC PREC SPEC SENS MCC F
ProMate 0.780 0.401 0.987 0.031 0.058 0.057
PIER 0.754 0.511 0.932 0.214 0.207 0.302
SPPIDER 0.759 0.472 0.783 0.676 0.410 0.556
PINUP 0.772 0.459 0.927 0.220 0.199 0.298
meta-PPISP 0.755 0.499 0.902 0.300 0.245 0.375
NN(ALL) 0.729 0.785 0.878 0.545 0.455 0.644
NN(STR+B) 0.727 0.787 0.881 0.538 0.452 0.639
NN(STR+F∗) 0.726 0.781 0.876 0.541 0.449 0.640
RF∗(ALL) 0.771 0.803 0.922 0.522 0.500 0.633
RF∗(STR+B) 0.760 0.789 0.920 0.497 0.474 0.610
RF∗(STR+F) 0.769 0.793 0.917 0.526 0.495 0.632
? instances with missing FOSTA value removed - 21% of the original dataset remained
ProMate (Neuvirth et al., 2004) is a Bayesian predictor trained exclusively on tran-
sient interfaces, therefore testing it on a mixed set of both obligate and transient
interfaces (i.e. PQSbench), might not be the best indication of how well it performs
the duties for which it was built. However, this evaluation is informative in the
SAAPdb context: it provides a measure of how well this classifier would perform
within the SAAPdb structural pipeline as PQSbench represents an average set of
chains to be added to the SAAPdb database. Although it displayed admirable per-
formance during cross-validation (70% accuracy with 63% sensitivity), testing it on
somewhat different data indicated this model has been overfitted: Zhou and Qin
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(2007) achieved accuracy of 38% for 50% sensitivity using the Enz35 dataset. Sim-
ilarly, ProMate did not perform well on PQSbench: with the default p > 0.70 score
(as suggested by Neuvirth et al.), it failed to predict a single interface residue for
49.8% of chains in PQSbench, favouring lower probability output scores, and in turn
predicting most test instances as surface residue.
PIER (Kufareva et al., 2007) groups heavy atoms of a protein into 32 categories, based
on their chemical properties, then trains a partial least squares regression model. PLS
regression combines principal component analysis and multiple regression in order
simultaneously to predict several mutually dependent class attributes, using a large
number of independent training attributes (Geladi and Kowalski, 1986). Kufareva et
al. (2007) reported 60% accuracy for 50% sensitivity during cross-validation; however,
when tested on PQSbench PIER outputs a high rate of ‘surfaces’, displaying poor
correlation with the actual class (MCC = 0.2).
PINUP (Liang et al., 2006) is a linear combination of three scores: amino acid propen-
sities (found to have the strongest individual prediction power of the three scores
used), conservation score and energy-score; the latter also being a linear combina-
tion of several elements originally developed by Liang and Grishin (2004) in order
numerically to characterise representative amino acid conformations (i.e. rotamers).
Trained on the same dataset as ProMate, it was reported to achieve 44.5% accuracy
and 42.2% coverage during leave-one-out cross-validation. In other words, it predicts
interfaces more often than ProMate, and therefore, is more often wrong in predic-
tion of interfaces. In the Zhou and Qin (2007) review, PINUP slightly outperformed
ProMate on both of the datasets, justifying the choice of all three scores which seem
more appropriately to represent interfaces than ProMate’s attributes of choice.
The PINUP raw score was obtained during meta-PPISP analysis of PQSbench (see
below), and a 0.50 cut-off point was introduced to indicate a residue predicted as in-
terface by PINUP, avoiding the patch-building, clustering, and patch-ranking-based
residue scoring. In this setup, PINUP showed a low correlation with the actual
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interface residues in the PQSbench set, rendering it inappropriate for interface pre-
diction based on this revisited performance.
Finally, the last tool used during benchmarking, building a predictor straight from
features of interfaces (in contrast to meta-PPISP which reuses previously developed
predictors) was SPPIDER (Porollo and Meller, 2007). This is a neural network
trained on a combination of structural and sequence-based scores with added differ-
ence between observed and predicted (by SABLE) solvent-accessibility. This proved
to be the most robust of all the surveyed methods: during cross-validation Porollo and
Meller achieved 63.7% accuracy with 60.3% sensitivity, which deteriorated to 33%
accuracy for 50% sensitivity in the Zhou and Qin benchmarking on Enz35. While this
classifier shows somewhat lower specificity than PIER and ProMate, indicating it is
more likely to predict a false positive, the overall performance measured by MCC and
the F-measure show significant improvement over the other two methods. The success
of SPPIDER in benchmarking additionally confirms that the solvent-accessibility of
a residue should be added to the list of interface predictors.
As mentioned above, one meta-predictor was also surveyed: meta-PPISP is a linear
combination of three previously defined interface-prediction models (Qin and Zhou,
2007), chosen for their maximal methodological difference in order to make the linear
regression as informative as possible. Combining the cons-PPISP (Chen and Zhou,
2005), Promate and PINUP scores, it expectedly outperforms each of these methods
utilised alone on the PQSbench dataset, however the MCC and F-measure indicate it
is still inferior to SPPIDER and all six models developed on the PQSnr dataset.
In summary, ProMate, PIER and PINUP were not very efficient in predicting in-
terface sites on the PQSbench dataset, while meta-PPISP displayed only slight im-
provement. The six models built in this chapter all clearly outperform these pre-
viously published methods and, when composite performance measures (MCC and
F-measure) are considered, are superior interface predictors even to the current state-
of-the-art structure-based interface prediction method: SPPIDER. Therefore, the
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best among the six, RF∗(ALL) will be added to the SAAPdb as the first mutation
effect based on a predictive model.
5.4 Conclusions
As previously stated, the main motivation behind this project was not to discover
something novel or revolutionary; rather, the focus was on completing existing knowl-
edge, and providing a robust method which would be easily applicable and maintain-
able within the SAAPdb pipeline. In that respect, this work shows that paying
attention to small inconsistencies is well worthwhile: after removing the most com-
mon pitfalls observed in previously published methods, a predictor outperforming
the competition was created, even without full model optimisation (addressed be-
low).
The dataset of interfaces gathered in the previous chapter was not without flaws:
during the manual inspection of small interfaces in Section 5.3.2.3, it was noticed that
PISA and PQS often differ in the orientation of monomers predicted in homodimers,
often with the PISA assembly making more sense in terms of biological activity, i.e.
creating larger and thus more stable interfaces, not occluding functional sites, etc. As
previously mentioned, there is a plan to re-build the predictors on PISA complexes
before incorporating this work into the SAAPdb.
Further, the class of non-interface surface residues is based on a negative observation;
in other words, there is no guarantee that the residues not involved in contacts we are
testing for at the moment are not involved in contacts with other, currently unknown,
interacting partners. However, once sufficient knowledge is obtained on all protein-
protein interactions, the need for this type of interface-predictor will disappear as
well. This methodological flaw is widely accepted in all interface-prediction models,
and the only current way to address it is to gather large amounts of training instances
for the model to process and be able to differentiate between the two classes.
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On a similar note, sampling the surface in the search of interface-characteristic fea-
tures using patches might result in obtaining patches simultaneously including pieces
of several interfaces, when a complex consists of more than two chains. The inter-
face datasets mostly consisted of binary interfaces; nevertheless this issue should not
be ignored. To that end, patches with varying sizes have been prepared: favouring
smaller patch radii was expected to minimise the occurrence of multiple interface
patches. Surprisingly, it turned out this issue is not relevant within the experimental
setup presented in this chapter: larger patches yielded better performance, with no
corrections for multiple interfaces in the same patch.
The obvious way to obtain an improved prediction is to use ever growing number of
complexes in the PDB; based on the results presented in the last two chapters, there
are additional routes to achieve improved prediction performance: (i) testing patches
larger in size, (ii) including solvent-accessibility and protrusion as predictors, (iii) ex-
panding amino acid propensities to profile-based propensities, (iv) testing various
thresholds for rASAo interface-surface overlap. Expansion of this project in these
directions was stopped owing to time restrictions.
The field of protein-protein interface prediction is extensive: constantly new meth-
ods, interface-distinguishing features and models appear. Nevertheless, it seems the
efficacy of these prediction methods has reached a plateau: even the best ones have
accuracy of 75-80%, specificity of 80-90%, correlation between the predicted and the
observed class from 0.4 to 0.5, and F-measure ∼ 0.6. With the limited data available
on which to train models, one approach to improve this level of performance is either
to narrow down the range of interfaces analysed and predicted (e.g. focus on either
transient or obligate interfaces), or to impose functional or structural restrictions
on the dataset (e.g. by considering only one family of proteins such as antibodies, or
just transmembrane proteins). However, the widely accepted enhancement is to start
combining methodologically-different interface predictors in meta-predictors, similar
to the approach of Qin and Zhou (2007) in meta-PPISP.
Chapter 6
Conclusions
The SAAPdb project aims to gather and analyse single amino acid polymorphisms,
and assess them in terms of effects these mutations are likely to have on protein
function, stability, folding and interactions. When the work presented in this thesis
started in October 2007, this resource was just published (Hurst et al., 2008), and
a new release was being prepared1, processing mutation data from 12 sources listed
in Table 2.1, testing for 16 structural effects and sequence conservation (listed in
Table 2.2). In the meantime, SAAPdb has undergone some major changes and a new
release is expected shortly. Consequently all results presented here are based on the
2008 release.
This chapter is structured around the two main goals of the SAAPdb project: data
collection and analyses (Section 6.1), and the expansion of SAAPdb methodology
(Section 6.2), ending with a look into the future in Section 6.3.
1made available to public in early 2008 via http://www.bioinf.org.uk/saap/db/
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6.1 Analyses of mutations
After the publication of the first draft of the human genome in 2000, and the devel-
opment of cheaper and faster second-generation sequencing platforms in 2005, a lot
of focus has turned to human genomic variation, resulting in an explosion of data
sources and tools processing these data.
This thesis focuses on exploring data already existing in SAAPdb. Chapter 3 presents
an analysis motivated by a specific evolutionary phenomenon: compensation of mu-
tations through epistatic interactions with other mutations, often also termed ‘fitness
reversal’. This analysis found that compensated mutations occur in more solvent-
accessible residues, and on average have milder effects when compared with uncom-
pensated disease-associated mutations (DAMs) (Baresˇic´ et al., 2010), which was in
accordance with previous findings by Ferrer-Costa et al. (2002). Finally, based on
the conservation of residues surrounding DAMs, it showed compensation appears
through random genetic drift, while uncompensated DAMs tend to occur in more
conserved structural environments.
A similarly conceived analysis2 was performed on a set of mutations in kinase do-
mains, provided by our collaborators (Izarzugaza et al., 2011), but has not been
described in this thesis. This highly populated family of proteins is involved in sig-
nal transduction, cell-cycle regulation and tumourigenesis. It has been shown that
kinases have unusually conserved structural features considering the heterogeneous
spectrum of sequences they adopt (Knight et al., 2007): a compromise between the
restrictions at the structural level neccessary to perform a specific task (i.e. bind-
ing ATP and transferring the phosphate group), and the specificity in binding to a
wide range of proteins targeted for phosphorylation. While the SAAPdb analysis
showed some family-specific trends, i.e. an increase in pathogenic kinase mutations
in interface residues and more neutral than pathogenic kinase mutations creating
2a subset of SAAPdb mutations of specific interest was compared with the remaining (background)
mutations, resulting in subset-specific preferences for the structural effects.
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destabilising voids in the protein structure, the unexpected finding was a significant
decrease in the number of structural consequences detected for kinase mutations,
when compared with the general frequency of annotation in SAAPdb mutation data
(Izarzugaza et al., 2011).
This fact has an interesting implication: while being broad, the spectrum of structural
features for which SAAPdb tests could still be expanded, since clearly some kinase-
specific restrictions on mutation positions exist, which SAAPdb is not capable of
identifying. Finally, the work on CPDs and kinases resulted in a series of scripts
automatically extracting a SAAPdb subset and creating a summary of trends for it,
which is potentially useful for future collaborations with experimental groups.
On the level of mutation entries, an obvious enhancement would be to add genomic-
level information, where available. For example, codon usage information might be
useful to experimentalists surveying known mutants in order to create novel mutants,
while the information on the allele frequencies might be informative during drug
design, targeting a special structural effect. Additionally, rather than just covering
SAAPs (i.e. mutations within the exons), SAAPdb would benefit from adding single
nucleotide variations in promotor regions, enhancers, mRNA splice sites, regions
of mRNA stabilised by secondary structure, etc. Indeed, Martin group has plans
to expand SAAPdb and provide mutations in non-coding regions of the genome as
well.
The primary limitation in expanding the coverage of publicly-available mutation data
is the lack of a standardised data format. While an appropriate format exists in the
form of the LOVD system (Fokkema et al., 2011) and is widely recommended as a
versatile and secure tool for human variation storage, its use is limited: only 54%
(842/1550) of LSMDBs in the Human Genome Variation Society’s repository3 have
been built using LOVD. Further, this tool is less than ideal for use during the SAAPdb
data gathering step, as it does not provide any option for bulk download of mutation
3http://www.hgvs.org/dblist/glsdb.html
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data or web services access to the data. Consequently, considerable time is spent
building dataset parsers, rather than utilising human variation data to identify new
trends.
6.2 Methodology utilised to analyse single amino acid
polymorphisms
SAAPdb links genomic-level information on single amino acid polymorphisms with
the phenotype data (i.e. the level of pathogenicity of a single amino acid polymor-
phism), by providing information on the intermediate level: it sets out to explain
which structural effects are caused by the single nucleotide variation that leads to
the observed phenotypic effect, or lack thereof.
Chapters 4 and 5 present a novel structural analysis, set out to increase the coverage
of mutations in protein-protein interfaces, stemming from the relatively low frac-
tion of multichain protein complexes in the Protein DataBank. Trained on a range
of previously identified (and then confirmed in Chapter 4) sequence-based, struc-
tural and evolutionary parameters, the RF∗(ALL) random forest model presented in
Chapter 5, when assessed on an independent set of interfaces not seen by any of the
predictors during training, outperforms all previously developed interface-predictors.
This also authenticates the choice of the PQSnr dataset as a representative set of
protein-protein interfaces, as well as the features identified in Chapter 4.
It is worth noting here that this new predicted interface category is the first pre-
dictive structural effect to be added to SAAPdb; all others are based on calculations
performed from structural or sequence information, and thresholds imposed on these
calculations. Once it is incorporated into the next version of the SAAPdb, it will
be interesting to see what will be the gain in coverage of mutations in interface,
in comparison with using three previously implemented categories: interface, pqs
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and binding, all of which rely on the presence of structures of complexes. Provided
this addition to the pipeline proves useful, other similar prediction methods can be
developed to complement the existing set of structural categories.
6.3 Future prospects
Unfortunately, the way SAAPdb was originally built is becoming increasingly incom-
patible with the rapid accumulation of mutation data. In effect, each time mutation
data are updated, the whole database is rebuilt from the ground up, every time
with more data to process. A more logical approach would be to apply structural
analyses to one mutation (or all mutations in one protein) at a time, thus enabling
incremental updates. Moreover, this might be offered as a web service in which a
user provides a novel single amino acid polymorphism and, provided the appropriate
protein structure is available, gets the range of structural effects, calculated in real
time, as an output. Further, SAAPdb currently outputs a categorical output based
on a cut-off for every effect, e.g. a void category will output ‘affecting’ if the largest
created void in the structure is greater than 275A˚3, and ‘ok’ for all values below
that threshold. Some of the SAAPdb categories (e.g. void, clash) would be more
intuitively described on a continuous scale.
To conclude, at present4, even after many other tools providing structural details
on single amino acid polymorphisms have been made available (for an overview see
Section 1.2.3), SAAPdb offers a plethora of additional information for a mutation
besides its mapping to protein sequence and structure: a large selection of precalcu-
lated structural effects and visualisation of mutations mapped onto the protein struc-
ture. However, as the field and the amount of gathered knowledge on SAAPs grows,
the focus is shifting to pathogenicity prediction. Indeed, some preliminary work
on the predictive power of SAAPdb categories performed by McMillan (2009) and
Ledda (2011) showed promising results: performance of classification with regards to
4three years after its original publication
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pathogenicity was comparable to, or better than, methods reviewed in Section 1.2.3.1,
and this aspect of the project is being actively developed at the moment. Once models
of satisfactory performance are built, the Martin group can move on to test them on
experimentally-obtained, independently-evaluated sets of mutations by participating
in the Critical Assessment of Genome Interpretation (Callaway, 2010).
In the meantime, the work presented in this thesis can be finely tuned and expanded
to enhance the understanding of the topic. All results obtained for compensated
mutations will have to be recalculated once the new, significantly enriched, dataset is
provided within the new release of SAAPdb. Moreover, Figure 3.7 indicated that the
FEP sequences containing neutralised mutation that is detrimental to humans can be
grouped into prokaryotic, eukaryotic and mammalian FEPs; it will be interesting to
expand this study and check whether these three groups have different preferences in
terms of compensation mechanisms. The protein-protein interface predicting model
can be enhanced in several ways, several of which have been proposed in Section 5.4,
covering further parameter optimisation, considering additional interface predictors
and alternate input data encoding.
As previously stated, the motivation behind the interface prediction modelling project
was to expand the list of effects covered by the SAAPdb. The model RF∗(ALL) pre-
sented in the Section 5.3.5.2 outperformed the previously published interface residue
classifiers on the benchmark dataset, and this model will be added to the next update
of the SAAPdb as the 18th category. Unfortunately, at the time of writing of this
chapter5, the SAAPdb was under severe reconstruction, addressing issues listed at
the beginning of this section. This initiative will result in more robust database, and
easier addition of new mutation datasets, and categories of effects. Once this upgrade
is completed, the predicted interface category will be incorporated into the struc-
tural pipeline of the SAAPdb. Next, propensities of neutral and disease-associated
SAAPs for occurence in predicted protein-protein interfaces will be calculated, and
compared with the trends of previously implemented interface categories, presented
5September 2011
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in Figure 1.8. In addition, a test will be performed to assess whether compensated
pathogenic deviations occur more/less often in predicted interface sites than uncom-
pensated disease-associated SAAPs.
The field of bioinformatics is still relatively new and growing. Covering the recent
advances across this field proves to be challenging for a person in regular contact
with it, let alone for the less computer-adept among the wet-lab scientists. Yet,
the latter are exactly the target group for whom most of the tools are currently
developed. The future of in silico analyses is in their easy use and combination,
which is facilitated through platforms like ICENI (Cohen et al., 2005) and Taverna
(Hull et al., 2006): methods incorporated into one of these frameworks are easily
combinable into workflows of in silico experiments. In turn, this eliminates data
parsing (storing and preparation), a tedious step when standardised data formats
such as XML and JSON are not utilised.
In summary, this thesis has investigated CPDs, showing that they have characteris-
tics which, on average, are distinct from uncompensated PDs, giving us insite into
mechanisms of evolution. Secondly it has developed a new form of analysis (predic-
tion of interface residues) that can be incorporated into the SAAPdb pipeline and,
as part of that, has developed a carefully filtered set of protein interfaces for training
prediction methods.
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